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“A school should be the most beautiful place in every town and village – 
so beautiful that the punishment for undutiful children should be  
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Dedicated with love and respect to my parents – without whom I would not be here 
And to all my friends, who make it worthwhile to be here 
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Abstract 
 
The aim of this dissertation was to investigate the possibility of synthesising small 
nitrogen heterocycles using solid-phase techniques, exploiting the properties of the  
novel, hydrophilic solid phase Versabeads. 
  
Chapter 1 contains a general introduction to solid-phase chemistry and describes how 
Process Chemistry has the potential to benefit from the employment of solid-phase 
techniques in the initial scale-up of a drug candidate. The scope and problems 
concerning the use of solid-phase chemistry on a larger scale in the synthesis of small 
organic molecules are discussed. 
 
Chapter 2 is a description of the development of the synthesis and use of two known 
solid-phase linkers: the REM linker and the carbamate linker, as well as the use of 
these two linkers in syntheses of piperazine derivatives.  
 
The development of a gram-scale synthesis protocol of a series of N-aryl and N-aryl-
N’- methyl piperazines based on the immobilization of bis(chloroethyl)amine on resin 
through the carbamate linker is described in Chapter 3. The scale-up to 0.19 mol 
reaction scale of a synthesis of an aryl piperazine on resin is demonstrated, as well as 
the possibility for reuse of the resin. 
 
During the work on the piperazine-forming reaction an interesting side reaction was 
discovered, which formed a previously unknown imidazolidin-2-one through 
cyclative cleavage. The investigations into the scope and mechanism of this reaction 
are reported in chapter 4. 
 
Chapter 5 concerns the use of the solid phase as a support for meso-
tetraphenylmetalloporphyrins, a well-known class of catalysts in organic chemistry. 
Two different meso-tetraphenylporphyrins were successfully immobilized on the resin 
and metallated with manganese. When tested as catalysts in the aqueous oxidation of 
sulphur, good conversions were obtained but the catalytic complexes appear to be 
cleaved from the resin under the reaction conditions. Attempts to synthesise 
porphyrins directly on the resin proved unsuccessful. 
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Dansk resume 
 
Det arbejde der beskrives i denne afhandling havde til formål at undersøge 
mulighederne for at syntetisere små nitrogenheterocycler ved hjælp af fastfase kemi 
på den nye, hydrofile resin Versabeads. 
 
Kapitel 1 giver en generel introduktion til fastfasekemi og beskriver hvordan 
Proceskemi muligvis kan udnytte denne teknik til den indledende opskalering af 
synteser af nye lægemiddelkandidater.  
 
Kapitel 2 beskriver arbejdet med at udvikle fastfasesyntese baseret på to kendte 
linker-strukturer: REM linkeren og carbamat – linkeren. De to linkere bliver testet i 
syntesen af et antal piperazin-derivater. 
 
Kapitel 3 omhandler udviklingen af en synteseprotokol til syntese af en serie N-aryl 
og N-aryl-N’-methylpiperaziner, baseret på bis(chlorethyl)amin immobiliseret på 
resinen gennem carbamatlinkeren. En af disse synteser bliver opskaleret til 0.19 mol 
skala. Desuden bliver mulighederne for at genbruge resinen undersøgt. 
 
Under arbejdet med at udvikle piperazinsyntesen viste der sig en interessant 
sidereaktion. Der blev dannet en hidtil ukendt imidazolidin-2-on forbindelse ved 
cyklativ kløvning fra resinen. Mekanismen bag denne reaktion bliver undersøgt 
nærmere i kapitel 4. 
 
I kapitel 5 undersøges resinens egenskaber som fast fase bærer af meso-tetraphenyl 
metalloporphyriner, der er kendte komplekser med katalytisk aktivitet. To forskellige 
meso- tetraphenylporphyriner bliver bundet kovalent til resinen og kompleksbundet 
med mangan. De herved dannede katalytiske komplekser er effektive katalysatorer for 
oxidation af sulfider, men synes at kløves fra resinen under reaktionsbetingelserne. 
Forsøg på porphyrinsyntese direkte på resinen viste sig ikke at give resultat. 
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Abbreviations 
 
Ac = acetyl 
AAS = Atomic Absorption Spectroscopy 
Ar = Aryl 
ATR = Attenuated Total Reflection 
BINAP = 2,2’-Bis(diphenylphosphino)-1,1’-binaphthyl 
boc = tert-butyloxycarbonyl 
dba = dibenzylacetone 
DBU = 1,8- diazabicyclo[5,4,0]undec-7-ene 
DCM = dichloromethane 
DIC =  N,N-diisopropylcarbodiimide 
DIPEA = diisopropyl ethylamine 
DMA = dimethylacetamide 
DME = diethylene glycol dimethyl ether 
DMF = dimethyl formamide 
dppf = 1,1’-bis(diphenylphosphino)ferrocene 
ELSD = Electronic Light Scattering Detection 
Et = ethyl 
Fmoc = 9-Fluorenylmethoxycarbonyl 
FTIR = Fourier Transformated Infra Red  
GC = gas chromatography 
HOBt = 1-hydroxybenzotriazole 
HPLC = high pressure liquid chromatography 
iPr = isopropyl 
LC/MS = Liquid Chromatography/Mass Spectrofotometry 
MAS = Magic Angle Spinning 
Me = methyl 
MeCN = acetonitrile 
Mes = 2,4,6 – trimethylphenyl     
MIBK = Methyl isobutyl ketone 
Ms = methanesulfonyl 
MODDE =  
nBu = n-butyl 
nPr = n-propyl 
NIR = Near Infrared Spectroscopy 
NMP = N-methylpyrrolidone 
NMR = Nuclear Magnetic Resonance 
o-tol = 2-methylphenyl 
PEG = poly(ethylene glycol) 
Ph = phenyl 
REM = Regenerated Michael (linker) 
tBu = tert-butyl 
THF = terahydrofuran 
TPFPP = 5,10,15,20 –tetra(pentafluorophenyl)porphyrin 
TPP = 5,10,15,20 - tetraphenylporphyrin 
Ts = tosyl 
UV = ultraviolet
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1 Introduction 
 
1.1 Pharmaceutical development – the need for speed 
1.1.1 Overview of the drug development process 
 
The development of a marketable new drug is a long and complicated process. From 
the time the idea is first realised until the final product is ready for approval by the 
authorities the average time span is 10-12 years and the costs exceed US$ 800 millon. 
(Figure 1).1, 2 
 
 
 
 
 
 
 
 
Figure 1: A schematic overview of the Drug Development process, with a 
scheme of the intensity of Process Chemistry work at different stages.1 Note that 
the workload is highest in the initial stages of development. 
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The vast majority of the drug candidates nominated for further development are 
eventually discontinued on the grounds of not being active enough or having 
undesirable side effects.  As an estimate based on the Research & Development 
process at H. Lundbeck A/S, only 3-4 % of the initial compounds to enter the 
development phase will ever develop to a marketable drug (Figure 2).3-5 
 
 
 
 
 
The pharmaceutical industry today is facing pressure from many sides. The increased 
competition means that new drugs have less time to prove their worth before new and 
better alternatives are marketed. Increased concerns over drug safety, and rising costs 
of medical care have led to higher demands for documentation by the authorities, 
mainly in the form of expensive clinical trials, and demands for lower prices. 
Furthermore generic competition is becoming more and more aggressive. 6, 7 
 
In the highly competitive climate of the pharmaceutical market, it is more important 
than ever that a pharmaceutical corporation is able to identify and develop new 
compounds into marketable drugs fast – and to identify and discontinue unmarketable 
drugs and compounds as soon as possible. 
Figure 2: The drug development “funnel”. Only about 3-4 % of the compounds 
selected for development make it to marketing.3 
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1.1.2 The role of the Process Research department 
 
The department of Process Research occupies a central role in the drug development 
process. When a new potential drug compound is transferred to the Process Research 
department it is said to move from the discovery phase to the development phase. This 
is very fitting as the resources and expenses associated with the project rise 
dramatically after this point. 1 
 
When a compound is selected for development the mission of Process Chemistry is 
twofold: 
 
1. To produce 200-300 g of the compound as soon as possible for the big four 
weeks toxicology test. 
2. To develop a route suitable for kg scale production according to the rules 
for Good Manufacturing Practice (GMP) and by that route make 20 kg of 
compound for the first doses in humans. 
 
 
The primary objective during the preceding Discovery phase, by contrast, is to 
produce a large range of compounds of interest in relatively small amounts within a 
short period of time. As a result, it is unsurprising that the synthetic methods used to 
produce the compounds at this stage are unsuited for larger scale production. Typical 
problems include low yielding or highly exothermic reactions, the use of toxic, 
sensitive or expensive reagents, and a significant focus on chromatography for all 
solution-phase purification steps. Therefore, in the development phase a prime focus 
is on developing new routes or methods that can be used for multi-gram and kg-scale 
synthesis of the compound. This consists in part of finding cheaper and less toxic 
starting materials and reagents, and purification methods more amenable to scale up 
(such as crystallisation). This can be a difficult process, and therefore has the risk of 
becoming a bottleneck in the overall development process. 
 
As in every step of pharmaceutical discovery and development some compounds will 
always fail the initial four-week toxicology test and be discontinued. An established 
flexible technique for fast initial scale-up to about 200 g would therefore be desirable, 
as it would potentially lower the process research work cost involved in developing a 
whole new kg-scale synthesis route for a drug, which does not make it to clinical 
testing. 
 
One common technique, which was invented with the specific purpose of lowering the 
time for synthesis work, is the solid-phase chemical synthesis technique. 
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1.2 Solid phase Chemistry 
1.2.1 The concept of solid phase chemistry 
 
“Such a system offers four main advantages: it simplifies and accelerates the 
multistep synthesis because it is possible to carry out all the reactions in a 
single reaction vessel, and thereby avoid the manipulations and attendant 
losses involved in the repeated transfer of materials; it avoids the large losses 
that normally are encountered during the isolation and purification of 
intermediates; it can result in high yields of final products through the use of 
excess reactants to force the reaction to completion; and it increases salvation 
and decreases aggregation of the intermediate products.”8 
 
When Prof. Merrifield described this, for a synthetic chemist, almost utopian system 
in his Nobel lecture, it had already been known and used for more than 20 years, and 
had become a routine technique in the synthesis of peptides and other biopolymers.9, 10 
The idea was as simple as it was ingenious. Peptide synthesis had been in rapid 
development since 1953, where du Vigneaud had accomplished the first peptide 
synthesis,11 but the development was hampered by the time-consuming procedures 
and the low solubility of heavily-protected intermediate peptides. By linking the 
peptide covalently to a solid support of polystyrene cross-linked with divinyl benzene 
(later known as Merrifield resin), the intermediate tedious and difficult purification 
steps were replaced by simple filtration (Figure 3). In this manner, Merrifield and his 
co-workers were able to synthesize large peptides such as bovine insulin in a matter of 
days.12 The method could even be automated, leaving the chemists even more time to 
think great thoughts.13, 14 
 
X X X
X
Linker Linker
Linker
Starting
material
Linker Product
Cleavage
Product
 
 
Figure 3: Traditional solid-phase synthesis. The starting material is immobilized on 
the reactive polymer (usually through some kind of added functionality, a linker) 
and the reaction steps are performed with filtration and wash between each step. The 
product is then cleaved from the resin, similar to deprotection in solution- phase 
reactions. 
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In spite of these obvious advantages, solid-phase chemistry was for a long time almost 
exclusively used for the synthesis of biopolymers such as peptides and 
oligonucleotides,15 although a few examples of small-molecule synthesis were 
attempted.16  
The reason for this reluctance to apply the method more broadly might be rooted in 
the limited number of analysis methods available to follow the reactions in solid-
phase chemistry. The usual chromatographic techniques for reaction monitoring are 
unavailable, and extra cleavage steps must be added, if a traditional analysis of 
intermediates is desired. Indeed one of the referees on Merrifields original paper 
expressed the opinion that solid-phase synthesis “should be shunned, as it violated the 
basic principles of synthetic organic chemistry, i.e. isolation and characterization of 
intermediates.”10 
 
This changed during the nineties when the development of new screening methods 
made it possible to screen millions of compounds for biological activity every year. 
The need for a technique, able to meet the demand for a large number of potential 
drugs outweighed the disadvantages and solid-phase combinatorial chemistry soon 
became an important tool in the pharmaceutical industry. 17, 18 
1.2.2 Combinatorial chemistry and high throughput screening 
 
Combinatorial chemistry is, simply put, the change from linear synthesis to branched 
synthesis. Instead of a synthesis where A is reacted with B to give C, A is reacted with 
a multitude of different compounds, thereby increasing the output exponentially with 
each step (Figure 4). Such a large number of reactions need to be performed with 
some degree of automation in order to be efficient, and here the easily-automated 
solid-phase technique held great potential.17, 19 
 
A
AB
AC
AD
ABE ACE ADE
ABF ACF ADF
ABG ACG ADG
B
C
D
Split
and 
mix
E
F
G
 
Not surprisingly the idea of combinatorial chemistry first emerged in peptide 
chemistry, where a number of different building blocks with comparable chemistry, 
the amino acids, were readily available. Peptides and other biooligomers are, 
however, not usually the best drug candidates, due to their low bioavailability and 
stability.17 The first solid-phase combinatorial synthesis of a small biologically-active 
molecule was published in 1992 by Bunin and Ellman20, leading to a very rapid 
Figure 4: Combinatorial chemistry through the popular “split-and-mix” strategy, 
where a solid-phase bound starting material (A) is reacted with three different 
compounds (B, C and D). The resins are then pooled and split up again for 
reaction with three new compounds (E, F, and G) resulting in the generation of 
nine new, structurally related compounds simultaneously. 
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development in the field of solid-phase synthesis of small molecues (MW< 600).15, 17, 
21, 22 
 
1.2.3 Multigram- and kg-scale solid-phase synthesis 
 
Multigram- and kg-scale synthesis of biopolymers on solid-phase has been a well-
established technique for many years. 23, 24 Today large-scale syntheses of 
biopolymers such as peptides 25 and oligonucleotides26-28 on solid phase are carried 
out routinely. Recently the first example of a multi- ton, partially solid-phase 
synthesis of a peptide-based drug (the Roche anti-HIV drug Fuzeon) was published. 
29, 30   
 
Larger-scale synthesis of small drug molecules on solid phase, however, remains a 
relatively unexplored field. Dr. Stephen Raillard of Affymax published his pioneering 
work on the scale-up of small molecule synthesis in 1999, 31 the idea being to save 
time in development, by capitalizing on the experiences gained in the combinatorial 
(solid-phase) discovery phase. Using high loading Merrifield resin (4.4 mmol/g), he 
and his co-workers produced three reasonably-complicated nitrogen heterocycles in 
high yield and purity over the course of a week – including the time used for linking 
the starting material to the resin (Scheme 1). 
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Scheme 1: Solid-phase synthesis of a diketopiperazine on multigram-scale by Ugi – 
reaction after Raillard et al. 31 a) Merrifield resin (3.9 mmol/g), CH3OOOK (1.5 
equiv), 2-methoxyethanol, reflux, 16 h. b) NaOH (2 equiv), dioxane/water (1:1), 
reflux, 16 h. c) Fmoc-valine (3 equiv), pyridine (3 equiv), 2,6-dichlorobenzoyl 
chloride (3 equiv), NMP, r.t., 24 h. d) 20% piperidine/NMP, r.t., 30 min. e) n-
pentylaldehyde (3 equiv), Boc-phenylalanine (3 equiv), cyclohexyl isocyanide (3 
equiv), DCM, r.t,,  15 h, f) (1) trifluoroacetic acid/DCM (1:1); r.t., 1h; (2) Acetic 
acid (1%), MeCN, r.t, 2 x 3 h; (3) 4% triethylamine/MeCN. Yield (from hydroxyl 
resin) 79 % 
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Raillard et al. made a number of important observations in this study:  
 
1. The established literature procedures could be used on larger scale with only 
minor modifications 
2. The simplified washing procedures greatly reduced the total synthesis time. 
3. Multistep reactions could be completed within a few days, yielding product 
with a purity > 90 % 
4. High concentrations of compound could be employed, meaning that low 
excesses of reagent (1.5-2 equiv) could be used without compromising yield 
and purity of the final product. 
 
A later synthesis by Meisenbach et al of Novartis 32 took a route originally developed 
for a combinatorial library synthesis, and scaled it to > 70 g scale (55 %) on modified 
Merrifield resin with few complications (Scheme 2). 
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A solution-phase route that was developed for comparison purposes gave lower yields 
(21-34%) on a similar scale. The principal problem observed in solution was the low 
solubility of the hydroxyketone intermediate, a phenomenon not encountered in the 
solid-phase route.  
 
Scheme 2: Meisenbach et al’s 70 g-scale solid-phase synthesis of a pyrimidine:32 a) 
Aminopolystyrene (4.48 mmol/g), Linker I (1.5 equiv), DIC (1.8 equiv), DMF, r.t., 16 
h; b) 20% diethylamine in DMF, r.t., 2 x 15 min.; c) 4-Carboxybenzaldehyde (1.3 
equiv), HOBt (1.3 equiv), DIC (1.5 equiv), DMF, r.t., 16 h; d) Acetophenone (1.5 
equiv), LiOH (0.5 equiv), THF/methanol (4:1), 23°C, 1.5 h.; e) Guanidine, 
hydrochloride (6 equiv), NaOEt (6 equiv), DMA, 100°C, aerobic atmosphere, 16 h; f) 
20% trifluoracetic acid in DCM and recrystallization from ethanol/water (9:1). Yield 
55% overall 
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As these two examples have shown, performing multi- gram scale chemistry on solid- 
phase holds many potential advantages as a rapid method for the generation of 
multiple grams of a small molecule.  
However, the disadvantages of solid-phase chemistry are still present. It is not 
possible to isolate and characterize the intermediates, and the progress of the reactions 
cannot be monitored by the traditional chromatographic methods. 
For scale-up using solid phases, other problems arise: large-scale solid-phase 
synthesis is usually performed in specialized equipment, such as reactors with fritted 
bottoms (the method used in the above mentioned examples) or as on-line automated 
synthesis, neither of which are common items in a scale-up or development 
laboratory. In addition, although the cost of standard Merrifield resin has dropped in 
recent years it would still be a significant extra expense. 
 
In order for a solid-phase route to be feasible as a routine technique on a larger scale, 
these problems will have to be adequately addressed. 
 
1.3 Resins in solid-phase chemistry 
1.3.1 The properties of the solid phase.  
 
The properties of the solid-phase used to support a chemical reaction are of great 
importance. The solid-phase can be considered an extra phase in which the reaction 
takes place, as most of the active sites of a resin are typically inside the bead. New 
parameters such as the ability of a reagent to diffuse into the bead, and reactions with 
the polymer framework must therefore be taken into consideration.33 
 
The typical resins used in solid-phase synthesis today are based on the cross-linked 
polystyrene resin originally developed by Merrifield. 19 Resin beads of a suitable size 
for reaction purposes were originally obtained by grinding down the polymerized 
product, but more uniform spherical beads are obtained nowadays by suspension 
polymerization, where the beads polymerise as a suspension in an inert media. With a 
careful choice of reaction conditions a high degree of control over the bead size can 
be obtained.15, 34Typical bead size (dry beads) is in the range 0.04 – 0.15 mm, 
however for some purposes, a larger bead size, so called macrobeads, is feasible.35, 36 
 
1.3.2 Swelling 
 
One of the most important parameters of a resin is the ability of the beads to expand in 
the solvent used for the reaction, thereby allowing efficient diffusion of reagents to 
the reactive sites. This property is referred to as swelling, as the bead size increases 
dramatically in such a favourable solvent. 19, 33 As previously mentioned most of the 
active sites in a resin bead are placed inside the resin, meaning that the ability of 
reagents to enter the resin is crucial. If the polymer is sufficiently swollen, reaction 
rates with reasonably non-polar reagents are usually not diffusion controlled and are 
therefore independent of bead size.37, 38 The swelling of resins can be conveniently 
measured by suspending the resin in the solvent in a fritted syringe for a while, then 
suck it dry and measure the volume of the resin (The syringe method).39, 40 
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Standard Merrifield resin is hydrophobic, and does not swell appreciably in a number 
of common solvents, including water and ethanol. 19 A lower degree of cross-linking 
will increase the swelling, but this tends to decrease the mechanical stability of the 
beads. 33 Although the use of standard Merrifield resin on a larger scale is feasible in 
spite of this drawback, it would be a huge advantage from a process chemistry point 
of view if non-toxic solvents such as water and ethanol could be used.  
1.3.3 Hydrophilic polymers 
 
Soluble-supported synthesis, where the reagent is bound to linear (not cross-linked) 
poly(ethylene glycol) (PEG) or another soluble polymer 19, 41 is one way of 
circumventing the swelling problem. The large polymer chain (>2000 g/mol) keeps 
the compound in solution until the synthesis is finished. The polymer is then 
precipitated by adding a solvent in which it is insoluble (e.g. heptane), after which it is 
possible to wash away impurities as with conventional solid-phase synthesis.  
In 1991 Dr. Ernst Bayer reported that he had linked PEG chains to Merrifield resin, 
thereby creating a solid phase compatible with the same broad spectrum of solvents as 
PEG itself. 42 Various PEG-grafted polystyrene resins, such as Tentagel™ 43, 44 and 
Argogel™, 45 are still frequently-used in solid-phase chemistry, due to their good 
swelling properties and convenience of use (Figure 5).  
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Polystyrene-PEG grafted resins, however, hold a number of drawbacks, the main ones 
being low chemical and mechanical stability, low loading and high cost, which 
generally precludes their use in the scaling up of small molecule solid-phase 
synthesis. 19 
 
Various derivatives of polyacrylamide have been used frequently as solid supports  
and are a cost efficient alternative to Polystyrene-PEG, 19 46 47 but they too suffer from 
low mechanical stability, which make them unsuitable for some applications, such as 
continuous flow synthesis48 and on-resin scale up.  
In the late nineties Meldal et al. developed a highly-stable hydrophilic resin based on 
Polyacrylamide cross-linked with PEG-based macromonomers (PEGA) (Figure 6). 
This new resin type was compatible with both polar and non-polar solvents, highly 
mechanically stable and comparatively cheap to produce. 39, 49-51 It was later marketed 
by VersaMatrix A/S under the tradename Versabeads A™.  
 
 
Figure 5: Tentagel™ and Argogel™.42-45 Polystyrene resins grafted with PEG
for better swelling properties. Argogel™ does not contain a benzylic ether group,
and is therefore more chemically stable.
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1.3.4 The SPOCC resin 
 
The capacity of PEGA was still low, with an average loading of 0.2-0.4 mmol 
available amino groups per gram, and the presence of amide groups in the framework 
means that the resin was not compatible with all chemical conditions (e.g. hydrolytic).  
 
 
 
Figure 7: Structure of epoxide based resin POEPOP and oxethane based resin 
SPOCC. 54 
Figure 6: Structure of the PEGA resin 
(Versabeads A)51 
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To circumvent this problem Meldal et. al. developed a new kind of polymer beads 
based solely on cross-linked PEG, through the ring opening polymerization52 of 
epoxide- and oxethane-capped PEG-based macromonomers. Of these two polymers, 
POEPOP53 and SPOCC54, SPOCC is the most stable, as it contains only alkane bonds 
and primary ether bonds (Figure 7).  
 
In later studies, where the properties of SPOCC and POEPOP were compared to 
traditional Polystyrene-PEG resins, the physical properties of the non- polystyrene 
containing resins were fully comparable to the much more expensive commercial 
brands (Table 1, Table 2). The diffusion rate of a test reagent was found to be 
somewhat slower in the non-polystyrene resins, but still in the same order of 
magnitude. 54-56 
 
 
 Amino- 
methylated 
polystyrene 
 
TentaGel ArgoGel POEPOP 
400 
SPOCC 
400 
SPOCC 
1500 
Bead size 
(μm) 
 
75-150 130 120-230 300-500 300-500 300-500 
Swelling 
in water 
(mL/g) 
 
- 3.8 2.8 2.5 3.5 6.0 
Swelling 
in THF 
(mL/g) 
 
7.2 2.8 5.0 2.5 2.5 4.5 
Swelling 
in MeCN 
(mL/g) 
6.7 1.8 4.4 2.5 2.5 4.5 
 
 
 
Table 1: Comparison of swelling properties of various commercially available resins 
with POEPOP 400 and SPOCC 400 and 1500 (values approximated from figure). 55 
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 Bead size 
(μm) 
 
Loading 
(mmol/g) 
Amount 
(g) 
Price 
(€) 
Price/equiv
(€/mmol) 
Rapp 
hydroxymethylated
polystyrene 
 
200-400a  1.5 100 360 0.240 
TentaGel 
 
130 0.3 100 1010 33.667 
ArgoGel 
 
120 0.5 100 1203b 24.06b 
Versabeads O 
 
100 -400 2.0 100 739 0.370 
 
 
For this study, three different SPOCC polymers were synthesized: SPOCC-400, 
SPOCC-900 and SPOCC-1500. The numbers refer to the molar weight of the PEG 
chain on the macromonomer. The polymers with longer chains showed better 
diffusion properties than those with shorter chains. The longer-chained monomers 
showed a tendency to form emulsions and aggregate during polymerization, which 
was later corrected by developing a new polymeric pentamethyldisiloxane surfactant, 
Polysurf. 57 (figure 10) 
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VersaMatrix A/S later marketed the SPOCC resins under the tradename Versabeads 
O™, with PEG chain lengths of 400 and 2000, with hydroxyl loadings in the area 
from 0.5 to 2.5 mmol/g.58-60 With their high mechanical stability, their high loading, 
their tolerance towards most reaction conditions and their reasonable price, the 
Versabeads can potentially be used in scaling up on solid phase, as described by 
Raillard and Meisenbach.31, 32 
Figure 10: Polysurf general structure.57 
Table 2: Price comparison for a number of standard resins. It should be noted that the 
commercially available TentaGel and ArgoGel bead sizes are usually much narrower 
distributed than Merrifield and Versabeads, a factor which contributes to the high 
price.a mesh size. b Price converted from US$ (1US$ = 0.83 €) 
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1.4 Functionalization – Linkers for large-scale solid-phase 
synthesis. 
 
A crucial point in any solid phase synthesis is the linker, the functionality that binds 
the molecule being synthesized to the resin. The linker can in many ways be 
compared to a protecting group in that its prime qualities are that it is stable under the 
reaction conditions employed in the synthesis and can be cleaved under conditions 
that do not adversely affect the product. As with protection groups, a number of 
different linkers have been developed over the years, for all kinds of functionalities 
and purposes.19, 61 
A linker for use in the solid-phase synthesis of small molecules on a larger scale must 
have some additional qualities. For economic reasons it must be cheap and easy to 
make and preferably reusable. It cannot be too large, as it would then decrease the 
loading of the resin and thereby reduce its cost-effectiveness. It should still be stable 
to the reaction conditions, but the cleavage conditions must be amenable for large-
scale synthesis using standard, general-purpose reactors. Examples of linkers that 
would be unsuitable for this purpose include many of the old linkers for peptide 
synthesis which were cleaved by hydrogen fluoride (a chemical generally to be 
avoided on larger scale) and photocleavable linkers, where the cleavage reaction is 
very difficult to scale.19 
 
1.4.1 Carbamate and Wang-carbamate linker 
 
The carbamate linker, generated from a resin-bound nucleophilic group and either 
phosgene or a phosgene equivalent, is a very popular linker for amines (Figure 11). 
As carbamates are also frequently used as protection groups in solution-phase 
chemistry, much literature exists on the formation and cleavage of various 
carbamates. It is not reusable, but as it is very small and comparatively cheap to make 
this is not really a problem. 
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The vast majority of the literature on solid-phase synthesis concerning the carbamate 
linker uses it in conjunction with the Wang linker, which gives an acid-labile 
combination, similar in reactivity to the p-methoxybenzyl carbamate group in solution 
chemistry.62 Standard Wang-linker carbamate cleavage conditions are 50% 
trifluoracetic acid in dichloromethane.19   
Figure 11: (A) Carbamate linker and(B) Carbamate linker combined with Wang 
linker 
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As the Wang linker is one of the most popular linkers in use today 19 its chemistry is 
well known, and many literary procedures exist for attachment of Wang- and Wang-
type linkers to PEG and PEG-based supports, both through nucleophilic addition or 
Mitsunobu reaction.45, 63-67 
 
An additional advantage of the carbamate linker is the possibility for cleavage under 
reductive conditions, thereby utilising the carbonyl carbon to create a tertiary (or 
secondary) methyl amine (Scheme 3).68 
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1.4.2 Sulphonic acid linker 
 
Derivatives of phenyl sulphonic acid are well-known protection groups for amides.62 
As the cleavage reaction is a simple hydrolysis the potential for reusability is clear. 
Resin-bound sulphonic acids are mainly used as scavengers for the removal of 
excesses of nucleophilic reagents, but a few examples of sulphonic acids as linkers for 
the solid-phase synthesis are known in literature (Sceme 4, Scheme 5).69-75 
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Scheme 3: Ho and Kukla’s synthesis of 1-methyl-4-phenylpiperazine on 
Wang/Merrifield resin68 a) N-methylmorpholine (3 equiv), 4-nitrophenyl 
chloroformate (3 equiv), r.t., overnight. b) 1-phenylpiperazine (5 equiv), 
diisopropylethylamine (5 equiv), DMF, r.t., overnight. c) Lithium aluminium hydride 
(10 equiv) in THF, 60°C, 14 h. Yield 84% (GC purity >95%) 
Scheme 4: A possible route to a sulphonic acid linker on SPOCC, originally 
performed on PEG soluble support.75  
Scheme 5: A sulphone linker in the synthesis of amines. 69 a) thiophenol, K2CO3, MeCN.
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1.4.3 boc- equivalents on resin 
 
The boc group is a very versatile protection group in organic chemistry. Examples of 
a solid phase analogue to the boc-protection group exist,76, 77 but as boc in solution is 
known to eliminate isobutene upon cleavage the easy reusability of this linker is a bit 
questionable. 
1.4.4 The REM linker 
 
The REM linker (REgenerable Michael linker) is based on the Michael-addition to 
α,β conjugated double bonds, and it is one of the few linkers available that produces 
tertiary amines upon cleavage. After the molecule is constructed on the resin, the 
nucleophilic atom used as an attachment point is made susceptible to elimination 
(typically Hoffmann elimination for amines, typically by quarternization), and cleaved 
under basic conditions (Scheme 6). 
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The original REM linker was based on acrylic acid, and has been used for the 
synthesis of number of compounds. The group at Organon, which originally 
developed the linker, has done extensive research on its properties, and synthesised 
several tertiary amines through electrophillic addition, transesterification and Stille 
Scheme 6: Synthesis of tertiary amines, here shown with an acrylic acid based 
REM linker on Merrifield resin after Morphy et al. Modifications on the resin 
bound amine before quaternization are not shown.79 
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Scheme 7: The synthesis of vinyl sulfone linker. 94 a) mercaptoethanol, Cs2CO3, 
DMF, r.t., 3 days. b) 3-chloroperbenzoic acid, DCM, r.t., 12 h. c) Mesyl chloride, 
pyridine, DCM, r.t. 2 h. d) base. 
chemistry.78-82 Of especial interest in the context of Versabeads is their discovery that 
water is a good medium for the quaternization reaction.81 
 
Other groups have worked with REM linkers, mainly in the synthesis of tertiary 
amines 83-87 A number of other kinds of compounds have been synthesised on an 
acrylic acid-based REM linker, including γ-lactams through intramolecular 
Mitsunobu,88 purines 89 and macrocycles. 90, 91 Experiments with resin reuse have 
shown good stability over 5 cycles.87 
 
Other Michael acceptor-based linkers have been developed with good results.92, 93 The 
most popular alternatives to acrylates are based on vinyl sulphones, which are 
inherently more stable to most reaction conditions than esters. Gani et al. made a 
sulphone based REM linker by oxidation of a resin-bound thioalcohol, followed by 
elimination (Scheme 7):94, 95  
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This linker has later been used in Pictet-Spengler synthesis on solid support.96, 97 
 
An equivalent to this linker has been made on SPOCC resin through a similar 
procedure. Here the objective was to make a safety-catch linker, where the linker is 
made labile before cleavage by oxidation of the sulphur atom (Scheme 8).98  
S
OH
S
O
O
NO2
S
O
O
NO2
O
O
O
O
S
O
O
NO2
OH
a) b) d)c)
e)
+
 
 
 
Another approach to the sulphone-based REM linker was that of Hainonen et al., who 
attached divinyl sulphone to hydroxyl-functionalized resin (Scheme 9) .99, 100 The 
addition of divinyl sulphone to PEG is a known reaction, as it has been investigated as 
a way to link PEG to proteins as a means of increasing the stability of the latter.101, 102 
 
Scheme 8: Synthesis of a vinyl sulphone linker on SPOCC as residue from a 
safety-catch linker.98 a) mesyl chloride, pyridine, DCM. b) 2-thioethanol, Cs2CO3, 
DMF. c) 4-nitrobenzoic acid, pyridine, DCM. d) 3-chloroperbenzoic acid, DCM. 
e) DBU, DCM.  
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Scheme 9: Synthesis of a REM-type linker from hydroxymethyl 
polystyrene and vinyl sulphone.99 a) Divinyl sulphone (excess), DBU 
(excess), r.t. overnight. Yield 40-50%  
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The REM-type linkers are specifically designed for reuse, and hold great potential for 
the purpose of large-scale solid-phase synthesis of amines. One limiting factor is, 
however, that the choice of quarternization agent seems to be restricted to the more 
reactive alkyl halides. An example of cleavage through an Oxidation-Cope 
rearrangement (to give hydroxylamines) is known,92 but otherwise good yields have 
mainly been obtained only with methyl-, allyl-, benzyl- and other acivated halides. 
 
1.4.5 Triazene-based linkers 
Bräse et al. have developed two reusable triazene-based linkers, Triazene 1 for the 
synthesis of arenes103 and Triazene T2 for the synthesis of amines. 104   
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Triazene T2 is comparatively simple to make, is reusable and its use in synthesis is 
well known.105-108 In 2004 a convenient large-scale synthesis of this type of linker was 
published.109 
Figure 12: Triazene-based linker T1 (for aromatic compounds) and T2 for 
amines, amides and ureas on Merrifield resin.103, 104 
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1.5 Analytical methods in solid-phase chemistry 
1.5.1 Analysis methods in general 
 
A major difficulty in solid-phase synthesis is the monitoring of the reactions and the 
characterization of the resin-bound intermediates and products, as the usual 
chromatography-based analysis methods are not available. Although a number of 
analysis methods have been developed successfully for the analysis of resin-bound 
compounds, 19, 110-114  all monitoring and analysis of a solid phase reaction can only be 
indirect, as no compounds are isolated between steps.  
 
For this project it was important to have a suite of reliable, multi-functional analysis 
methods, which could be easily performed without the use of special equipment not 
present in a typical scale-up and development lab. 
1.5.2 Cleave and analyze 
 
Treating a small sample of resin with a cleaving agent is an obvious way of getting 
information about the intermediates, and has been practiced with success in the 
synthesis of heterocycles on solid phase.115, 116 Methods that require very small 
cleavage samples have been developed.117 These methods are, however, time 
consuming and laborious, and require an additional step in the process, which might 
tamper with intermediates not stable to cleavage conditions. They are therefore best 
suited for monitoring of well-defined solid-phase reactions, such as peptide synthesis.  
 
1.5.3 Staining reagents 
 
Adding a reagent which changes colour upon reaction with certain functional groups 
is a very common qualitative (and in some cases quantitative) method of reaction 
monitoring, as it is fast, easy to carry out and does not require special equipment. The 
Kaiser-ninhydrin test for free amino groups has been a standard monitoring method in 
solid-phase peptide synthesis for many years (Scheme 10).118, 119 
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The Kaiser test is only sensitive to primary amines. Secondary amines and primary 
aromatic amines can be detected with other reagents, e.g. the chloranil and isatin tests. 
120-122 Chloranil has also been used for diffusion studies, by studying amino 
functionalized beads acylated at various reaction times, then stained with chloranil 
under microscope.56 
Other reagents have been developed for hydroxyl-,123, 124 thio-,125 carbonyl-,126 and 
carboxyl-127 groups, as well as for activated halogens128 The topic has been covered in 
several reviews. 19, 110, 129, 130 
On a larger scale, where it is generally not favourable to drive reactions to completion 
with large excesses of starting material, the staining reagents might be too sensitive, 
as most of them are designed to detect very small amounts of functional groups (For 
instance the Kaiser test can detect below 1 μmol of amino groups119) An attempt was 
made to confirm the formation of the carbamate linker through addition of ethylene 
diamine with a subsequent Kaiser test, but this proved unsuccessful as even unreacted 
Versabeads O gave positive test for amino groups. Later analysis by VersaMatrix A/S 
revealed that some amino group contamination was present on resin, possibly from 
the acetonitrile used as solvent in the polymerization step. This problem has later been 
corrected, and peptide synthesis on Versabeads has been successfully monitored with 
the Kaiser test.58 The initial negative result discouraged the use of staining reagents 
for further reaction monitoring in the course of the project. 
 
1.5.4 Addition and cleavage of UV-active compounds 
 
The addition and subsequent cleavage of a compound with known spectrophotometric 
properties is a well-established method for monitoring in solid-phase synthesis.110, 129 
Scheme 10: Mechanism of the Kaiser-ninhydrin test.119
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The common peptide protection group 9-Fluorenylmethoxycarbonyl (Fmoc)131 is 
commonly used for this purpose, as it forms a range of easily detected species upon 
cleavage. A real-time monitoring method based on Fmoc cleavage has been 
developed for peptide synthesis.132 The Kaiser test has been used for this purpose as 
well,119 although more reliable reagents have since been developed.110, 133 
 
The loading of the Versabeads was determined by the well-known Fmoc-glycine 
method, where Fmoc protected glycine is attached to resin, followed by cleavage and 
analysis of the adduct in solution (Scheme 11).134, 135 
 
OH
O
N
H
O
O
O
O
N
H
O
O
N
OH
a)
+
b)
UV-active
 
 
 
 
 
 
 
 
It was speculated that the attachment of a commercially-available mono-Fmoc 
protected hexandiamine could be used to determine the loading of chloroformyl linker 
on resin. However, as this was laborious, results were inconsistent, and the substrate 
was expensive, it was decided to abandon this method. 
 
Loading of primary and secondary amino groups has frequently been determined 
through addition of picric acid, followed by release of the salt and UV 
determination.136 An attempt to quantify the tertiary amine in resin-bound 1-
diphenylmethylpiperazine by this method gave results in the right order of magnitude, 
but with too large a spreading. Experiments with resin-bound diethanolamine might 
have been more beneficial.    
 
4-Nitrophenyl carbamates, which are commonly used in solid-phase synthesis as 
chlorocarbamate equivalents, form UV active nitrophenolates upon cleavage. This 
have been exploited previously for loading measurements and reaction monitoring 137-
139  4-Nitrophenyl was considered as a cheap alternative to Fmoc-glycine for loading 
measurements, but the method was not developed due to time constraints. 
 
Scheme 11: The Fmoc-glycine loading measurement method used to determine 
loading of Versabeads134,135 a) Fmoc-glycine, 3 equiv; 1-methylimidazole, 6 equiv; 
2,4,6-mesitylenesulfonyl-3-nitro-1,2,4-triazolide, 6 equiv; dichloromethane; rt; 1 
h, reaction repeated once   b) 20% piperidine in dimethyl formamide. UV-
measurements performed at 290 nm, and compared to standard.  
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1.5.5 Elemental analysis 
 
Combustion elemental analysis is one of the few methods available for quantitative 
determinations of product bound to solid phase. 19, 140, 141 Unlike the cleave-and- 
analyse method it has the advantage of not requiring additional steps. Yan et al. 
demonstrated that this method can be used to obtain a very reliable estimate of the 
yield in the various steps of a solid-phase peptide synthesis.141 This method was used 
frequently in the project, in order to determine the loading of halogen- and nitrogen-
containing species. The only disadvantages with this method were that it does not give 
any structural information and could not be performed in the laboratory. The method 
is also of course destructive, but the amounts required are minimal compared to the 
scale of the reactions. 
 
1.5.6 Atomic Absorption Spectroscopy  
 
Atomic Absorption Spectroscopy (AAS) is a common method for quantitative 
determination of metals. A liquid sample containing the metal is ionized in an 
acetylene flame and the metal content is determined by measuring the absorption of 
the light from an ion-specific hollow cathode lamp.142 The method has also been used 
to determine the metal content in resin-bound metal-containing catalysts.143, 144  
This method was used in the determination of the loading of metalloporpyrins on 
resin, and the amount of metal leaching into reaction solution from these. The resin 
samples were destroyed by heating in concentrated nitric acid, which was filtered and 
diluted to gain suitable analysis solutions. These were then measured against a 
standard curve of Mn.  
1.5.7 Potentiometric Titration – the Dorman Test 
 
The Dorman test is a method for determining the loading of amino groups on resin by 
treating the resin with pyridine hydrochloride, followed by neutralization and 
potentiometric titration with silver nitrate.145 This was initially considered as an 
alternative to elemental analysis for halogens, but was not implemented, as a chloride-
specific electrode was not readily available, and there was a question as to how to 
hydrolyze all resin-bound chloride efficiently. It might have been developed as an 
alternative to elemental analysis, by performing control titration analyses of resin 
samples of known chloride content. 
 
1.5.8  13C gel-phase NMR 
 
When resin is swollen, the resin-bound species approximate to a solution and are 
therefore visible in the NMR spectrum. In fact, most known NMR methods can be 
used to characterize resin-bound species, as demonstrated in a study by the Ley 
group.146 13C gel-phase NMR spectroscopy has been used extensively for the 
monitoring of solid-phase reactions,110, 113, 114 often as MAS (magic angle spinning) 
NMR,147, 148 or combined with 13C enriched compounds,79, 149-151 but often good 
spectral resolution can be obtained with Standard samples swelled in an NMR tube, 
and spectrum aquired in a similar manner to standard solution phase samples.146, 152, 
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153 Multiple scans are usually required, and the spectral peaks obtained will be broader 
than standard in solution due to the differences in relaxation time between inside and 
outside the resin. Despite this broadening, this analysis method holds the most 
potential for monitoring the reactions, being sensitive to a multitude of compound 
functionality, providing structural information, being non-destructive and not 
requiring other equipment than a standard NMR spectrometer. 
13C gel-phase NMR was after some initial studies implemented as the method of 
choice for the monitoring of species on resin. In the beginning of the project only 
overnight scan methods (13312 scans) were employed, but it was later discovered that 
a shorter ½ hour method (1024 scans) could often be enough for practical monitoring 
of reactions. Acquisition times of 7.5 min for certain optimized conditions have been 
reported. 152 
An especially interesting feature was the ability to estimate the extent of resin loading 
and cleavage from the resin by means of the ratio of the two carbon peaks closest to 
the resin’s terminal hydroxyl group, which shift very characteristically, depending on 
whether the group is derivatized or not (Figure 13). 
 
 
  
 
 
 
 
1.5.9 1H MAS NMR 
 
The gel phase technique cannot be applied to 1H NMR spectroscopy, due to the short 
relaxation times of protons, which make the differences in magnetic properties too 
great for traditional NMR. This can be avoided by spinning the swollen sample in the 
β 
β 
α 
α 
Figure 13: 13C gel-phase NMR spectra of Versabeads O 400 (top) and derivatized 
resin (bottom) in deuterochloroform. Note the change in position of the carbons α- and 
β- to the oxygen atom. α moves from 61 ppm to 64 ppm and β from 72 ppm to 69 
ppm. In practice the β- carbon peaks will often be obscured by the large framework 
peak at 70 ppm  
OH
OR
α
αβ 
β 
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“magic angle” (θ = 54.7°), whereby the macroscopic dipolar interactions are averaged 
out. MAS NMR is today a routine tool in the monitoring of solid-phase reactions in 
combinatorial chemistry.19, 110, 113, 147, 148, 154, 155  
SPOCC – derived resins have shown favourable qualities in 1H MAS NMR compared 
to standard Merrifield, due to their flexibility and lack of aromatic groups. 55, 147, 155 
However MAS NMR requires special equipment and trained personnel, and is 
therefore not as easy to implement as a routine monitoring technique as 13C gel-phase 
NMR, which can be run with standard NMR equipment.  
 
1.5.10  19F NMR  
 
NMR active heteronucleii can be used for monitoring the reaction, as the resin 
framework will not interfere with the NMR spectrum of heteroatoms in gel phase. The 
most common nucleus to be used in this fashion is 19F19, 110, 156, 157, but other NMR 
active nuclei, such as 15N 158 and 31P 159 have also been used. The 19F NMR 
monitoring method does not need to be limited to the solid-phase synthesis of 
fluorine-containing compounds. For instance it is possible to “tag” a linker with 
fluorine, thereby obtaining a quick way of monitoring addition and cleavage from the 
changes in the 19F spectrum. 160-163 19F spectroscopy has also been used for 
optimization work by attaching fluorinated reagents to linker and reagent and then 
comparing the peaks.81  
In the current project 19F gel phase NMR was used as part of the process to prove the 
formation of the chloroformyl linker, as well as to identify fluorine- containing 
species on resin.  
 
1.5.11 FTIR method 
 
FTIR is a much-used method for the investigation of reactions on solid phase as an 
FTIR spectrum can be obtained very quickly from a single bead. FTIR analysis does 
not give a clear picture of the compound structure, but it is one of the few methods in 
solid phase reaction monitoring which can be compared to the standard 
chromatographic methods used in solution-phase chemistry. 110, 112, 164-167 
FTIR was measured with the attenuated total reflection (ATR) technique, which 
allows measurement directly on the dry beads.164, 167. FTIR was extensively used in 
the beginning of the project to monitor attachment and cleavage from the resin judged 
by the C=O stretch. With the chloroformyl linker the change in absorption from 1776 
cm-1 to 1701 cm-1 could be used to determine if the carbamate was formed, while the 
difference between the stretch of conjugated and unconjugated ester C=O, from 1724 
cm-1 to 1734 cm-1 was used to monitor addition and cleavage from the REM linke 
(Figure 14) 
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The immobilisation and metallation of porphyrins on solid phase was also monitored 
by the use of FTIR, through the addition and later visible changes in the aromatic 
stretches. 
 
1.5.12 Near infrared spectroscopy (NIR) 
 
Near infrared spectroscopy (NIR) is often used at H. Lundbeck A/S to investigate the 
stability of drug formulations. This method has in some cases been used to investigate 
solid-phase chemistry as well.168 Attempts were made to use NIR in the current 
project, but the spectra obtained with the NIR machine at Lundbeck were not 
sufficiently resolved to provide useful information (Figure 15).169  
Figure 14: Addition of amine to REM resin causes the C=O stretch to move from 
1724 cm-1 to 1734 cm-1 due to loss of conjugation 
O
O
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1.5.13 Other methods – mass spectroscopy 
 
A number of special methods for solid phase reaction analysis based on mass 
spectrophotometry, such as MALDI-TOF, ion-spray MS and tandem MS have been 
developed as routine tools for monitoring solid-phase reactions, but these methods are 
rather specialised and were not considered for the project.19, 110 
Raman spectroscopy has been used for reaction monitoring on solid-phase but was not 
considered for the project, as no convenient probe was available.32 
Figure 15: A comparison between the NIR spectra of unfunctionalized Versabeads O400 
(purple spectrum) and Versabeads reacted with phosgene (green and red spectrum). The 
carbonyl group would be expected to appear at approximately 4-5000 cm-1. 169 
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1.6 Solid-phase synthesis equipment 
 
To avoid loss of resin between steps, solid-phase synthesis is usually performed in 
fritted reactors. Usually a normal disposable polypropylene syringe, equipped with a 
frit in the bottom and a valve at the outlet is used as a reactor (Figure 14). Solid-phase 
synthesis can be performed with normal flasks and filters, but the transfer of solid 
phase from flask to filter and back can be quite cumbersome. Automated on-line 
solid-phase synthesisers are available and are used frequently for large-scale synthesis 
of peptides and other biopolymers.25, 27, 28 
 
 
 
 
 
 
The resin is suspended in solvent and reagents are added in a manner similar to 
traditional solution phase synthesis. As most resins are susceptible to mechanical 
stress and therefore not compatible with magnetic stirring, the preferred agitation 
method is gentle shaking performed on a shaking board or by fixing the syringe to a 
wheel  
After the reaction has taken place the solvent is removed by suction filtration, and the 
resin is washed to remove remaining reagents. New reagents are added and a new 
cycle of react, filter and wash is performed  
When the final product is obtained on the resin, it is washed thoroughly to remove all 
traces of leftover reagent (usually until no reagent is detected in the washes). 
Cleavage reagents are then added and the filtrate, which now contains the product, is 
collected. The product is then isolated by traditional workup procedures. 19 
If heating is necessary, special Teflon reaction vessels are available, or, for larger 
scale synthesis, glass reactors, which are larger glass versions of the syringe, with a 
frit and a valve in the bottom (Figure 5, Figure 6). 19 31, 32 
Figure 14: Typical setup for solid-phase reactions. Syringes with fritting and a 
bottom valve are connected to a form of suction and a reservoir. 14 
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In the context of this project it was desirable to develop a technique, which employed 
a minimum of “unusual” equipment, not found in a normal development laboratory. 
The use of standard round-bottomed flasks and traditional fritted glass Büchner 
funnels for the filtrations and washings was possible, but cumbersome, and was 
discovered to be a potential source of loss, as the Versabeads had a tendency to cling 
to glassware. 
 
The solution to this problem was to employ a thin glass pipe closed in one end with a 
sinter. This allowed easy wash of the beads directly in their round-bottomed flasks 
through suction (Figure 16 and 17).  
Figure 15: Solid-phase reactors with a volume of 250 mL (A) and 1.5 L (B) used for the 
work of Meisenbach et al. They are equipped with a sintered filter in the bottom and a 
heat cape for temperature regulation.32 
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Figure 16: Glass tube with sintered 
end, used for purification between 
the steps in larger-scale solid-phase 
synthesis. 
Figure 17: Typical reaction setup for large-scale solid-phase synthesis in the 
current project. Note the sintered glass tube connected to a reservoir, which allows 
for easy washing and draining between steps. The tube is removed during reaction.
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2 Results and Discussion 
2.1 Synthesis of Versabeads 
2.1.1 Polymerization theory 
Versabeads are synthesised through cationic ring opening polymerization of oxethane-
capped macromonomers. When this reaction was developed by Meldal et al., it was 
the first time cationic polymerization was used in the manufacture of resins for solid-
phase synthesis.54 It is generally assumed that the ring-opening polymerization of 
oxethanes proceeds through nucleophilic attack on the α-carbon with simultaneous 
ring opening (Scheme 12). 52 
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The resin was made through suspension polymerization, a well-established technique 
for obtaining beaded polymers of a uniform size. A solution of the hydrophilic 
monomers and initiator is suspended in a hydrophobic medium (typically silicon or 
paraffin oil), and aggregates in small droplets, the size of which can be regulated 
through stirring speed and addition of surfactant.52, 170 Suitable hydroxyl 
functionalization was obtained by copolymerization between mono- and di-dioxetane 
capped PEG chains (Figure 16).54 
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Scheme 12: The polymerization of oxethanes to form Versabeads. Trace 
amounts of water needs to be present to supply the protons. In this case the 
polymerization is always initiated on methyl oxethanes, due to steric hindrance. 
Figure 16: Macromonomers used in the synthesis of SPOCC of the Versabeads type. 
The length of the PEG chain in the dioxethane monomer is determining for the 
properties of the resin. 
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2.1.2 The synthesis of monomers 
 
The two varieties of monomers necessary for producing a SPOCC resin were prepared 
according to in-house procedures from VersaMatrix A/S from custom-made, oxetane-
capped PEGalcohols obtained from Perstorp A/S. Unlike Meldal et. al. in their initial 
experiments, ethyl-substituted oxethanes were used, as they were commercially 
available.  
 
Two varieties of monomers were used for polymerization. The protected mono 
oxethane alcohol TOP30 (n=3) was protected with acetic acid anhydride under 
standard conditions to give monomer 1 in 71% yield (Scheme 13). The alcohol 
TOP120 (n=12) was capped with the tosylate of 3-(ethyloxethan-3-yl)methanol 2 to 
give 67 % yield of macromonomer 3 (contaminated with 3% (w/w) p-
toluenesulphonic acid) (Scheme 13). 
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Scheme 13: Synthesis of protected macromonomer (1) for SPOCC 
polymerization. a) Acetic acid anhydride (2.6 equiv), pyridine, r.t., 
overnight, 71% 
Scheme 14: Synthesis of difunctionalized macromonomer (3) for SPOCC. a) Tosyl 
chloride (1.2 equiv), NaOH (1.2 equiv), water/THF, 5°C, 3 h, 64%. b) 2 (1.2 equiv), 
potassium tert-butoxide (1.5 equiv), THF, r.t., overnight. 
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Scheme 15: Polymerization a) 44 mol% 1, 56 mol% 3, Polysurf 30 (1%),
BF3*OEt2 (0.2 equiv), acetonitrile, Ar atmosphere, - 20°C, then silicon oil,
250 rpm, 2 h, r.t., then r.t., overnight. b) Sieving and wash, then 4 M aqueous
HCl, 60°C, 2 h. 
 
2.1.3 Polymerization 
 
The polymerization reactions were carried out in a three-necked baffled flask34, 170 
using a procedure modified slightly from the one described by Meldal et al. 57, 59 A 
mixture of 44 mol% 1 and 56 mol% 3 was polymerized (Scheme 15) 
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Sieving of the resin product gave two major fractions, one the desired 120 – 80 μm 
diameter and one 80-40 μm diameter. Following deacetylation by heating in 4 M 
aqueous hydrochloric acid the hydroxyl loading of the resin was determined by the 
Fmoc-glycine method 135, 171 to be approximately 0.4-0.5 mmol/g (desired loading 
around 1 mmol/g). At a total yield of 15 g beads this meant a yield of 7.5 mmol 
hydroxyl groups, a yield of 33% of what was expected. It should be recalled that the 
polymerization process was still in the optimization phase at this point. 
 
2.1.4 Further work with SPOCC by VersaMatrix A/S 
 
The final Versabeads O products were produced through a different method. Instead 
of pure ethyl-substituted oxethanes as macromonomers, a mixture of ethyl- and 
methyl-substituted oxethans were used, as the pure ethyl-substituted oxethane 
alcohols were found to be less reactive. With a mixture of methyl substituted di-
oxethane capped macromonomers and ethyl-substituted mono-oxethane capped 
macromonomers a relatively uniform chemical structure could be ensured. The 
disubstituted macromonomers were synthesised from commercially available 3-
bromomethyl-3-methyloxethane and PEG of various chain length. Finally silicon oil 
was substituted by paraffin oil as polymerization medium out of economic 
concerns.58-60 As the physical and chemical properties of the resins were not found to 
depend significantly upon the synthesis pathway, the specific methods of resin 
synthesis and the type of starting material (methyl or ethyl monomers) have not been 
noted in the experimental.  
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2.2 Linker synthesis 
 
It was initially decided to investigate the carbamate linker and REM linker as linkers 
for amino functionalities on SPOCC resin, as they were deemed the most amenable 
for scale-up and reuse. 
2.2.1 Carbamate linker synthesis 
2.2.1.1 Synthesis methods 
 
The carbamate linker is most commonly prepared by reacting phosgene or a phosgene 
equivalent with a hydroxyl group on the resin, and thereafter with an amine. Various 
starting materials are available for this transformation (Table 3). 
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Entry Compound Available 
quantities 
Equivalents 
(mmol) 
Price 
(€) 
Price/equivalent
(€/mmol) 
1 A 500 mL 945 145.3 0.15
10 g 101a 44.4 0.442 B 
50 g 505a 164.3 0.32
3 C 10 g
50 g
250 g
50
250
1250
38.6
138
555
0.77
0.55
0.44
4 D 25 g
100 g
154
617
46.6
154.6
0.30
0.25
5 E 5 g
25 g
20
100
55.7
217.2
2.8
2.2
Table 3: Comparison of prices for phosgene and various phosgene equivalents. 
(after FLUKA, 2004-05) a1 mmol of B = 3 mmol of A. 
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2.2.1.1.1 Phosgene  
Phosgene (Table 3, compound A) is the cheapest and simplest reagent for the 
synthesis of a carbamate linker, and has been frequently employed for this purpose, 
usually as a solution in toluene.172-176 No additional base is needed. Phosgene is very 
toxic and volatile, and although the commercially available 20 % (w/w) toluene 
solution is fairly safe to handle in an efficient hood, some alternative form is 
preferable for use on larger scale. 
2.2.1.1.2 Bis(trichloromethyl) carbonate (triphosgene) 
Bis(trichloromethyl)carbonate (Table 3, compound B), also known as BTC or 
triphosgene, is a white crystalline solid which is obtained by the extensive 
chlorination of dimethyl carbonate.174, 177, 178 When exposed to base or heat it 
decomposes slowly to form 3 equivalents of phosgene.179-181 
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Triphosgene still develops the very-toxic phosgene, but it is markedly easier to  
control than the gaseous phosgene, and have been frequently used as a phosgene 
source, also on large scale.182 It has also been employed for the generation of solid- 
and solution-phase carbamate linkers in several instances 176, 183, 184 
 
2.2.1.1.3 p-Nitrophenyl chloroformate 
p-Nitrophenyl chloroformate (Table 3, compound C) is a popular and safe phosgene 
substitute for linking amines to solid phase via the carbamate linker.68, 137, 185-191 It has 
the added advantage of being easier to detect on resin, as it is clearly visible and 
distinct in the NMR spectrum. p-Nitrophenol is strongly coloured and the reagent has 
been used as a quantification agent for hydrophilic polymer similar to Fmoc 
glycine.137 Compared to phosgene and triphosgene it has the disadvantages of being 
more expensive and, as the p-nitrophenol ring is lost during carbamate formation, less 
atom economic as well.  
Scheme 16: Decomposition of triphosgene 178
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2.2.1.1.4 Other phosgene equivalents 
Carbonyl diimidazole (Table 3, compound D) is cheaper pr. mol than 4-nitrophenyl 
chloroformate, and has previously been used to generate a carbamate linker, 173, 192, 193 
but it loses two imidazole molecules in the process and was therefore rejected as not 
atom economic. 
Di-N-succinimidyl carbonate 194 (Table 3, compound E) has been used to generate 
carbamate linkers, but it is both more expensive and less atom economic than the 
alternatives. 
 
Salvatore et. al. used carbon dioxide in combination with amines to generate 
carbamate linkers in one step 195. This has the potential to be a good route to the 
carbamate linker, as it uses only non-toxic reagents and saves a step. However, the 
method was deemed to be too complicated to develop given the limited timeframe of 
the project. 
 
2.2.2 Synthesis and proof of concept. 
 
Triphosgene was initially chosen as the starting material for the generation of the 
linker, and was reacted with the freshly-prepared resin using pyridine as a base196 to 
give chloroformyl resin 4 (Scheme 17). 
 
O Cl
O
O
O OCl
Cl
Cl
Cl
Cl
Cl
OH +
a)
4  
 
 
The chloroformyl group was easy to identify in the resin FTIR spectrum as a sharp 
peak at 1771 cm-1,173 and elemental analysis for Cl yielded a loading of 0.3 mmol/g. 
The linker was not visible in 1H MAS NMR and 13C gel-phase NMR, but later 
attachment of N-methyl-N-benzyl amine175 (5) showed a change in the IR spectrum, 
where the carbonylic stretch had moved to 1705 cm-1 as expected (Scheme 18). 
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Scheme 17: Initial synthesis of chloroformate linker 4. a) triphosgene (8 equiv), 
pyridine (2.5 equiv), DCM, r.t., overnight. 
Scheme 18: Making a derivative of the chloroformate linker as proof of concept. a) N-benzyl-
N-methylamine (17 equiv), DIPEA (4 equiv), DMF, r.t., overnight. 
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Final proof of concept was achieved by reacting 4-fluoroaniline with 
chloroformylated resin and hydroxyl resin with 4-fluorophenyl isocyanate197, and 
comparing the 13C and 19F NMR spectra of the two products (6), which were found to 
be identical (Scheme 19) 
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In this synthesis the linker was made using phosgene in toluene as the starting 
material. It was not entirely sure which starting material was better, as a proper yield 
could not be established until a suitable cleaving reaction was found. 
 
2.2.2.1 Cleavage of the carbamate linker  
 
To investigate the properties of the new linker, 1-diphenylmethylpiperazine was 
chosen as a standard compound for attach and cleavage tests, because of its good UV 
absorbing qualities and characteristic aromatic proton NMR spectrum.  
Attachment of amines to the carbamate linker to form compound 7 seemed to proceed 
without difficulty, using the same conditions as Hauske and Dorff (excess amine and 
non-nucleophilic base) as judged by IR and CHN 173 (Scheme 20) 
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Cleavage of the linker proved more difficult. Initial experiments with the standard 
cleavage method for carbamate – Wang linker (50% trifluoracetic acid in DCM) 
Scheme 19: Proof of concept for the chloroformyl linker 4. a) phosgene (20% (w/w) 
in toluene, 9 equiv), THF, r.t., overnight. b) 4-fluoroaniline (24 equiv), 6 h, THF, 
r.t., 6 h. c) 4-fluorophenyl isocyanate (13 equiv), triethylamine (cat.), DCM, r.t., 20 
h. 
Scheme 20: Attachment of test compound a) Phosgene (20% (w/w) in toluene, 5 
equiv), THF, r.t., 7 h OR triphosgene (5 equiv), pyridine (5 equiv), THF, r.t. 7 h. 
b) 1-dimethylphenylpiperazine (5 equiv), triethylamine (5 equiv), THF, r.t., 
overnight. 
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showed that this linker was stable under the conditions (Table 4, entry 1). This was 
not surprising, as methyl- and ethyl carbamate protection groups in solution are 
cleaved under much more forcing conditions than benzylic carbamates. 62 
Experiments with more forcing conditions and microwave heating revealed that quite 
forcing conditions were needed to cleave the linker (Table 4).  
The beads gained a brown colour, but later investigation by microscope and IR 
revealed that they did not appear to be damaged. In an attempt to find milder cleavage 
conditions a series of experiments were performed with mineral base in alcohol and 
microwave heating (Table 5). 
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Entry Conditions Result Yielda 
 
Reference: 
1 trifluoracetic acid/DCM 
(1.5:1), r.t. 1h, repeated 
 
N analysis 1.1% 
 
- 198 
2 
 
Concentrated aqueous 
HBr(48%)/acetic acid 
(1:1), r.t., overnight 
 
N analysis 2.4% 
 
- 199 
3 LiOH (1.5 mmol, 20 
equiv) water/ethanol 
(1:2), 80°C, 1.5 hb 
 
N analysis 2.4% <5 % 200 
4 Concentrated aqueous 
HBr(48%)/acetic acid 
(1:1), 80°C, 1.5 hb 
 
N analysis 2.2 % <5 % 199 
5 trifluoracetic acid/DCM 
(1.5:1), 80°C, 1.5 hb 
 
N analysis 2.4 % decomposed 198 
6 NH3 (4M in methanol), 
r.t., overnight, then 
60 °C/1.5 hb 
 
IR = 1701 cm-1 none 201 
7 KOH (5 equiv)/ethanol 
150 °C/2 hb 
 
No carbamate 
stretch in IR 
42 %c 202 
 
 
 .  
Table 4: Initial attempts to cleave the carbamate linker. aYield estimated from ELSD 
spectrum. Method gave lower results than the actual (test gave 73% of actual 
compound content). bHeated with microwaves in closed Process Vials on an Emrys 
Optimizer  cIsolated crude yield (estimated from weight and 1H NMR purity) 
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Entry Reagent /equiv Solvent Conditions IR 
(cm-1) 
Yield 8 
(ELSD)a 
1 KOH/ 
1.5 equiv 
ethanol/ 
6% water 
 
150°C, 30 min 1702 16%b 
2 LiOH/ 
1.5 equiv 
ethanol/ 
6% water 
 
150°C, 30 min 1701 16%b 
3 NaOH/ 1.5 
equiv 
ethanol/ 
6% water 
 
150°C, 30 min 1701 16%b 
4 LiOH/1.5 equiv methanol/ 
6% water 
 
150°C, 30 min 1702 41% 
5 LiOH/1.5 equiv methanol/ 
6% water 
 
150°C, 60 min 1702 41% 
6 HBr/ 5 equiv methanol/water 
 
150°C, 30 min 1705 none 
7 KOH/ 5 equiv methanol/water 
 
150°C, 30 min 1701 45% 
8 LiOH/ 
5 equiv 
 
methanol 
 
150°C, 1.5 h 1701 58% 
9 KOH/ 
5 equiv 
methanol 
 
150°C, 1 h  no 58% 
 
 
Unfortunately yields from these screening reactions were uniformly low, and IR 
spectra of the resins still showed a carbamate stretch after reaction. Only prolonged 
heating with methanolic potassium hydroxide seemed to cleave the linker completely 
(Table 5, entry 9). It was decided to temporarily abandon these efforts and examine 
cleavage under reductive conditions instead. 
Table 5: Selected results from the screening of cleavage conditions with 
microwave heating  aEstimated from ELSD spectrum. Method gave lower results 
than the actual (test gave 73% of actual compound content) bThese reactions 
yielded an approx. equal (by ELSD) amount of the N-ethyl carbamate of 8. 
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2.2.2.2 Reductive cleavage 
 
As previously mentioned Wang carbamate linker can be cleaved with Lithium 
aluminium hydride to yield methyl amines.68, 203 This reagent tends to form large 
excesses of solid aluminium salts, which can be problematic to separate from the 
product, especially in a solid-phase synthesis where prolonged washing procedures 
are employed. It was therefore decided initially to use lithium borohydride as a 
cleaving agent instead, after a standard procedure in THF containing 1 equivalent of 
methanol. 204 
 
To determine both the feasibility of this cleavage method and to compare the 
triphosgene-based method with the phosgene-based method, two chloroformylated 
resins were prepared, one using triphosgene and pyridine, one using phosgene in 
toluene. Both were reacted with a solution of 1-diphenylmethylpiperazine in THF 
under the same conditions, and both were then cleaved using the same conditions: 10 
equivalents of lithium borohydride in THF (Scheme 21, a)) 
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The product was completely cleaved from the resins, as judged by the disappearance 
of the carbonyl stretch in the IR spectrum.  
 
In both products a significant amount of the secondary amine resulting from 
nucleophilic cleavage was present (~20%), and both reaction products contained a 
small amount of impurity in the form of a yellow oil.   
The crude yield from the phosgene-functionalized resin was significantly larger than 
the yield from the triphosgene-functionalised resin, so the phosgene-functionalised 
resin was chosen for further reactions.  
 
The yellow oil impurity appeared in all reactions cleaved with this method. Treatment 
of 12.2 g of non-functionalized Versabeads with lithium borohydride-methanol in 
THF after the same method yielded 400 mg of the impurity. The NMR spectrum of 
this material showed a mixture of aliphatic and aromatic protons, and as it had a 
similar mass spectrum as vacuum grease and contained aliphatic protons similar to the 
paraffin oil used for polymerization, it was initially believed to be an impurity from 
Scheme 21: Reductive cleavage of the test compound. a) LiBH4 (10 equiv), 
methanol (10 equiv), THF, reflux, overnight b) LiAlH4 (10 equiv), THF, reflux 
overnight. 
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the resin production process, but the Versabeads treated with reductive conditions had 
not lost weight proportional to the impurity formed. Upon closer examination the 
yellow oil was discovered to be a mixture of stabilizer from the THF (10) and the 
compound 2-methyl-2,4-pentandiol (11), the latter in all likelihood formed during the 
quench of the reduction using acetone.205 
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Changing the quench reagent to ethyl acetate, and a wash of the acidic water phase 
during workup removes both impurities from the final product. 
The presence of the secondary amine upon cleavage with lithium borohydride 
persisted, and cutting down the use of reduction agent to only 5 equivalents of 
reducing agent did not yield complete cleavage from resin. The comparison between 
cleavage with 10 equivalents of solid lithium borohydride and 10 equivalents of solid 
lithium aluminium hydride with the same reaction times revealed that nucleophilic 
cleavage did not occur when lithium aluminium hydride was used. It was therefore 
decided to use lithium aluminium hydride as the cleavage agent. This reagent was 
quenched with water and the by-product 11 was therefore not formed. The THF 
stabilizer 10 was removed through wash of the acidic aqueous phase with ethyl 
acetate. 
 
 
2.2.2.3 Optimization of linker formation 
 
To determine optimum conditions for the synthesis of the carbamate linker a series of 
experiments with various reaction times and equivalents of phosgene was performed. 
It was discovered that two equivalents of phosgene for 2 hours was enough to ensure 
full loading of the resin (Table 6). The > 100% yield is calculated based on the 
loading measured through the Fmoc- glycine method. It is believed that the small 
phosgene molecule is able to react with those less accessible hydroxy functionalities 
on the resin that the large Fmoc- glycine molecule cannot reach. 
Scheme 22: By-products from the LiBH4 – methanol reductive cleavage 
method: THF-stabilizer (10), and side-product from acetone quench (11). 
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2.2.2.4 Nucleophilic- and base-mediated cleavage revisited 
 
 The initial experiments with nucleophilic cleavage under microwave heating had 
revealed that forcing conditions were needed to cleave the carbamate linker. When 
conventional heating was applied to a suspension of a resin-bound piperazine with 10 
equivalents of potassium hydroxide in methanol the linker was completely cleaved 
upon reflux. The product hereby generated was the methyl carbamate of the amine in 
question (see scheme 35). 
This prompted a more thorough investigation of base-mediated cleavage, and it was 
found that cleavage using potassium tert-butoxide yielded complete cleavage upon 
reflux with 2 equivalents in diethylene glycol dimethyl ether (DME), probably due to 
the presence of trace amounts of water.   
When methanol-wet resin was employed in the cleavage reaction the methyl 
carbamate was formed, in some cases as the only product. Similar nucleophilic 
cleavage to yield additional functionalization is known,183, 184, 189, 206 and a cleavage 
protocol based on this could potentially expand the scope of this linker greatly.  
Experiments with adding 10 equivalents of a higher aliphatic alcohol (decanol) to the 
cleavage reaction did, however, not lead to the formation of carbamate 13 in solution 
(Scheme 23), and further experiments in this field were abandoned due to time 
constraints. 
Entry equiv 
phosgene 
time (h) IR 
(cm-1) 
Cl (%) loading 
(mmol/g)  
Yield
1 2 4 1775 6.93/6.96 2.0 118% 
2 2 2 1775 6.46/6.44 1.8 106% 
3 5 2 1774 7.27/7.34 2.1 121% 
4 2 6 1775; 
1743a 
5.53/5.45 1.6 91% 
5 5 6 1776; 
1749a 
7.12/7.05 2.0 118% 
Table 6: Screening for optimised conditions for the generation of the chloroformyl 
linker 4. a) Phosgene in toluene (20% w/w), THF, r.t. aPossibly cross-linking 
between sites.  
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Attempts to cleave the carbamate linker with potassium hydroxide in water did not 
yield promising results. 
 
2.2.3 The synthesis of various REM linkers 
 
The REM linker concept has several advantages in the context of amine synthesis on a 
larger scale on Versabeads. Both the attachment reaction and the cleavage reaction 
have been shown to be enhanced by aqueous media, meaning that it is an ideal 
showcase for the advantages of having the compound immobilized on a hydrophilic 
resin. 
2.2.3.1 Sulfone-based REM linker 
 
Heinonen et al produced their sulfone-based REM linker in one step from divinyl 
sulfone by reaction with a Wang linker via a Michael reaction using a catalytic 
amount of DBU as base. 99, 100, 207 When this was attempted on SPOCC to synthesise 
the linker 14 no addition was observed by IR, but elemental analysis showed sulfur 
content corresponding to ca. 40 % loading, and possible vinylic protons were seen in 
the 1H MAS NMR spectrum (Table 7, entry 1). An attempt was made to add N-
benzyl-N-methylamine to the resin 97 but as this did not yield any changes in the NMR 
spectrum it was concluded that the handle had not been made, and that the sulfur 
found in the elemental analysis had to come from another source, possibly 
polymerized divinyl sulfone left inside the resin. 
 
Attempts to form this linker using divinyl sulphone and other reagents such as Triton 
B 102, 208 (table 7, entry 2) or NaOH 209 (table 7, entry 3) did not produce any changes 
in the IR spectrum, and again no changes in the spectrum were seen upon addition of 
nucleophiles. The resin was probably not sufficiently nucleophilic to add to the 
sulphone. An attempt to activate the resin using tert-butoxide as a base resulted in 
polymerization of the divinyl sulphone.  
Scheme 23: a) phosgene (20% w/w in toluene, 2 equiv), THF, r.t., 2 h. b) 1-(3,4-
dichlorophenyl)-piperazine (2.5 equiv), triethylamine (5 equiv), THF, r.t., 
overnight. c) 1-decanol (5 equiv), potassium tert-butoxide (5 equiv), DME, 
reflux, 5 h. No yield. 
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Entry Equivalents divinyl 
sulphone 
Base Conditions Reference 
1 12 DBU 1 equiv, DCM, 
r.t. overnight 
99 
2 1.5 Triton Ba  catalytic base, 
DCM, r.t., 4 
days 
208 
3 9 NaOH 0.35 equiv, 
THF, r.t., 3 
days 
209 
 
 
 
 
 
VersaMatrix A/S also produces Versabeads functionalized with an allyl ether moiety. 
As it is known that divinyl sulphone can undergo cross-methathesis reactions with the 
second generation Grubbs carbene catalyst (A, scheme 24), and cross metathesis on 
resin is known, 210, 211 it was decided to try this approach in order to form the vinyl 
sulphone linker 15. Resin, flask and solvent were carefully dried and degassed prior to 
reaction, but IR and elemental analysis detected no sulphone linker on the resin after 
the reaction. An attempt to synthesise the linker using the more stable second-
generation Hoveyda carbene (B, Scheme 24) 212 as catalyst proved to be unsuccessful 
as well. 
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Table 7: Attempted synthesis of a sulfone REM linker in one step from divinyl 
sulfone. aTriton B: a 40 % aqueous solution of N-benzyl-N- trimethylammonium 
hydroxide.
Scheme 24: Attempted synthesis of a sulfone REM linker (15) through methathesis. 
a) divinyl sulfone (2 equiv), A (0.1 equiv), DCM, reflux, overnight. b) divinyl sulfone 
(6 equiv), B (0.1 equiv), DCM, reflux, overnight. (Mes- = 2, 4, 6 – trimethylphenyl-) 
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The resin had gained a greyish colour after reaction, and it was speculated whether the 
lack of success with the metathesis reaction was due to the crown-ether like structure 
of the resin trapping the metal. Recently however, Grubbs et al has demonstrated the 
immobilization of an analogue of A on PEG and its utility in aqueous reactions,213 and 
although the flexible PEG chain cannot entirely be compared to SPOCC, this indicates 
that the catalyst should be stable under the conditions. The problem is therefore rather 
one of reactivity. Breed, Ramsden and Brown notes that solid-phase cross metathesis 
reactions are difficult to get to run to completion. 214 
 
It was decided to investigate using acrylates as a linker instead, as the synthetic 
procedures for making ester bonds are better established than the ones for addition of 
divinyl sulphone to resin. 
2.2.3.2 Acrylic acid-based REM linker 
 
The acrylic acid handle 15 was formed through the procedure developed by Morphy 
et al. 79 The linker synthesis proceeded to completion judged by 13C gel-phase NMR 
and it was decided to test it with the same reactions as used in the original reference, 
where 1-diphenylmethylpiperazine was used as a test compound (Scheme 25) 
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The Michael addition of 1-diphenylmethyl piperazine to 16 to form resin 17 
proceeded to completion according to 13C gel-phase NMR. The following reaction 
between 17 and allyl bromide in water did not give complete reaction, judged by 13C 
gel-phase NMR. The final crude yield of 19 after basic cleavage was 32 % (Scheme 
26). 
 
Scheme 25: Synthesis of the REM linker 16 and subsequent derivatization a)  
Acryloyl chloride (10 equiv), DIPEA (10 equiv), DCM, r.t., overnight. b) 1-
diphenylmethylpiperazine (5 equiv), THF or DMF, r.t., overnight 
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A small-scale experiment where the test reaction was assisted by microwave heating 
gave a promising result of 19% yield of 1-allyl-4-diphenylmethylpiperazine and 
complete cleavage from resin by 13C gel-phase NMR, as indicated by the presence of 
acrylic carbon. A later experiment with microwave heating gave a yield of 40 % 
overall yield of 19 (Scheme 27). 
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As large-scale microwave chemistry is still in its infancy this route was not further 
explored, but it holds potential in future combinatorial uses of REM.  
Morphy et al. attached piperazine to the REM linker and was able to synthesise allyl 
piperazine derivatives with different N-substituents from this. When these reactions 
were performed on Versabeads, the expected products were isolated in reasonable 
crude yields (Scheme 28).  
 
Scheme 27: a) 1-diphenylmethylpiperazine (5 equiv), THF, 60°C, microwave, 
1 h. b) allyl bromide (5 equiv), water, 60°C, microwave, r.t., 1h. c) DIPEA (2.2 
equiv), DCM, 60°C, microwave, 45 min. Yield: 40% 
Scheme 26: Reaction with allyl bromide, followed by cleavage a) allyl 
bromide (5 equiv), water, r.t., 6.5 h, repeated overnight. b) DIPEA (2 equiv), 
DCM, r.t. 5 h. Crude yield 32% 
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It was known from Morphy et al that interaction between basic centres on resin could 
lead to premature cleavage in the quaternization step81 (Scheme 29). Compound was 
detected by LC/MS in the washing from many of the synthesis.  
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When the test reaction was scaled up to gram scale on high loading resin (1.6 
mmol/g), yield of 17 were low, and significant cleavage was again seen in the 
quarternization step. This made it clear that the REM linker protocol was promising, 
but required much effort if it was to be developed for large-scale synthesis. The 
problem with insufficient quarternization and premature cleavage needed to be 
addressed, and new conditions for the attachment of compound, using fewer 
equivalents of compound and non-carcinogenic solvents had to be developed. 
 
Scheme 29: Proposed intra-resin premature cleavage mechanism.81 
Scheme 28: Synthesis of substituted piperazines on REM resin. a) piperazine (12 
equiv), DMF, r.t., overnight. b) phenyl isocyanate (10 equiv), DMF, r.t., overnight.
c) benzoyl chloride (2 equiv), triethylamine (2 equiv), DCM, r.t., overnight. d) 
allyl bromide (5-6 equiv), water, r.t., overnight. e) DIPEA (3-4 equiv), DCM, r.t. 
6-7 h. Crude yield 22 (35%) 24 (38%)  
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As the carbamate linker protocol was at this point much closer to a scalable synthesis 
route it was decided to concentrate the efforts on this linker. 
 
2.2.4 Wang linker 
 
As previously mentioned, the majority of uses of a carbamate linker in literature are in 
conjunction with a Wang linker in order to facilitate cleavage. When it was observed 
in our case that very harsh conditions were required to cleave the carbamate linker 
from Versabeads, an attempt was made to attach a Wang linker to the resin. Two 
methods were investigated: nucleophilic addition and a Mitsunobu route (Scheme 30). 
 
The resin was functionalized using a procedure developed by Meldal et al. via 
triphenylphosphine-assisted substitution of hydroxide with bromide.54 13C Gel phase 
NMR indicated complete reaction (i.e. only brominated product was observed), but 
elemental analysis indicated a loading of only approximately 30% of theoretical 
maximum. An attempted bromide substitution by 4-hydroxybenzylalcohol did not 
yield the desired Wang linker, as judged by 13C gel-phase NMR. It appears that the 
main reaction has been some sort of cross-linking, as no peaks from -CH2OH is 
visible in any of the spectra, although Br- loading of 25 was low. 
Reaction between Versabeads and 4-hydroxybenzaldehyde under Mitsunobu 
conditions yielded almost complete functionalisation by 13C gel-phase NMR.215 The 
resin-bound aldehyde 26 was then reduced to the alcohol using sodium borohydride to 
give Wang linker 27.31 Conversion was complete judged by 13C gel-phase NMR 
(Scheme 30).  Later experiments demonstrated that mesylation of the resin followed 
by nucleophilic addition was another efficient way to immobilize hydroxybenzyl 
aldehyde on resin (Scheme 30).63 
Further experiments with Wang linkers were abandoned when the reductive cleavage 
of the carbamate linker from the resin was developed, as this required fewer steps 
from Versabeads to synthesis product. Wang-functionalized Versabeads were later 
commercialized by VersaMatrix A/S.60 
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Scheme 30: Synthesis of Wang linker on Versabeads. a) Br2 (5 equiv), 
triphenylphosphine (5 equiv), imidazole (5 equiv), DCM,  r.t. 21 h b) 4-
hydroxybenzylalcohol (3 equiv), K2CO3 (3 equiv), KI (0.03 equiv), DMF, 60 °C, 20 
h. c) 4-hydroxybenzaldehyde (2 equiv), triphenylphosphine (2 equiv), DEAD (2 
equiv), THF, r.t. 22 h d) Mesyl chloride (20 equiv), pyridine (8 equiv), DCM, r.t., 2 
x 1 h. e) 4-hydroxybenzaldehyde (6 equiv), NaOH (5 equiv), DMF, 90 °C, 
overnight. f) NaBH4 (5 equiv), N-methylmorpholine/ethanol (1:1), r.t. overnight. 
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3 Synthesis of N-aryl piperazines from resin-bound 
mustards 
3.1 N-Aryl Piperazine – an important pharmacophore 
 
N- and N,N’-substituted aryl piperazines are frequently-encountered phamacophores 
in many compounds with different biological profiles. 
In the field of the central nervous system (the core area of H. Lundbeck A/S), N-aryl 
piperazines are key compounds for interaction with the 5-HT1A receptor, which plays 
an important role in the treatment of depression and anxiety.216-221 Among the drugs 
containing this structure are the anxiolytic Buspirone and the Wyeth experimental 
drug Lecozotan (Figure 19). 
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In addition, N-aryl piperazines are very potent agonists of the nicotinic acetylcholine 
receptors. These receptors are distributed widely throughout the body, and are 
believed to be involved in the treatment of a number of neurodegenerative diseases, 
including Alzheimers disease.222 Compounds containing the N-aryl piperazine 
structure have also been known to bind selectively to the dopamine D3 receptor, an 
important target in the treatment of Parkinsons disease and the control of substance 
abuse.223-225 
 
Outside the central nervous system the N-aryl piperazine pharmacophore is found in 
several compounds which display α,β adrenoreceptor antagonistic activity.226, 227 
Figure 19: Examples of known anti-depressant and anxiolytic drugs and drug 
candidates based on the aryl piperazine pharmacophore (A) Buspirone218 (B) 
Flesinoxan218 (C) Lecozotan219 (D) Vilazodone220 
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Several experimental anti-cancer compounds containing the N-aryl piperazine moiety 
have been identified,228, 229 as well as a number of potential anti-osteoperosis drugs. 
230 
 
3.2 Synthesis methods for making N- Aryl piperazines 
 
Broadly speaking, there are two commonly-used methods for constructing aryl 
piperazines: the direct addition of piperazine to the ring or the addition of an aniline 
derivative to a mustard or mustard-like compound. A method based on the 
intramolecular ring opening of oxazolidin-2-ones has also been reported.231 
3.2.1 Reactions with piperazines 
 
The typical synthesis method for N-aryl amines today is through Pd- or Ni- catalyzed 
addition (Buchwald-Hartwig chemistry). Developed in the late nineties by Buchwald 
and Hartwig separately, these protocols have given high yields under mild reaction 
conditions and have shown high degree of tolerance to functional groups.232-234 
 
Before the Buchwald-Hartwig protocol was developed, aromatic amines were often 
synthesised by the copper-mediated Ullmann reaction,235 or through benzyne 
intermediates236 but this requires much more forcing conditions, and in the case of 
benzyne intermediates will often produce more than one regioisomer. 
 
Some activated aryl halides and aryl ethers can add amines directly without catalyst, 
but this again requires forcing conditions and generally requires activating groups on 
the resin. 237, 238 
 
Transition metal complexes with aromatic rings are known to be activated towards 
nucleophilic addition, and a few N-aryl piperazines have been synthesised in this 
manner,239, 240 but these pathways employ a stoichiometric amount of metal and are 
therefore economically and environmentally unfeasible. 
 
A general problem for the above-mentioned methods of attachment of diamines such 
as piperazine to aryls is the formation of diarylated product, which lowers the yield 
and requires separation. This is usually countered with the use of either 
monoprotected diamines or high excess of reagent. 241, 242 Some catalytic systems, 
such as the Ni/bipyridine system developed by Fort et al. 243and the Pd/BINAP system 
by Gala et al.244 have given good yields of monoarylated piperazine with about 
equimolar amounts of piperazine and reagent. 
 
3.2.2 Piperazine ring formation from mustards 
3.2.2.1 N-aryl piperazines from mustards in solution 
Prelog demonstrated the synthesis of piperazines through base-mediated addition of 
anilines to mustards in the thirties.245, 246 (Scheme 31) 
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These initial experiments were performed at reflux in methanol or, for the less 
reactive anilines, in n-butanol and gave generally good yields.  
  
Yung et al. synthesised a line of aryl piperazines by heating equimolar amounts of 
mustard and aniline at reflux in ethanol with 2 equivalents of sodium carbonate as a 
base, to synthesise compounds for antibacterial activity.247 The results are 
summarized in table 8.  
 
RNH2NH
Cl
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R- Reflux time, h yield, % 
Me 28 47 
Et 12 32 
i-Pr 51 87 
t-Bu 44 15 
OPh 45 79 
F 46 30 
Br 23 32 
 
 
 
 
The results show that the reaction is very substrate specific.  There is a huge 
difference in yields between electron-rich and electron-poor anilines, and even 
between 4-fluoro and 4-bromoaniline, where the reaction is shown to be twice as fast 
with the less electronegative bromide compared to fluoride. 
 
A later study by Martin et al shows that the reaction is dependent on steric and 
electronic factors.248 (Table 9) There is a marked improvement in yield when the 2-
isopropyl group on the aniline is replaced with an isopropyloxy group (table 9, entry 4 
and 6), but almost no difference between the yield from the larger n-butyl and n-
butoxy groups in the same position (Table 9, entry 3 and 5) (the latter might in part be 
a result of the different precipitation agents). Note also the different reactivity of 2- 
and 3 –fluoroaniline (Table 9, entry 7 and 8). 
Table 8: Aryl piperazine synthesis after Yung et al.247 a) bis(chloroethyl)amine, 
hydrochloride, aniline (1 equiv), Na2CO3 (2 equiv) , ethanol, reflux, 51 h.  
Scheme 31: Prelog’s synthesis of 1-(4-tolyl-) piperazine245 a) 
bis(bromoethyl)amine, hydrobromide (1 equiv), 4-methylaniline (2 equiv)  
methanol, reflux, 12 h. Yield: 85 % A, 6 % B. 
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Entry -R1 -R2 Yield 
(%) 
Salt form 
1 Et  H 26 hydrochloride 
2 nPr  H 26 fumarate 
3 nBu  H 14 tartate 
4 iPr  H 21 fumarate 
5 nBuO  H 10 fumarate 
6 iPrO  H 38 fumarate 
7 F  H 27 fumarate 
8 H  F 51 fumarate 
9 H  NO2 44 fumarate 
 
 
 
 
 
 
High temperatures are an important factor in these reactions. Brewster et al.obtained 
markedly better yields and purities when they employed 2-butoxyethanol (170 °C) as 
a solvent instead of n-butanol (116 °C), 249 and Orus et al obtained a yield of 76% of 
N-(4-nitrophenyl)-piperazine hydrochloride after 24 h at reflux in chlorobenzene (130 
°C), 250 almost twice the yield obtained by Martin et al for the same reaction in n-
butanol.248  Orus later used these conditions to synthesise a series of N-
quinoloylpiperazines, but the yields were generally low.251 
 
It is well known that iodine can catalyze the addition of nucleophiles to alkyl 
chlorides. This method has been used in the addition of anilines to bis(chloroethyl) 
amine hydrochloride in diglyme (160 °C) , but as the procedure was employed as part 
of a longer reaction sequence yields can not be directly compared to those from other 
methods. In one case, a yield of 75% of 1-(biphenyl-2-yl)piperazine were obtained in 
one step after 3.5 h at reflux, which indicates that the use of catalytic iodide can be an 
improvement of the reaction in general.252 
 
In a recent study by Liu and Robicaud, it was shown that heating 
bis(chloroethylamine), hydrochloride and various anilines together without base in 
diethylene glycol monomethyl ether gave yields > 60% after 6 - 12 hours of heating, 
even with electron-poor or sterically-hindered anilines.253 However, no results for 
electron-poor and sterically-hindered anilines, or 2,6-substituted anilines were 
reported (Table 10). 
 
Table 9: Yield from Martin et al.s synthesis of aryl piperazines.248 a) 
bis(chloroethyl)amine, hydrochloride, aniline, n-butanol, reflux, 48 h, then K2CO3, 
reflux , 48 h.  
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Ar- Yield (%) 
Phenyl 79 
4-fluorophenyl 87 
4-chlorophenyl 87 
2-methylphenyl 66 
3-methoxyphenyl 95 
3-trifluormethylphenyl 67 
3,5-ditrifluoromethylphenyl 65 
4-nitrophenyl 90 
3-hydroxyphenyl 87 
3-ethylcarboxyphenyl 90 
2-naphtyl 60 
 
 
 
 
 
 
Bis(bromoethyl) amine is generally more reactive than bis(chloroethyl) amine, and 
has been exploited to for instance make radiolabelled compounds .254 However, this 
increased reactivity can be a problem, as more than one molecule of aniline can be 
added to the mustard. 245 The level of this side product can be suppressed by not 
adding base to the reaction.255, 256 A number of N-aryl piperazine syntheses with 
bis(bromethyl)amine employing basic alumina as a solid catalyst have given good 
yields of the N-aryl piperazines. 257, 258 
 
Very recently Kumar et al. performed a very rapid synthesis of an aryl piperazine 
using microwave heating of the free mustard with poly(ethylene glycol) as the solvent 
on a 5 mmol scale (Scheme 32).259  
NH
Cl
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OR
+
N
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Scheme 32: Microwave assisted synthesis of aryl piperazines in poly(ethylene 
glycol). a) bis(chloroethyl)amine (1 equiv); aminonaphthalen (1 equiv, R = -H or 
R = -Me), PEG-400, domestic microwave oven (800-1000 W), 3 x 10 s. Yield R = 
-H 46%, R = -Me: 54%. 
Table 10: Easy synthesis of aryl piperazines253 a) ArNH2 (1 equiv), 
bis(chloroethyl)amine, hydrochloride (1 equiv), diethylene glycol monomethyl ether,
150 °C, 6-12 h.  
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3.2.2.2 Neat N-aryl piperazine synthesis form mustards 
 
Neat, acidic synthesis of piperazine after the protocol developed by Pollard260 have 
been employed in the synthesis of many of the simpler N-aryl piperazines. Here the 
aniline, ethanoldiamine and concentrated hydrochloric acid are mixed, and water is 
distilled off. This avoids the use of toxic mustard, but requires prolonged heating at 
temperatures above 200°C and gives only modest yields. 
 
More recently, good yields have been obtained from microwave heating of 
bis(chloroethyl)amine hydrochloride and anilines (47-73% yields after 1 min of 
heating at 700 MW).261 
 
3.2.3 Solid phase synthesis of aryl piperazines 
 
As amines are key pharmacophores a number of solid phase synthesis routes to 
amines have been developed, 19, 262 but relatively few of these make a N-aryl 
piperazine directly on resin. 
Unassisted SnAr couplings have been developed both on solid263 and soluble (PEG) 
supports, 264 and such aromatic C-N coupling reactions have been utilized in the 
combinatorial synthesis of known drug structures, using Wang Resin.265, 266 Forcing 
conditions are still needed. 
 
Pd-catalyzed Buchwald-Hartwig synthesis have been utilized in the combinatorial 
synthesis of N-aryl piperazines, both with piperazine itself,267, 268 and with N-aryl 
piperazine to form N,N’-biaryl piperazines269 In a study by Ruhland et al. a piperazine 
was immobilized on resin, and Buchwald-Hartwig chemistry, followed by sequential 
cross coupling was performed to prepare N-biaryl and N- teraryl piperazines on 
resin.270 (Scheme 33) 
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As previously mentioned one of the routes to N-aryl piperazines is the nucleophilic 
addition to metal aryl complexes. Ruhland et al. immobilized piperazine on resin and 
added various iron aryl complexes, thereby avoiding biarylation and making 
separation of the metal from the reaction easy.271 
 
Activation of the phenyl ring has also been achieved by adding phenyl groups to 
resin-bound bismuth, then cleaving the metal-aryl bond with N-aryl piperazine, 
yielding N,N’ – diaryl piperazines.272 
 
Very few examples exist of the direct formation of piperazine rings on resin. A 
number of 2,5-diketopiperazines have been formed on resin, usually through 
cyclization- cleavage, where the product is cleaved from the resin by means of 
nucleophilic ring closure.273, 274 An example of large scale solid phase synthesis by 
such a protocol was described by Raillard et al.31 
 
An example of piperazine ring formation on resin was demonstrated by Houghten et 
al. who cleaved a 2,3-diketopiperazine from methylbenzhydryl-functionalized resin 
under reductive condition, thereby obtaining a substituted piperazine ring.275, 276 
 
The on-resin synthesis of unsubstituted piperazine rings through mustard or mustard- 
like techniques was to the best of our knowledge not known prior to the publication of 
the work presented in this thesis.277 An article by Dolle et al that describes the 
synthesis of piperazines from resin-bound bis-mesylated diethanolamine was 
Scheme 33: Combinatorial synthesis of a diaryl piperazine after Ruhland et al. 270 
a) Merrifield resin, piperazine (10 equiv), N-methylmorpholine (5.4 equiv.), 
THF/DMF (1:1), 60 °C, 16 h; b) 3-bromophenol (15 equiv) Pd2dba3 (20 mol %), 
P(o-tol)3 (30 mol %), potassium tert-butoxide (40.0 equiv), toluene, 90 °C, 24 h; c) 
4-nitrophenyl triflate (2.5 equiv), K2CO3 (2.5 equiv.), 50 °C, 2-3 days; d) 
bis(pinacolato)diboron (2.5 equiv), PdCl2(dppf)*CH2Cl2 (10 mol %), dppf (5 mol 
%), dry dioxane, 90 °C, 24 h; e)  2-iodothiophene (6.0 equiv.), Pd(PPh3)4 (10 mol 
%) K2CO3 (6.0 equiv), DMF/THF 1/1, 60 °C, 1 d. f) methyl chloroformate, DCM, 
0 °C for 30 min, then room temperature for 16 h.  
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published in 2006, but no aryl piperazines were formed using this method278 (Scheme 
34). 
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3.3  Experimental work 
3.3.1 Immobilization of mustards 
 
Both bis(chloroethyl)amine, hydrochloride and bis(bromoethyl)amine, hydrobromide 
were available as starting materials for the piperazine formation on resin. 
Bis(chloroethyl)amine, hydrochloride is commercially available and 
bis(bromoethyl)amine, hydrobromide is custom-made for H. Lundbeck A/S for 
synthesis purposes. The latter mustard is more reactive than the first, but it is 
delivered in a form mixed with morpholine, which needs to be removed through 
recrystallization. As this is a rather cumbersome process it was quickly decided to use 
the commercially-available product. 
 
The mustard was initially immobilized by adding a 5-fold excess of 
bis(bromoethyl)amine hydrobromide and a 15-fold excess of triethyl amine in 
dichloromethane to form 29.279 Immobilization proceeded to completion overnight as 
determined by 13C gel-phase NMR (Table 11, entry 1). Later Br-elemental analysis of 
the resin showed only 80% loading of the mustard. 13C gel-phase NMR and elemental 
analysis (nitrogen content higher than bromide content/2) indicated either that the 
remainder of the chloroformyl groups had reacted with the morpholine which was still 
present in the starting material or that 29 have hydrolyzed and formed resin-bound 
morpholine 30 under the reaction conditions. This was later confirmed by reacting 
morpholine with 4 for spectral comparison. 
 
Scheme 34: Solid-phase piperazine synthesis on α-methylbenzyl polystyrene resin 
after Dolle et al.278 a) diethanolamine (5 equiv), diisopropyl ethylamine (20 equiv), 
60 °C, 44 h; b) mesyl chloride (11 equiv), diisopropyl ethylamine (13 equiv), N,N-
dimethylaminopyridine (0.6 equiv), DCM, 0 ° C → r.t., overnight c) RNH2 (10 
equiv), DIPEA (20 equiv), NMP, microwave, 160°C, 30 min. d)trifluoracetic 
acid/DCM 1:1, 1h. 
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Entry equiv. 
phosgene 
equiv.  
mustard 
base other 
conditions 
NMR 
yielda 
 
Yieldb 
 
1 12 5 triethylamine 
(15 equiv) 
 
dry DCM, 
r.t., 24 h 
100%c  90% 
2 5 5 triethylamine 
 (5 equiv) 
water, 
r.t., 
overnight 
 
ca. 
100% 
114% 
3 5 2 triethylamine 
 (6 equiv) 
water, 
r.t., 19 h 
 
56% 58% 
4 2 2 K2CO3 
(3 equiv) 
water, 
80 ° C, 
overnight 
0 % N/A 
 
 
 
 
As chloroformates are known to be quite stable in water it was decided to replace 
dichloromethane with water under the same conditions. This turned out to be an 
improvement, as the yield by Br-analysis increased to 112% (Table 11, entry 2). The 
most likely reason for this improvement is the reagent concentration effect, which 
presumably concentrated both the hydrophobic mustard and amine base inside the 
resin. The >100% yields with respect to the loading determined by the Fmoc-glycine 
method, can be explained by the fact that the large Fmoc-glycine molecule cannot 
access some of the more hindered hydroxyl groups in the resin, and so therefore the 
effective loading of hydroxyl groups will be larger than specified by the manufacturer 
in reactions with small molecules such as phosgene and mustard. 
 
The initial route employing 5 equivalents of mustard and 15 equivalents of triethyl 
amine could easily be applied to high-loading resin on a 0.15 mol scale. However, for 
scale-up purposes a route employing fewer equivalents of reagents was desirable. An 
initial screening experiment with a lower amount of mustard (2 equivalents) did not 
proceed to completion at room temperature (Table 11, entry 3). Heating the reaction 
to reflux280 did not give any reaction by 13C gel-phase NMR, but resulted in 
regeneration of the starting resin (Table 11, entry 4). It was later discovered that the 
resin-bound mustard is not stable in warm aqueous base, but as no product was 
Table 11: Immobilization of mustard on resin. a) Phosgene (20 % w/w in toluene), r.t. 
b) bis(bromoethyl)amine, hydrobromide, base. a Extent of reaction with resin 
estimated from 13C gel-phase NMR b Yield of 29 estimated from Br - elemental 
analysis cSpectrum also contains resin-bound morpholine 30. 
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detected on resin during the early stages of the reaction, the unsatisfactory reaction 
was more likely the result of hydrolysis of the chloroformyl linker. 
 
A screening experiment with various bases (Table 12) showed that complete 
immobilization could be reached with 2 equivalents bis(chloroethyl)amine 
hydrochloride and 6 equivalents of potassium carbonate, and this route was chosen for 
future scale-up purposes, although 3.5 equivalents of bis(chloroethyl)amine, 
hydrochloride was employed in most experiments, due to an initial miscalculation. 
 
 
 
OH
O
N
O
Cl
Cl
a) b)
31  
 
Entry base Amount NMR Peak 
height 
(64 ppm) 
NMR Peak 
height 
(61 ppm) 
NMR 
conversion 
1 triethylamine 3.2 mL  
(2.4 g) 
 
59 mm - full 
2 K2CO3 3.2 g 
 
55 mm - full 
3 pyridine 1.9 mL (1.8 g) 
 
- 35 mm none 
4 DIPEA 2.4 mL (3.0 g) 75 mm - full 
 
 
 
 
 
 
 
 
It should be noted that the resin-bound mustards are quite stable. After 8 month of 
storage in a closed container no difference was seen in the 13C gel-phase NMR 
spectrum of the resin-bound chloromustard 31. The 13C gel-phase NMR spectrum of 
29 showed a small amount of hydrolysis after 6 month.
Table 12: Screening of various bases in the immobilization of mustard. a) 
phosgene (20 % w/w in toluene, 2.5 equiv), THF, 2.5 h. b) bis(chloroethyl)amine, 
hydrochloride (2 equiv), base (6 equiv), water, r.t., 4 h. 
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3.3.2 Synthesis of various N-Aryl piperazines 
3.3.2.1 Initial experiments 
 
4-Fluoroaniline was chosen for the initial experiments, as it is easy to detect on resin 
with 19F NMR spectroscopy. It is a liquid at room temperature and therefore 
convenient for the investigation of the reagent concentration effect in water (Table 13, 
entry 1 and 2). The reaction was initially performed at room temperature, as it was 
believed that the reagent concentration effect would help force the reaction to 
completion. NMR and later elemental analysis showed that the desired resin-bound 
piperazine 32 was formed, but a significant amount of mustard 29 was still present. 
The yield was determined as 47% by fluorine elemental analysis. Later scaling up to 
gram-scale of this reaction, followed by reductive cleavage and purification by 
precipitation with oxalic acid yielded only 9 % of the corresponding 1-(4-
fluorophenyl)-4-methylpiperazine 33 (and ca. 20 % of the final product was found to 
be by products from addition of two aniline molecules to the mustard: bis(N-(4-
fluoroanilinoethylene)amine (34) and N-methyl bis(N-(4-fluoroanilinoethylene)amine 
(35)).281 
 
Reaction with the more-nucleophilic 4-iodoaniline (a good precursor for further 
reactions) to form 36 did not run to completion (Table 13, entry 3). Heating the 
reaction at reflux gave complete conversion, but yielded only a small amount of 1-(4-
iodophenyl)-4-methylpiperazine (37) upon reductive cleavage (table 13, entry 4). 
Judged by 13C gel-phase NMR a significant amount of cleavage had occurred during 
the piperazine-formation step. Synthesis with electron-rich methoxyaniline to form 38 
also resulted mainly in cleavage (table 13, entry 8). 
 
Attempted synthesis with amino- substituted heteroaromates 2-aminopyridine and 2-
aminopyrimidine gave no detectable yield of resin-bound piperazines 39 and 40 
(Table 13, entry 9-10). Upon heating of the reaction only hydrolysis of mustard 29 to 
30 was seen (Table 13, Entry 11) 
 
Experiments with resin-bound bis(chloroethyl)amine 31 gave the same picture (Table 
13: entry 6 and 7): very low yields, even when catalytic iodide was added, and 
significant cleavage. It was decided to investigate the addition in more detail. 
Experiments showed that the resin-bound product was stable under the reaction 
conditions, and an experiment where resin-bound mustard was treated under reaction 
conditions (but in the absence of an aniline) showed reasonable stability (no 
significant changes in the 13C gel-phase NMR spectrum after 4 hrs). 
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Entry -X S V -R Conditions Result Prod 
1 Br CH CH F 4-fluoroaniline (8 equiv), 
K2CO3 (3 equiv), water, 
r.t., overnight. 
47%a  32 
2 Br CH CH F 4-fluoroaniline (6 equiv), 
K2CO3 (3 equiv), water, 
r.t., 21 h. b 
30% 
conv.c 
32d 
3 Br CH CH I 4-iodoaniline (5 equiv), 
K2CO3 (2.5 equiv), 
water/MeCN (3:1), r.t., 24 
h. 
21% 
conv.c 
36e 
4 Br CH CH I 4-iodoaniline (6 equiv), 
K2CO3 (2.5 equiv), water 
/MeCN (3:1), 78 °C, 21 h. 
100% 
cleavagec 
36 
5 Br CH CH F 4-fluoroaniline (5 equiv), 
K2CO3 (2.5 equiv), water, 
100 °C, 18 h. 
89 % 
cleavagec 
32 
6 Cl CH CH F 4-fluoroaniline (5 equiv), 
K2CO3 (3 equiv), water, 
100 °C, 17 h. 
91 % 
cleavagec 
32 
7 Cl CH CH F 4-fluoroaniline (5 equiv), 
K2CO3 (3 equiv), KI (0.2 
equiv), water, 100 °C, 23 h.
87 % 
cleavagec 
32 
8 Br CH CH OMe 4-methoxyaniline (5 
equiv), K2CO3 (2.5 equiv), 
water, 60 °C, 18 h. 
55% 
cleavage c 
38 
9 Br N CH H 2-aminopyridine (5 equiv), 
K2CO3 (2.5 equiv), water, 
r.t., 26 h. 
no 
reaction 
39 
10 Br N N H Pyrimidin-2-ylamine (5 
equiv), K2CO3 (2.5 equiv), 
water, r.t., overnight 
no 
reaction 
40 
11 Br N N H Pyrimidin-2-ylamine (5 
equiv), K2CO3 (2.5 equiv), 
water, microwave, 100 °C, 
6 min. 
30 formed 
 
40 
Table 13: Initial piperazine synthesis experiments. aYield by F elemental 
analysis. b Gram-scale  c Conversion by comparison of relative height of mustard 
and piperazine peaks in 13C gel-phase NMR spectrum. d Reductive cleavage 
yielded ca. 9 % of a mixture of 33 and 34/35 (20 % by UV254).  
d Cleavage extent estimated by comparison of the relative heights of -CH2OH 
and –CH2OR peaks in the 13C gel-phase NMR spectrum e Crude yield of 
corresponding 1-(4-iodophenyl)-4-methylpiperazine 37 after reductive cleavage  
< 6 % 
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It is known that the reaction between amine and mustard can form an oxazilodin-2-
one by-product from the monoalkylation of the mustard.282 Upon investigation of the 
washing from the resin a significant amount of a carbonyl-containing by-product was 
found, but after purification it was discovered that the main impurity was not the 
expected oxazilodin-2-one 41 but instead the previously unknown imidazol-2-one 42 
(Figure 17) formed by addition of two aniline molecules to the mustard and cyclative 
cleavage. 
 
NO
O
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H
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NN
O
N
H
OMe
MeO
41 42  
 
The mechanism and possible use of this interesting and previously-unknown side 
reaction will be described in detail in a later chapter. 
 
It is believed that this side reaction is the result of the reaction concentration effect 
being too efficient in water and favouring the second addition of aniline.  
Various other, less-polar solvents were tried and the resin products were analyzed 
using the short NMR method (1024 scans) (Table 14). 
 
NH2 OMeN
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Entry Solvent 61 ppm peak 
height 
64 ppm peak 
height 
Cleavage 
(calculated) 
1 DMF 12 mm 12 mm ~50% 
2 THF - - - 
3 MIBK 3 mm 23 mm ~10% 
4 Water 9 mm 3 mm ~75% 
5 n-butanol 12 mm 2 mm ~90% 
6 Ethanol 42 mm 12 mm ~80 % 
7 DME 4 mm 27 mm ~10 % 
 
It appeared that the best solvents for the piperazine formation were polar, non- 
nucleophilic solvents. Methyl isobutyl ketone (MIBK) was chosen as it has a higher 
boiling point than DME, which is the only other solvent of those examined that 
Figure 17: The expected oxazilodin-2-one byproduct (41) and the actual main 
by product, the imidazolidin-2-one (42). 
Table 14: Solvent screening for minimizing cleavage from resin in the synthesis of 
38 a) 4-methoxyaniline (5 equiv), K2CO3 (2.5 equiv), KI (0.2 equiv), 80 °C, 
overnight. 
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suppressed cleavage to less than 50%. MIBK has been used previously as a solvent in 
these kinds of reactions.283, 284 As no data existed on the swelling of Versabeads in 
MIBK, the swelling of resin 31 in MIBK was measured by the syringe method and 
found to be acceptable (2.3 mL/g). 
 
Initial experiments in MIBK on a larger scale showed incomplete reaction even after 
reflux overnight (117°C). It appeared that the potassium carbonate was not 
sufficiently soluble in MIBK, so after screening various liquid bases pyridine was 
chosen as a replacement. To lower the risk of solvent boiling away during the long 
reaction times and to keep the concentration of pyridine (b.p. 115 °C) in solution high 
a reaction temperature slightly lower than reflux (100 °C) was chosen. 
 
With these conditions and the cleavage conditions previously described, a series of N-
aryl and N-aryl-N’-methyl piperazines were synthesized (Table 15). The reactions 
were monitored conveniently by 13C gel-phase NMR. As expected, the required 
reaction times for complete reaction of the mustard were very dependent on the nature 
of the aniline used, with the longest reaction times necessary for the electron-deficient 
3,4-dichloroaniline, which needed 112 h to give a complete reaction.  
 
The reaction yields were fair to good, especially for 46a , which after basic cleavage 
could be isolated as a CHN-pure product in 60% overall yield (88 % average yield pr. 
step) after aqueous workup (Table 15, entry 1)). Some of the yields of secondary 
amines were lowered due to the accidental presence of methanol during the cleavage 
reaction, yielding a significant amount of the corresponding N-methyl carbamate, 
which was separated through precipitation of the desired piperazine with oxalic acid. 
 
To demonstrate that cleavage to give carbamates is a useful reaction, the N- methyl 
carbamate of 1-(4-methoxyphenyl)-piperazine 48 was obtained by cleavage in 
methanolic potassium hydroxide yielding 32% of CHN-pure compound upon aqueous 
workup (Scheme 35). 
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Scheme 35: Synthesis of a methyl carbamate through nucleophilic cleavage. a) 4-
methoxyaniline (5 equiv), pyridine (5 equiv), KI (5 equiv), MIBK, 100°C, 15 h, b) 
KOH (10 equiv), methanol, reflux, 3.5 h. Yield: 32% 
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43: R1 = H     ; R2 = H
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44: R1 = Cl    ; R2 = Cl
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Entry Compound 
 
-R1 -R2 -R3 Reaction 
time, step c) 
(h) 
Crude 
yielda 
(%) 
Crude 
purityb 
(%) 
Purified 
yield 
(%) 
1 45a OMe H Me 28  60c 100  
 
60c  
2 45b H H Me 86  50  75-80 d 37  
3    45c e F H Me 49  41  99  21  
4 45d Cl Cl Me 112 22  ca. 60 d,f 4  
5 46a OMe H H 32  46  55 g 20h  
6 46b H H H 60  40  ca 70 dg 17h 
7 46c F H H 66  39  77  
 
23h 
8 46d Cl Cl H 111  34  85  6h 
Table 15: Yield of aryl piperazines synthesised on resin on gram-scale. a)  
phosgene (20 % w/w in toluene, 2 equiv), THF, r.t., 2h; b)  bis(chloroethyl)-
amine, hydrochloride (3.5 equiv), K2CO3 (6 equiv), water, r.t., 6 h; c) aniline 
derivative (5 equiv), pyridine (10 equiv), KI (0.2 equiv), MIBK, 100 °C; d) 
(Entry 1-4) LiAlH4 (10 equiv), THF, reflux, overnight; e) (entry 5-8) potassium 
tert-butoxide (2 equiv), DME, reflux, 3 h. 
 aOverall yield based on 1.97 mmol/g loading of Versabeads™ bPurity from 
HPLC cCHN pure  dDue to problems from overlapping peaks on the HPLC, the 
crude purity is estimated from 1H NMR e same structure as 33  f10-15 % of 1-(4-
chlorophenyl)-4-methylpiperazine 47 was also present. gDue to contamination of 
the DME with methanol a significant amount of the corresponding methyl 
carbamate was formed (Entry 5: 35 %, entry 6: 5-10 %) hIsolated as the 
corresponding oxalate. 
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A problem was encountered in the reductive cleavage of resin 44. A significant 
amount of 1-(4-chlorophenyl)-4-methylpiperazine 47 (10-15 %) was found in the final 
product, and had to be separated through Kugelrohr distillation. The cleavage of 
chlorine from aromatic rings under reductive conditions is a well-known 
phenomenon.285 A later microwave screening reaction using the milder, more 
oxophillic reagent Zn(BH4)2, generated in situ 286-288 did not form any of the 
monochlorophenyl by-product, but complete cleavage from the resin was not achieved 
under these conditions. The crude product appeared to be a mixture of the expected 
product 45d and some kind of complex of this, possibly the boronic acid salt (Scheme 
36). 
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To prove that the method could be employed in the synthesis of a known drug, the 
free base of the Ferrer experimental antidepressant Sifaprazine 289 was synthesised 
(Scheme 37). The 2-benzylaniline used for this synthesis is very sterically hindered, 
and an initial experiment using the standard conditions (Table 15) gave a crude yield 
of approximately 10%. The reaction was optimized using microwave heating and it 
was found that adding iodide in excess instead of as a catalytic amount (3 equivalents) 
accelerated the reaction. The reaction was repeated using these conditions yielding 2.7 
% of the free base of Sifaprazine.   
O
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Reaction with the even more sterically-hindered 2,6-dimethylaniline to give resin-
bound compound 51 was tried, but did not run to completion. After 6 days of reaction 
only 25% conversion was seen in the 13C gel-phase NMR spectrum (Table 16, entry 
1). An experiment with microwave heating after 6 hrs at 150 °C gave full conversion, 
but an unclear 13C gel-phase spectrum, and a later cleavage experiment yielded a very 
small amount (< 2 %) of a complicated mixture of products (Table 16, entry 2).  
An experiment with microwave-assisted ring closure of the more-nucleophilic 2,6-
dimethoxyaniline yielded only very small conversion, confirming the predominance 
of steric factors over electronic in this type of reaction (Table 16, entry 3). 
Scheme 36: Cleavage of carbamate linker with zinc borohydride. a) NaBH4 (3 
equiv), ZnCl2 (1.5 equiv), THF, microwave, 110 °C, 30 min b) NaBH4 (6 
equiv), ZnCl2 (3 equiv), THF, reflux, 3 h.  
Scheme 37: Synthesis of Sifaprazine free base 50 on solid phase a) 2-benzylamine 
(5 equiv), pyridine (10 equiv), KI (3 equiv), MIBK, 100°C, 76 h. b) LiAlH4 (10 
equiv), 1 M in THF, reflux, 19 h, 2.7 % 
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3.3.3 Scale-up of the piperazine reaction 
3.3.3.1 Condition optimization using microwave chemistry 
 
The high-yielding synthesis of 45a was chosen to demonstrate scale-up on resin.  
The route needed some modifications before it could be scaled up. Using a 5-fold 
excess of 4-methoxyaniline was clearly not desirable on a larger scale, as was the 
addition of a large amount of solid lithium aluminium hydride before heating to 
reflux. When working on a larger scale it is generally preferable to add reagents as 
solutions, in order to maintain good control over the addition and avoid problems with 
dust. It is also preferable to add reagents to the reaction mixture after heating it to the 
desired reaction temperature to minimize the risk of runaway reactions.290 The use of 
a large amount of phosgene solution was clearly undesirable as well, and at least had 
to be supplied in a safer form.  
As previously mentioned, the reaction between 31 and 2-benzylaniline was favoured 
by the use of an excess of potassium iodide. A short series of microwave reactions 
was set up and evaluated using 13C gel-phase NMR to find optimum conditions (Table 
17). 
Entry R Conditions Conversion Compound 
1 Me 2,6-dimethylaniline (5 equiv), 
pyridine (10 equiv), KI (0.2 equiv), 
MIBK, 90 °C, 6 days. 
25 % 51 
2 Me 2,6-dimethylaniline (5 equiv), 
pyridine (10 equiv), KI (0.2 equiv), 
MIBK, microwave, 150 °C, 6 h. 
complete a 51 
3 MeO 2,6- dimethoxyaniline (5 equiv), 
pyridine (10 equiv), KI (0.2 equiv), 
MIBK, microwave, 150 °C, 1 h. 
12 % 52 
Table 16: Attempted piperazine formation with 2,6-disubstituted aniline derivatives
aConversion was complete, judged by 13C gel-phase NMR, but the yield upon 
cleavage (potassium tert-butoxide, DME, microwave) was very low, and gave a 
mixture of products. 
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In a cleavage-optimization experiment, resin from Table 17, entry 1 was cleaved by 
suspending the resin in a commercially-available 1 M solution of lithium aluminium 
hydride in THF and heating with microwaves. Complete cleavage was achieved using 
only 4.2 equivalents of lithium aluminium hydride under conditions corresponding to 
4 h at reflux. Likewise, water was replaced with the less-reactive ethyl acetate as a 
quenching agent. The final crude yield of 32% was acceptable. 
 
The use of triphosgene, decomposed to phosgene by heating to 50 °C in THF.180, 181 
was found to be the most acceptable alternative to the commercial solution of 
phosgene in toluene. In addition complete substitution of the resin could be achieved 
with only 1.5 equivalents of triphosgene and 1.5 equivalents of mustard, as judged by 
13C gel-phase NMR. 
 
Upon scaling these conditions to gram-scale a yield of 39 % of the 1-methyl-4-(4-
methoxyphenyl) piperazine was obtained. This yield was lower than expected 
(previous experiments had given 60 %) and this was attributed to the formation of 
chloroformyl handle 4 being slower with triphosgene than with phosgene. 
 
Using the same optimized conditions, but with 3 h reaction time to form the 
chloroformyl linker the reaction was performed on a 0.19-mol scale (100 g 
Versabeads) and yielded the test compound in an overall yield of 21.1 g (55%) 
(Scheme 38). 
Entry equiv. 
4-MeO- 
aniline 
equiv. 
pyridine 
equiv. 
KI 
Peak 
height 
41 ppm 
(mm) 
Peak 
height 
43 ppm 
(mm) 
Conversion
1 2 4 4   complete 
2 1.2 2 0.4 - - low 
3 1.5 3 1 73 15 ~20% 
4 2 4 2 25 30 ~55% 
5 2 4 1 73 20 ~20% 
Table 17: Microwave-assisted screening of conditions for optimizing the synthesis 
of 1-methyl-4-(1-methoxyphenyl)-piperazine. a) MIBK, microwave, 150 °C, 1 h. 
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3.3.4 Discussion of resin stability and resin re-use  
 
For solid-phase synthesis to be a useful tool in initial development chemistry, the 
resin must be reusable, otherwise the high initial cost of the resin would render the 
process un-economic.  
Resins based on the SPOCC structure are known to be highly chemically stable. 
Initial experiments by Meldal et al showed that their SPOCC resin beads were stable 
to concentrated hydrochloric acid, n-butyllithium and heating at reflux with thionyl 
chloride in toluene.291 
The resin had also demonstrated a high degree of mechanical stability, being quite 
stable against the gentle magnetic stirring used in smaller-scale preparations. More 
vigorous magnetic stirring resulted in visible breakdown of the beads.  
After reductive cleavage the beads had gained a brownish colour, whereas they turned 
completely black after cleavage with base. Examination of the beads by 13C gel-phase 
NMR showed no differences to the starting beads. The excess aluminium salts present 
in the resins from reductive cleavage could easily be removed by suspending the resin 
in 4 M hydrochloric acid overnight. 
 
To demonstrate the stability of the resin, some of the resin from the gram scale 
experiment was reused after cleavage in the same reaction under the same conditions, 
but on a smaller scale. The resin loss can be attributed to removal of resin for NMR 
monitoring and elemental analysis and some was lost clinging to glassware. Loss due 
to beads being grinded down to a smaller size than the filter cannot be ruled out, as 
traces of dark material had been observed in several reactions. The yield was almost 
the same as in the first cycle (38 %), but the resin gained an even darker colour and 
elemental analysis revealed significant increase in its nitrogen content. The latter was 
probably from aniline polymers trapped in the resin matrix. This did not seem to 
affect the yield, but might potentially effect a gradual change in the physical 
properties of the resin. Such changed properties could account for the fact that more 
broken beads were found in the reused resin (Figure 18), but this could also simply 
mean that damaged beads had accumulated over two cycles instead of one, or that the 
magnetic stirring employed in the second cycle had been too vigorous. 
 
Scheme 38: The large-scale (100 g Versabeads (0.19 mol)) solid-phase synthesis 
of 1-methyl-4-(1-methoxyphenyl)-piperazine 45a a) triphosgene (0.5 equiv), THF, 
50 °C, 3 h. b) bis(chloroethyl)amine , hydrochloride (1.5 equiv), K2CO3 (4 equiv), 
r.t. 4 h. c) 4-methoxyaniline (2 equiv), pyridine (5 equiv), KI (4 equiv), MIBK, 
100 °C, 28 h. d) LiAlH4 (4.2 equiv), THF, reflux, 4 h. Overall yield: 55% 
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Figure 18: Electron microscope images of resin before reaction (A), after mustard 
immobilization (B), after one reaction cycle (C) and after two reaction cycles (D). 
Enlarged 100 times. 
A 
C 
D
B 
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4 Synthesis of an imidazilodin-2-one by cyclative 
cleavage 
 
 
Cyclative cleavage is a well-established technique to form heterocycles on solid-
phase. 19, 273 It is especially desirable because the resulting compounds do not need to 
contain any memory of the linkage to the resin (so-called traceless synthesis). The 
large amounts of the previously unknown imidazolidin-2-one 42, which was produced 
as by-products when performed in water prompted an investigation into the 
mechanism of the reaction.  
 
4.1 Synthesis and application of imidazolidin-2-ones 
 
N-phenyl substituted imidazolidin-2-ones are interesting compounds, as they are a 
structural feature of many biologically active compounds, for example 
antiparasitics292, antivirals 293 and CNS active compounds.294, 295 The 
antischizophrenic Zetidoline is an example of a commercially available drug, 
containing the structure (Figure 19).296 
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 In solution phase chemistry imidazolidin-2-ones can be prepared by the same 
methods as other ureas. The most common routes are via the condensation of ureas 
with diamines.297 A number of other routes to these compounds have been 
developed297, 298, including the reaction of  phosgene or phosgene equivalents with 
diamines,295, 299 addition of isocyanates,297, 298, 300 selective reduction of imidazilodin-
2,4-diones,301 oxidative carbonylation,298 addition of lithiated n-BOC amines to 
imines  or from tert-butyl nosyloxycarbamate.302 303 
 
A number of solid-phase syntheses of imidazilodin-2,4-diones are known, many 
employing cyclitative cleavage.19, 274 It has been reported that protic solvents promote 
the cyclitative cleavage of hydrantoin from resin, but only for N-aryl ureas 304 
(Scheme 39). 
Figure 19: Zetidoline 296 
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The solid-phase synthesis of imidazolidin-2-one structures on solid phase are less 
extensively reported and generally use phosgene equivalents to generate the 
imidazolidin-2-one moiety.276, 305-308 A solid-phase synthesis based on isocyanate has 
also been published.309 
 
4.2 Mechanistic investigation 
 
Elucidating the mechanism behind the reaction between aniline and mustard reagent 
in polar solvents is not simple, given that a number of possible reaction routes exist, 
and it is not immediately obvious which one will be predominant (Figure 20). 
Two main parameters were monitored in the experimental work directed towards the 
elucidation of the mechanism. They were (a) the yield of cyclic urea, which was 
isolated from the reaction mixture by automated flash chromatography, and (b) the 
extent of cleavage from the resin, as estimated from the height of the relevant peaks in 
the 13C gel-phase NMR spectrum. 
 
4.2.1 Preliminary experiments 
 
Preliminary experiments with various amounts of iodide seem to indicate a slight 
increase in the yield upon increase of the amount of iodide (Table 18). 
 
 
Scheme 39: Cleavage of hydrantoin from TentaGel resin. a) water, 65°C, 4 
h, 87 % yield. 304 
 80
N
X
O
O
N
+
Ar
H
H
N
X
O
O
N
H
Ar
N
Cl
O
O
Cl
N
X
O
O
OH
N
X
O
O
N
OH
O
O
N
H
Ar
N
X
N
O
Ar
N
N
+
O
O
Ar
H
H
N
NH
O
O
Ar
N
OH
N
O
Ar
N
OH
O
O
N
N
O
Ar
N
+
Ar
H
H
N
O
O
NH
Ar
N
H
Ar
N
N
O
Ar
Ar
N
O
O
N
+
Ar
H N
OH
O
O
N
+
Ar
H
H
N
N
+
O
O
N
H
Ar
Ar
H
H
N
H
NHAr
NH
Ar
N
O
O
N
Ar
N
N
+
O
O
N
+
Ar
Ar
H
H
H
H
 
 
 
 
Figure 20: Possible pathways in the reaction between mustard and aniline nucleophile Main
products in red, main side products in blue, other possible products (not detected) in light
blue. For clarity the involvement of iodide in the reactions have been omitted. 
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A number of by-products were formed in trace amounts and identified by NMR 
(figure 21): 
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4.2.2 Cyclative cleavage in solution-phase vs. solid-phase 
 
A systematic study of the reaction was planned to identify the determining factors in 
the reaction and to gain insight into the mechanism of cleavage.  
Initially the reaction was compared to solution phase reactions with similar substrates 
under microwave conditions to elucidate whether performing the reaction on solid 
phase caused the imidazolidin-2-one formation (Scheme 40). 
 
entry equiv KI 64 ppm 
peak height 
(mm) 
61 ppm 
peak height 
(mm) 
Cleavage  
(%) 
Yield 
37 
(%) 
1 0.2 23  43  65 36 
2 1.0 14 35 71 42 
Table 18: a) 4-methoxyaniline (5 equiv), K2CO3 (2.5 equiv), KI, water, 80°C, 23 h.  
a Estimated from  13C gel-phase NMR spectrum. 
Figure 21: Hydrolysis byproducts (41 and 53) and product from incomplete 
imidazolidin-2-one formation (54) found in table 18, entry 2. 
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An experiment with resin-bound mustard 31 was run under the same conditions for 
comparison (Table 19). 
 
N
Cl
Cl
O
RO
N N OMe
O
RO
NN
O
N
H
MeO
OMe
+
a)
55 : R = Et- : 
56 : R = MeOCH2CH2- : 
42
 
 
Entry R- Yield of 42 
(%) 
Piperazine 
compound 
formed 
Yield of 
piperazine (%) 
1 ethyl    4% a,b 57 - 
2 2-methoxyethyl 10% 58 11% 
3 Versabeads VO 
400 
   20% 38   39% c 
 
 
The yield was markedly better when the resin-bound mustard 31 was employed, but 
lower than the yield from reactions with conventional heating under comparable 
conditions (Table 18, entry 2) 
 
Scheme 40: a) chloroformate R=ethyl, 2-methoxyethyl, 1.2 equiv), K2CO3 (2 
equiv), water, r.t.. 2.5 h. b) 4-methoxyaniline (5 equiv), K2CO3 (2.5 equiv ),  KI
(1 equiv), water, microwave, 120°C, 2400 s. 
Table 19: Results from the reaction of various mustard derivatives. a15% of 4-
methoxyphenyl carbamic acid ethyl ester was also formed. b  (4-methoxyphenyl) 
carbamic acid ethyl ester 59 (15% of theoretical yield) and a trace amount of 41 
was also found. c Estimated from 13C gel-phase NMR spectrum. 
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4.2.3 Microwave screening experiments 
 
A series of experiments was run in order to obtain an initial feeling for which 
parameters were important for the reaction (Table 20). 
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The higher reaction temperatures seem to favour piperazine formation over cyclitative 
cleavage. An explanation could be that the increased reaction rates favours the 
intramolecular reaction over the intermolecular reaction. Another explanation could 
be that the hydrophobic interaction between the aniline molecules are lessened and the 
aniline is therefore more evenly distributed in the reaction mixture. 
 
Because of the significantly lower yields of product obtained from the synthesis with 
microwave heating (Table 20) compared to those with conventional heating (table 
18), it was decided to continue the investigation using conventional heating. 
Entry equiv. 
K2CO3 
equiv. 
pyridine 
equiv. 
iodide 
Conditions Yield 
42 (%) 
Cleavagea
(%) 
1 2.5 0 1 5 ml H2O; 120°C; 2400 s 16 30 
2 0 0 10 5 mL H2O; 150°C; 3180 s 4 21 
3b 4 0 1 5 mL H2O; 150°C; 3600 s N/A 30 
4 0 5 1 5 mL H2O; 150°C; 3180 s trace 42 
5 0 5 0 5 mL H2O; 150°C; 3180 s trace 50 
6 0 -d 0 5 mL pyridine; 150°C; 3180 s 4 e 
7 2.5 0 1 5 mL H2O; 80°C; 23 h 29 55 
8 2.5 0 1 10 mL H2O; 150°C; 3180 s 29 40 
Table 20: a) 4-methoxyaniline (5 equiv), microwave heating.  a Estimated from 13C 
gel-phase NMR spectrum. b Only 2 eqivalents of 4-methoxyaniline were used. c No 
traceable yield. d Pyridine used as solvent e No visible cleavage by 13C gel-phase  
NMR. 
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4.2.4 NMR–monitored experiments 
 
In an attempt to monitor the reaction in real time, resin and reagents were heated 
together in an NMR tube in the spectrometer at 80 °C, where 13C spectra were 
obtained at regular intervals. When a reaction between the resin-bound mustard and 2 
equivalents of potassium iodide (in the absence of an aniline) was performed in 
deuterated water, the iodo intermediate was detected as a peak appearing at 
approximately 3 ppm after 3 hrs. As a rough estimate, approximately 30 % of the 
alkyl chloride had been converted to the alkyl iodide. This indicates that chloride-
iodide exchange occurs smoothly. Therefore, if an alkyl iodide peak is not observed in 
these reactions, it implies simply that the alkyl iodide has a short lifetime (Table 21). 
 
O
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I
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31 59  
 
Entry time (h) Conversion (%)a 
1 0 0 
2 3.5 6 
3 5.5 15 
4 9 22 
5 13.5 31 
 
The reaction between resin bound mustard and aniline was not performed under these 
conditions due to practical problems with the mixing in the NMR tube. Instead, an 
experiment was performed in the usual fashion, and samples were removed at regular 
intervals, immediately quenched through cooling and removal of solvent, and the 
resultant resin samples were then prepared for 13C gel-phase NMR (Scheme 41).  
Table 21: Reaction between 31 and iodide in an NMR tube. a) KI (2 equiv), D2O, 80 
°C. aConversion estimated from cutting and weighing of peaks at 3 ppm (-CH2I) and 41 
ppm (-CH2Cl). 
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Unfortunately only reactant and product were visible in the spectra, as most of the 
possible intermediates give peaks in the same area as the reactant and product, but 
some information could be extracted from the experiment. By comparing the peaks at 
64 ppm and 61 ppm it was discovered that the reaction had reached about 50 % 
cleavage after 3.5 h and were close to completion after 7 hrs, meaning that overnight 
reaction would most likely been sufficient for a realistic maximum yield. It could also 
be assumed that the iodo intermediates were relatively short-lived when base was 
present as no –CH2I peak was visible at 3.5 ppm. 
4.2.5 Parallel experiments at different temperatures 
 
To identify the determining parameters in the reaction a series of experiments at three 
different temperatures were set up using Design of Experiments (table 22, 23 and 24). 
Scheme 41: Reaction between 4-methoxyaniline and 31 monitored by NMR. a) 4-
methoxyaniline (5 equiv), K2CO3 (2.5 equiv), KI (2 equiv), 80 °C, 24 h. 
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Entry equiv K2CO3 equiv KI time (h) Yield of 42 
(%)a 
Cleavage (%)b 
1 2.5 2 23 h 38 68 
2 2.5 1 23 h 31 - c 
3 2.5 0 23 h 31 58 
4 1.25 2 overnight 39 65 
5 1.25 1 23 h 28 71 
6 1.25 0 overnight 38 74 
7 0 2 overnight 5 c 
8 0 1 overnight 5 c 
9 0 0 overnight 16 c 
 
 
The reactions were initially run for 23 hours, but experiments showed that full 
reaction could be reached overnight (15-17 h), so this was chosen due to time 
constraints. The general picture from the reaction at 80 °C was that yields were high 
when base was present, but dropped dramatically when only iodide was present (Tale 
22). 
 
When the reaction was run at 60 °C yields were generally lower and the reactions did 
not run to completion overnight (peak from –CH2Cl still visible in the 13C gel phase 
NMR spectrum) (Table 23). The reason might be that 4-methoxyaniline (m.p. = 57-
58°C) was only partly melted at this low temperature and slow in diffusing into the 
beads. This is consistent with the fact that significant cleavage from resin was still 
observed, but no phenyl-containing cleavage product was isolated. Therefore, the 
hydrolytic cleavage without aniline involvement was significant compared to aniline 
addition.  
 
Table 22: Screening reaction between 31 and 4-methoxyaniline at 80 °C. a) 4-
methoxyaniline (5 equiv), K2CO3, KI, water. aIsolated yield of 42 after purification
with FlashMaster (based on initial Versabeads loading). bEstimated from 13C gel-
phase NMR.c No cleavage detected.
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Entry equiv 
K2CO3 
equiv KI time  Yield of 
42 (%)a 
Conversion to 38   
(%)b 
1 2.5 2 overnight 4 -c 
2 2.5 1 overnight 15 - c 
3 2.5 0 overnight 10 23 
4 1.25 2 overnight 10 low 
5 1.25 1 overnight 14 23 
6 1.25 0 overnight 5 32 
7 0 2 overnight 6 31 
8 0 1 overnight 8 - c 
9 0 0 overnight 4 35 
 
 
More surprising, the yields at 100 °C are generally slightly lower than seen at 80 °C 
(Table 24). As the extent of cleavage from resin was still about the same, it is possible 
that the higher temperature favours hydrolysis. This was consistent with the fact that 
more hydrolysis product seemed to be formed (This was estimated from the printouts 
from the FlashMaster, which recorded the UV absorption of the eluent). Otherwise the 
yields showed the same pattern as for 80 °C, similar for all reactions with base, and 
dropping dramatically without base. 
 
Table 23: Screening reaction between 31 and 4-methoxyaniline at 60 °C. a) 4-
methoxyaniline (5 equiv), K2CO3, KI, water. aIsolated yield of 37 after purification
with FlashMaster. bEstimated from 13C gel-phase NMR. cNot estimated due to
poor spectral resolution. 
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Analysis of the results with MODDE showed that the yield of imidazolidin-2-one 42 
was independent of the iodide addition, but affected by the amount of base and the 
temperature. This is consistent with results from literature, where the piperazine 
formation has been shown to be favoured over the addition of a second aromatic 
amine molecule when no base was added.245 
 
Most of the reactions yielded trace amounts of hydrolysis by-products, especially at 
100 °C. Investigation of some of these by NMR showed that when base was present in 
the reaction mixture the hydrolysis product formed was almost exclusively the 1-(2-
hydroxyethyl)-imidazolidin-2-one 53, while the product formed in the absence of base 
(but in the presence of iodide) was the oxazilodin-2-one 41. When neither base nor 
iodide was present a mixture of the two was isolated with the ratio of 1:3 53/41.  
 
Entry equiv K2CO3 equiv KI time  Yield of 42 
 (%)a 
Cleavage 
from resin 
(%)b 
1 2.5 2 overnight 27 63 
2 2.5 1 overnight 34 68 
3 2.5 0 overnight 25 - 
4 1.25 2 overnight 29 65 
5 1.25 1 overnight 29 68 
6 1.25 0 overnight 25 70 
7 0 2 overnight 2 27 
8 0 1 overnight 4 48 
9 0 0 overnight 15  
Table 24: Screening reaction between 31 and 4-methoxyaniline at 100 °C. a) 4-
methoxyaniline (5 equiv), K2CO3, KI, water. aIsolated yield of 42 after purification
with FlashMaster. bEstimated from 13C gel-phase NMR. 
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Figure 22: The proposed 
differently-favoured reaction 
pathways under neutral and 
basic conditions, judged by 
the proportion of byproducts 
(table 25). Under basic 
conditions neutralisation of 
both species are fast and the 
different nucleophilicities of 
the resin-bound species is the 
determining factor. When 
conditions are neutral/slightly 
basic the different acidity of 
the groups becomes a factor.  
  
4.3 Preliminary conclusions 
 
The information gathered so far indicate that the yield of cyclic urea is dependent on 
the lifetime of the ionic intermediate 60 (Figure 23 and 24). When base is present the 
ionic intermediates are short-lived, meaning that the proportion of neutral 
intermediates is high. This means that an aniline molecule is more likely to undergo 
nucleophilic addition when it encounters an electrophile. It is also clear from the 
proportions of the byproducts that the imidazol-2-one ring formation is favoured over 
hydrolysis and oxazilodin-2-one ring formation under basic conditions, thereby 
disfavouring the formation of hydrolysis byproducts. (Figures 22 and 23)  In addition, 
hydrophobic clumping of the aniline (which would lead to higher local concentrations 
of the aniline) is also likely to be very important, since the cyclic urea is not observed 
in other solvents. 
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Entry 
 
 
 
 
equiv K2CO3 
 
 
 
 
equiv KI
 
NN
O
OH
Ar
53   :   NO
O
N
H
Ar
41  
1 2.5 2 1:0.11 
2 1.25 1 1:0.22 
3 1.25 0 1:0.17 
4 0 1 1:7 
5 0 0 1:3 
Table 25: Reaction temperature 80 °C. Estimated ratios by comparison between 
double doublets at 3.60 ppm (41) and 3.65 ppm (53) 
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When base is not present (except for the aniline) the neutralisation is slower, and the 
addition of anilines therefore disfavoured, as an aniline molecule is more likely to 
neutralize 60, and less likely to add to an electrophile. Intramolecular ring closure to 
form the piperazine is therefore comperatively more favoured, which explains the 
higher proportion of piperazine ring closure (Figure 24). 
  
Figure 23: The proposed dominant reaction routes in the presence of 
additional base. The equilibrium between intermediates 60 and 61 is shifted
towards 61, and addition of more than one equivalent of aniline is therefore 
favoured. 
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It was clear that the formation of 42 would be favoured by the addition of more 
equivalents of aniline. This was confirmed by running a reaction with 10 equivalents 
of 4-methoxyaniline instead of 5 under the conditions employed in table 22, entry 1. 
A yield of 51 % of the imidazolidin-2-one 42 was obtained, with 60 % cleavage, 
indicating that the diaddition was greatly favoured over the hydrolysis reactions 
(Table 22, entry 1 had 68% cleavage). 
  
4.4 Perspectives 
 
This new method for synthesising imidazol-2-ones through cyclative cleavage in 
water holds potential for expansion and further investigation. More information on the 
mechanism, scope and limitations of the reaction can be gained by employing other 
anilines and amines in the reaction. Examining the reaction with fluoroanilines would 
be of special interest as this could potentially yield important mechanistic information 
through the use of 19F spectroscopy. 
The scope of the reaction would be greatly enhanced if it could be performed in a way 
so two different nucleophiles could be added to form the imidazolidin-2-one. One way 
of achieving this would be to substitute the carbamate with a dual electrophile  
(Scheme 42). Such additions have been performed on solid-phase bound carbamates 
before with good results.189, 197, 310, 311 
Figure 24: The proposed dominant reaction routes when no additional base is 
present. The long-lived ionic intermediate 60 disfavours a second nucleophilic 
addition of basic aniline. 
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Scheme 42: Possible solid-phase route to differently substituted 1-arylimidazolidin-
2-ones through cyclative cleavage. 
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5 Immobilization and catalytic effect of  manganese 
porphyrin complexes 
5.1 Solid-phase reagents in organic synthesis 
 
Immobilizing the reagents on a solid support instead of the compound is another way 
of utilizing solid-support techniques in organic chemistry. The advantage of this 
approach is that both reagent and product are in solution, meaning that the traditional 
methods of reaction monitoring are available. The immobilized reagents can be easily 
removed and often regenerated and reused. If purification of the product is done with 
scavenger resins, the traditional advantages of solid-phase chemistry, easy use of 
excess and fast purification through filtration, can also be retained (Figure 25). 
 
 
 
 
 
 
The immobilization of reagents on solid phase and their subsequent use in synthesis 
and purification of organic compounds has been extensively reviewed over the last 
decade.312-318 
5.1.1 Ley group research on solid-supported reagents and 
catalysts 
 
The Ley group at University of Cambridge has been one of the most active groups in 
the development of solid phase reagents and scavengers. In recent years the group has 
published papers on immobilized metal-based reagents,319, 320 organic reagents321-323 
and enzymes.324 Several synthetic protocols based on solid phase reagents have been 
developed by the group,325-328 as well as a number of total syntheses of natural 
products329, 330 and drug compounds331 based on this kind of reagents. 
 
Figure 25: Traditional solid-phase synthesis (a) compared to solid-phase synthesis
with immobilized reagents (b) 316 
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Much of this work is aimed at developing automated or on-line synthesis procedures 
based on solid phase reagents, and the group has published several papers on this 
subject. 332-335 
 
5.2 meso-Tetraphenylmetalloporphyrins as catalysts for 
epoxidation 
 
Metalloporphyrins are efficient catalysts for a number of oxidative transformations in 
nature, and a number of catalysts based on these structures have been developed, 
usually stabilized through meso-phenyl substitution (Figure 26) 336-338 These catalysts 
have been shown to catalyze efficiently the epoxidation of alkenes under mild 
conditions with cheap oxidants such as bleach and hydrogen peroxide. Especially 
iron-, manganese- and ruthenium porphyrins have been used for this purpose336, 338-340 
If chiral substituents are introduced, asymmetric epoxidation, a very important 
organic reaction, can be obtained with good e.e. values (50-80 %).341 
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As porphyrins can be cumbersome and expensive to prepare, a number of studies have 
been carried out where metalloporphyrin catalysts are immobilized on a solid 
support.341-348 Especially interesting in the context of Versabeads is the work of de 
Miguel et al., who immobilized a manganese 5,10,15,20 tetraphenylporphyrin (TPP) 
analogue on Argogel and obtained good yields of various epoxides in aqueous phase 
employing sodium periodate as the oxidant (Table 26).349  Unfortunately the ArgoGel 
supported catalyst showed limited stability in these reactions and lost almost all 
activity after 3 cycles of styrene epoxidation. How ever, similar catalytic complex 
immobilized on soluble PEG support had proven stable for up to 6 cycles 346, 350 and 
with the known chemical stability and good swelling properties of Versabeads O, it 
was believed that this support could prove superior to ArgoGel for this use. 
Figure 26: General structure for meso-tetraphenylmetalloporphyrin catalysts. 
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Entry Substrate Yield of epoxide (%)a 
1 styrene 80 
2 1-methylstyrene 51 
3 (Z)-cyclooctene 98 
4 cyclohexene 90 
5 bicyclo[2.2.1]hept-2-ene 64 
 
5.3 Synthesis and test of manganese meso-
tetraphenylporphyrins immobilized on Versabeads. 
 
5.3.1 Porphyrin synthesis methods 
 
Simple meso-phenylsubstituted porphyrins are usually made by condensation of 
pyrroles and aldehydes, followed by oxidation. The earliest syntheses of phenyl-
substituted porphyrins were performed by heating the relevant benzaldehydes with 
pyrrole at reflux in propionic acid under aerobic conditions (Scheme 43). 
Unsymmetrical substitution patterns could be achieved by adding differently 
substituted benzaldehydes, thereby forming a statistical mixture of the possible 
products, which were then separated. 354 
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Table 26: Brule and de Miguel epoxidations of olefins with manganese TPP 
porphyrin supported covalently on ArgoGel.349 Conditions: 
Catalyst:imidazole:substrate:NaIO4 molar ration 1:10:23:46 in acetonitrile/water (2:1) 
at room temperature. aYield determined by GC (based on stating materials consumed 
an by-products present. 
Scheme 43: Synthesis of porphyrins by acid-mediated condensation (reflux in 
propionic acid in aerobic atmosphere). If differently substituted benzaldehydes are 
used a statistic mixture of the possible compounds are formed.354 
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A more recently developed, gentler approach utilizes a Lewis acid mediated 
condensation between the substrates followed by oxidation. 351-353 
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5.3.2 Synthesis of the catalytic complex 
 
5-(4-methoxy)-10,15,20-tetraphenylporphyrin (62) was made by condensation of 
benzaldehyde, 4-methoxybenzaldehyde and pyrrole in refluxing propionic acid after 
the method developed by Little et al.354 The reaction itself was simple as the products 
crystallize from the acid upon cooling, but the separation of 62 from the byproducts, 
tetraphenylporphyrin (63) and particularly the small amount of dimethoxy products 
(64 and 65) required extensive column chromatography. The final yield of 2 % of 62 
is very normal for synthesis of unsymmetrical porphyrins by this method (Scheme 
45). 
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Scheme 45: Synthesis of 62 a) 4-methoxybenzaldehyde (1 equiv), benzaldehyde 
(3 equiv), distilled pyrrole (4 equiv), propionic acid, reflux, 3 h.  The desired 
prophyrin was separated from the other products (63-65) by column 
chromatography. Yield 2 %.  
Scheme 44: Lindsay et al.’s acid mediated synthesis of porphyrins 351  a) Acid, 
e.g. trifluoracetic acid or boron trifluoride. b) mild oxidant, e.g. chloranil. 
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The compound 5-(4-hydroxy)-10,15,20-tetraphenylporphyrin (66) was made by 
cleavage of the methoxy group with BBr3 (Scheme 46). 355, 356  
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In a later experiment an attempt was made to cleave the methoxy group before 
chromatographic separation of the products. The theory was that the increase in 
polarity difference between the porphyrins in the mixture would make 
chromatographic separation easier. Using this method, an overall yield of 1.3 % was 
achieved, and chromatographic separation was better and less time-consuming. 
66 was attached to Versabeads through mesylation and nucleophilic addition, thereby 
forming the complex 67 (Scheme 47).63  
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Another resin-bound porphyrin complex was made through addition of commercially 
available meso- Tetra(pentafluorophenyl)-porphyrin (TPFPP) to Versabeads A 
through nucleophilic addition in dimethyl formamide (Scheme 48). 357 It is known that 
Scheme 46: Deprotection of the hydroxyl group to form 66 a) BBr3 (4.5 equiv), 
dichloromethane, -78 °C → r.t., overnight. Yield 73% (Overall yield from starting 
materials 1.5 %).
Scheme 47: Immobilization of 66 on Versabeads O a) Mesyl chloride (20 equiv), 
pyridine (84 equiv), DCM, r.t.,1.5 h, repeated. b) 66 (1.3 equiv), NaOH (1.1 equiv), 
DMF, 90 °C overnight. Yield 70% (Estimated from CHN and Weight gain) 
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the reactivity of tetraphenylporphyrin complexes in oxidation reactions can be 
increased by having electron withdrawing groups on the phenyl rings.336 
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The immobilized porphyrins were metallated with Mn under the conditions used by 
de Miguel et al. (2h reflux in dimethyl formamide with excess MnCl2*4H2O) 349 to 
give the catalytic complexes 69 and 70. The metal content of the resins were 
determined by AAS. Resin samples were dissolved in warm nitric acid and diluted, 
after which the concentration was determined by evaporating the samples in an 
acetylene/oxygen flame and comparing it to standards. 
 
From the described methods several batches of 69 and 70 were made, with mixed 
results (Table 27). The differences might be attributed to pollution with oxygen which 
might have oxidized manganese (II) to a state unavailable for the porphyrins 
(reference state rigorous anhydrous and anaerobic conditions)  
 
Scheme 48: Immobilisation of 5,10,15,20 – meso tetra(pentafluorophenyl)porphyrin 
(TPFPP) on Versabeads A800 (PEGA) to form complex 68 (Ar = C6F5-). a) TPFPP 
(1.4 equiv), DIPEA (1.4 equiv), DMF, 110 °C, overnight. 
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entry Catalyst made theoretical max. 
loading 
(mmol/g) 
AAS loading 
(mmol/g) 
Yield 
(%) 
1 69 0.8 0.9 100 
2 69 0.8 0.2 25 
3 70 0.26 0.08 30 
4 69 0.26 0.03 11 
5 69 0.8 0.29 37 
6 70 0.26 0.05/0.06 20 
 
5.3.3 Attempted synthesis of porphyrin directly on solid phase 
 
Earlier work has examined the synthesis of tetraphenylporphyrins directly on resin 
from a resin-bound aldehyde.358, 359 If the porphyrin could be synthesised directly on 
resin it could potentially avoid the cumbersome chromatographic separation of the 
porphyrins. An attempt was made to condense the porphyrins directly on resin using 
immobilised 4-hydroxybenzaldehyde.63 As the propionic acid route produced huge 
amounts of polymeric impurities which might be trapped in resin, it was decided to try 
the milder Lewis acid mediated condensation of dipyrrolephenyl, followed by 
oxidation instead. Meso-phenyldipyrromethane 71 was produced in 53% yield 
(Scheme 49), but subsequent attempts to condense this compound with immobilized 
4-hydroxybenzaldehyde (26) and benzaldehyde (Scheme 50) did not produce any of 
the characteristic bands in the IR spectrum. The reason might be that the condensation 
of benzaldehyde and polymerization was too favoured, compared to diffusion into the 
beads and reaction with the resin-bound aldehydes.  
 
Table 27: Determination of the metal content in the various batches of catalytic 
complexes 69 and 70 by AAS 
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Recently Yang et al has succeeded in making simple porphyrin on polystyrene 
through the propionic acid route, followed by oxidation with 2,3 dichloro-5,6-
dicyanoqunoline.360 
 
5.3.4 Test reactions 
5.3.4.1 Sulphide oxidation 
 
Due to the carcinogenic nature of epoxides the oxidation of alkenes was not a feasible 
test reaction for the catalysts due to administrative reasons. Instead the oxidation of 
thioanisole to sulphoxide with tert-butyl hydroperoxide was chosen as a test case for 
the catalyst, Oxidation to sulphoxides has previously been used in investigation of the 
catalytic properties of iron porphyrin complexes in water.347, 361 tert-Butyl 
hydroperoxide  has been reported to oxidize sulphides, in some cases with MnO4 as 
co-reactant,362, 363 but a blind test reaction with oxidant gave no oxidation of the 
sulphide. 
Scheme 50: Attempted synthesis of porphyrins directly on resin. a) 71 (4 equiv), 
benzaldehyde (4 equiv), trifluoracetic acid (1 equiv), dichloromethane, r.t, 2 h b) 
2,3-dichloro-5,6-dicyanoquinoline (6 equiv) c) 71 (3 equiv), benzaldehyde (1.5 
equiv), boron trifluoride etherate (1.2 equiv), DCM, r.t., 2 h.  
  
Scheme 49: Synthesis of meso-phenyldipyrromethane 71 a) Trifluoracetic acid 
(cat.), pyrrole, r.t., 50 min. 
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Entry substratea: 
oxidantb: 
imidazole 
(mmol/equiv) 
Catalyst (mmol) Other additivesc Solventd 
(mL:mL) 
 
Other 
conditionse 
1 0.23 : 0.44 : 0.1/ 
9 : 18 : 4 
none 0.025 mmol 
MnCl2*4H2O 
4 : 2 stirred 
2 0.23 : 0.44 : 0.1/ 
85  :  163 : 37 
69 
(0.0027) 
- 4 : 2 stirred 
3 0.23 : 2.2 : 0.1/ 
9 : 90 : 4 
none 0.025 mmol 
MnCl2*4H2O 
4 : 2 stirred 
4 0.23 :  2.2 : 0.1/ 
85 : 815 : 37 
69 
(0.0027) 
- 4 : 2 stirred 
5 0.23 : 0.44 : 0.1/ 
85 : 163 : 37 
69 
(0.0027) 
- 4 : 2 shaken 
6 0.17 : 1.7 : 0.1/ 
63 : 630 : 37 
69 
(0.0027) 
- 3 : 1.5 stirred 
7 0.23 : 2.2 : 0.1/ 
85 : 815 : 37 
69 
(0.0027) 
1 mmol 2,6-di-
tert-butyl-4-
methoxyphenol 
4 : 2 shaken 
8 0.23 : 2.2 : 0.1/ 
77 : 733 : 33 
70 
(0.003) 
- 4 : 2 shaken 
9 0.23 : 2.2 : 0.1/ 
85 : 815 : 37 
69 
(0.0027) 
- 2 : 1 shaken 
10 0.23 : 2.2 : 0.1/ 
85 : 815 : 37 
69 
(0.0027) 
- 4 : 2 stirred g 
11 0.23 : 2.2 : 0.1/ 
77 : 733 : 33 
70 
(0.003) 
- 4 : 2 stirred g,h 
12 0.23 : 2.2 : 0.1/ 
- 
- Versabeads/Mni 4 : 2 stirred g 
13 0.23 : 0.44 : 0.1/ 
230 : 440 : 100 
70 
(0.001) 
- 4 : 2 stirred g,h 
14 0.23 : 0.44 : 0.1/ 
58 : 110 : 25 
69 
(0.004) 
- 4 : 2 stirred g,h 
 
Table 28: Conditions for the test of 69 and 70 as catalysts in the oxidation of thioanisole.   
a thioanisole, added as a standard solution in acetonitrile. b tert-butyl hydroperoxide, added as 
commercially available 70 % aqueous solution. c All reactions contained 1,2-dichlorobenzene, 
which was used as an internal standard for GC monitoring. d acetonitrile/water e all reactions 
were performed at room temperature. f radical inhibitor. g catalyst protected in an Irori Kan™ 
and removed after 1 h. h catalyst reused under the same conditions. iVersabeads O treated with 
MnCl2*4H2O in dimethyl formamide at reflux 
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Entry a Times 
reused 
GC conversion (%)b
  15 min 1 h 2 h 3 h later 
1  - - 0 - 48 h :  8; 
65 h :  3. 
2  15 31 39 46 17 h : 52;  
20 h : 54; 
48 h : 56. 
3  - 3 - - 53 h : 19. 
4  26 44 56 -   4 h : 68; 
17 h : 80; 
  20 h : 81. d 
 
5  20 24 32 36 24 h : 45; 
  29 h : 44.d 
6  34 60 66 71 20 h : 86; 
28 h : 87.  
7  11 - - 49 5 h : 59; 
24 h : 77; 
48 h : 70.d 
8  60 69 71 - 4 h : 72; 
5 h : 72. 
9  34 56 67 73 4 h : 77; 
5 h : 77; 
7 h : 80. 
10  17 35 46 54 4 h : 61. 
 1 1 14 23 19 4 h : 15; 
7 h : 28. 
11  55 77 - 82 5 h : 84; 
24 h : 85. d 
 1 - 41  - 4 h : 65; 
6 h : 72; 
24 h :  77.  
 2  5 - 9 4 h : 13; 
24 h : 37. d 
12  - - 0 - 24 h : 0.1. 
13  30 48 52 - 5 h : 60. 
 1 6 16 21 25 - 
 2 4 12 9 13 - 
 3 4 10 18 - 72 h : 32. 
 4 - - 10 - - 
 5 - 3 5 - 5 h : 8. 
14  18 33 - 41  9 h : 47. 
 1 - 0.5 - - - 
Table 29: Results from the use of 69 and 70 in the oxidation of thioanisole as described 
in table 28. aEntry numbers corresponds to entries in table 28. bGC (Program: 60 °C, 3 
min; 8 °C/min until 160 °C). Conversion measured as disappearance of starting material 
relative to 1,2-dichloromethane. c Catalyst removed after 1 h. d Mn content in solution 
determined by AAS: Entry 4 : 0.58 μmol (22 %); entry 5: 0.86  μmol (35 %); Entry 7: 
0.02 μmol (1 %); entry 11, first run: 1.5 μmol (50 %); entry 11, second reuse: 0.75 
μmol.(25 %). 
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Reactions were monitored by the use of GC with 1,2-dichlorobenzene as an internal 
standard. A graph over catalyst activity (Figure 27) reveals that the first experiments) 
showed that conversion and rate depended on oxidant concentration and method of 
agitation, as stirring gave faster reaction rate and larger conversion than shaking 
((Entry 2, 4 and 5). An increased catalyst: substrate ratio (Entry 6) gave a higher rate 
initially as did an increase in substrate concentration (Entry 9).  
In all reactions catalyst seemed to be leaching into solution, judged by the rapid 
colouring of the reaction solution after addition of the oxidant. Furthermore the 
catalyst beads were physically broken down during the course of the reaction. This 
was initially believed to be the result of mechanical stress from the magnetic stirring, 
but the employment of shaking as an agitation method, and later the use of Irori 
kans™ 364 for bead protection did not prevent breakdown and leaching. On the 
contrary, upon removal of the Irori kan™ with the catalyst after 1h of reaction it was 
demonstrated that the reaction continued without the catalyst. Reuse of the catalyst 
showed that the catalyst had lost significant activity after the first reaction. (Table 29, 
entry 10)  Subsequent AAS analysis of some of the reaction solutions detected the 
presence of a significant amount of Mn in the solution. 
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It was suspected that the catalyst might not have been properly attached to the resin 
before reaction, but an experiment with Mn adsorbed to SPOCC had no catalytic 
effect in reaction (Entry 12) and when porphyrin was adsorbed to resin (as opposed to 
covalently attached) to the beads were visibly different in colour and IR spectrum 
from 67. An experiment with non-metallated porphyrin in a reaction solution proved 
that 67 was stable to reaction conditions, and that the leaching and breakdown of the 
beads most likely was caused by chemical instability towards the catalyst itself.  
Figure 27: A comparison of the initial activities of catalysts 69 and 70 under 
various conditions. Not surprising an increased amount of oxidant leads to 
higher reaction rate (Entry 2 and 4), and an increased concentration further 
improves the rate (Entry 9) Note the differences between reactions with 
stirring (Entry 4), shaking (Entry 5) and stirring with catalyst in Irori kan™ 
(Entry 10). Also note the high initial activity (and fast deactivation) of 70 
(entry 8) compared to 69 (Entry 4). 
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Catalyst breakdown and deactivation might be attributed to the formation of highly 
active radical intermediates, involving Mn(IV) and Mn(V). The formation of these 
can be prevented by adding a radical inhibitor to the reaction according to a study 
performed by Serra et al. 365 In one experiment  the radical inhibitor 2,6-ditertbutyl-4-
methoxyphenol was added to the reaction mixture, which resulted in increased yield 
and conversion (Table 29, Entry 7) The solution was again discoloured as the reaction 
progressed, but the Mn content found by AAS was remarkably low (1 % of 
theoretically possible compared to 33% for Entry 4). This might indicate that the 
highly active intermediates are partly responsible for the deactivation and breakdown. 
On the other hand the solution analyzed with AAS had a tendency to split in two 
phases, due to the high amount of organic material present, hence this result might not 
be considered conclusive.  
A new batch of 69 was prepared (Table 27, entry 5). Upon use in the test reaction 
(Table 29, entry 10) with removal after 1 hour, this catalyst deactivated much faster 
than seen in earlier experiments with a catalyst with a lower loading, and showed 
virtually no activity in the second run (table 29, entry 14).  
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Experiments with 70 as catalyst showed a higher initial rate of oxidation than with 69, 
but also a faster deactivation, which might indicate that the electron-deficient catalyst 
is more active, but also more prone to breaking down the resin. This could also be a 
question of Versabeads A being less stable than Versabeads O, as the former contains 
amide bonds (Table 29, entry 8).  
A later experiment where catalyst 70 was reused six times showed that the activity 
seemed to stabilize after two reuses (at a level of approximately 20 % of the initial 
activity), again indicating that lower loading levels might be more stable. The catalyst 
was, however, completely destroyed after six runs (only traces of the beads were left 
in the Irori Kan™) (table 29, Entry 13 and figure 28). 
 
 
Figure 28: Reuse of catalyst 70 (Table 29, entry 13). The results indicate that 
an approximate steady state is reached between the third and the fifth run.  
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5.3.4.2 Epoxidation 
 
In an attempt to reproduce the de Miguel epoxidation of styrene with 70 and sodium 
periodate as oxidant (Scheme 51), 54% conversion was reached in 12 h (for 
comparison de Miguel et al reached 80%, but with a substrate/catalyst ration of 23:1). 
When the catalyst was removed the reaction continued, eventually reaching 84% 
conversion in 24 h. Upon reuse of the catalyst only 14% conversion was obtained. 
 
O
a)
 
 
 
5.4 Lanthanide porphyrin 
 
Lanthanide salts are versatile catalysts in a number of organic transformations, for 
instance air- and water-stable Lewis acids. 366 367, 368 Lanthanides supported on ion-
exchange resin have been used to catalyse a number of reactions in water with good 
results.369 
In a 1999 article by Wong et al. phenyl isocyanate was trimerised in 100% yield using 
0.33 mol% of an Ytterbium tetraphenylporphyrin complex (Figure 29) as a Lewis acid 
catalyst under neat conditions. The catalyst showed remarkable stability, as it was 
reused two times without loss of activity. 370 
This prompted an investigation into whether an Yb porphyrin could be made on resin. 
Resin was treated with a large excess of YbCl3*6H2O at reflux in DMF, but there was 
no detectible change as measured by IR. As mono lanthanide porphyrins are known to 
be unstable towards acid,371 it is possible that the HCl formed upon addition have 
prevented immobilization of the metal. Further experiments were not attempted. 
Scheme 51: Epoxidation of styrene with 70 after the protocol of de Miguel et al. a) 70 (Irori
Kan™): imidazole: styrene: NaIO4 1:39:73:153, 1,2-dichlorobenzene, acetonitrile/water (2:1),
r.t. Conversion: 12 h: 54 %, 24 h: 84 %. Conversion upon reuse: 12 h: 14 % 
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5.5 Perspectives 
 
It was demonstrated that porphyrins can be immobilized and metallated on 
Versabeads, and analyzed successfully by AAS. The functionalised resin was 
apparently not stable to oxidative conditions, but the immobilized metalloporphyrins 
might still be useful in other metalloporphyrin-catalyzed reactions, such as 
cyclopropanation.  
 
 
Figure 29: A stable Ytterbium porphyrin complex with catalytic properties by 
Wong et al. 370 
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6 Conclusion 
 
The present dissertation has investigated a number of possible uses for the SPOCC- 
based high-loading resin Versabeads, with special reference to the possibilities of 
performing chemistry in water and scaling-up of on-resin reactions to gram-scale. 
Furthermore, attempts were made to immobilize metalloporphyrin catalytic 
complexes on the resin.  
 
6.1 Large- scale synthesis on solid phase  
 
Two linkers based on known solid-phase chemistry were made on Versabeads and 
used in the synthesis of compounds of pharmaceutical interest: the acrylic acid based 
REM linker and the chloroformyl linker based on addition of phosgene. The 
chloroformyl linker was functionalized readily by the reaction of an amine salt in 
water. This reaction was used to synthesise a series of piperazines with different 
functionalities in good to fair overall yields and purities. The possibility of 
introducing additional functionalities through addition of nucleophiles in the cleavage 
step was briefly explored. This seems a promising concept, although further 
experiments did not yield any compound. 
  
Likewise it was demonstrated that microwave heating could be used for rapid 
optimisation of reaction conditions on Versabeads similar to solution phase. The time-
consuming reaction between mustard and anilines was optimized in a few days 
employing microwave heating. In the context of the desired acceleration of the initial 
drug development process this is a very interesting result 
Using these optimized conditions a small organic molecule 45a was synthesised on a 
0.19 mol scale in good yield and excellent purity with only simple washing 
procedures as purification between steps. 
 
The high-loading Versabeads could be reused without loss of activity. The question 
remains as to whether or not their physical properties change upon reuse, the extent of 
bead breakdown, and how to minimize it. 
 
The REM linker was synthesised on resin and used for synthesis of difunctionalized  
piperazines. Again excellent compatibility between aqueous chemistry and 
Versabeads was demonstrated, as the reaction between allyl bromide and resin-bound 
piperazine took place with good yields. The good microwave properties of the resin 
was also documented, as evidenced from the good yields obtained by heating the 
reactions in this fashion. The REM linker based synthesis pathway was not explored 
in depth but appears promising. 
 
The possibility of attaching a Wang linker to Versabeads was briefly explored and 
appeared to give a promising result. The easy access to attachment of various 
aromatic linkers based on phenol derivatives through direct nucleophilic addition or 
Mitsunobu reaction is a very useful result for further derivatization of the resin. 
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An important result was the discovery that cleavage of derivatized resin caused a 
distinct change in the 13C gel-phase NMR spectrum, and the possibility to monitor 
reactions directly on the solid-phase through the use of short-time NMR experiments 
which made the solid-phase method more amenable for routine use as a tool in 
development chemistry. 
 
It was shown that multi-step larger-scale solid phase synthesis could be easily 
accomplished in standard three-necked round-bottomed flasks using a glass tube 
equipped with a sinter to remove solvent from the reaction suspension, thereby 
avoiding the use of special solid-phase vessels for gram-scale solid-phase chemistry, 
which increases the practical use of this reaction pathway.  
 
In short, it was demonstrated that a small molecule could be synthesised quickly and 
efficiently through solid-phase techniques using Versabeads. 
6.2 Synthesis of imidazolidin-2-ones by cyclative cleavage 
 
The surprising generation of an imidazolidin-2-one upon reaction between an aniline 
and the resin-bound mustard 31 in water led to a closer investigation of the 
mechanism and conditions behind the cyclative cleavage. Apparently the lifetime of 
the ionic intermediate 60 from the first addition of aniline is likely to be the 
determining factor for the ratio between cyclative cleavage and piperazine formation.  
 
The cyclative cleavage reaction is very interesting, as the carbamate linker is 
otherwise very chemically stable, and it is quite possible that the favouring of this 
very interesting reaction is unique for hydrophilic resins like Versabeads. As 
described the reaction also takes place to some extent with mustard derivatives in 
aqueous solution, and this reaction has prompted further investigation at H. Lundbeck 
A/S. 
 
6.3 Immobilization of metalloporphyrin catalysts on 
Versabeads 
 
During the 6-month stay at the Ley group in Cambridge 5-(4-hydroxy)-10,15,20- 
mesotetraphenylporphyrin suitable for covalent linking to Versabeads was 
successfully synthesised and added to Versabeads O by known methods. 5,10,15,20 
meso tetrapentafluorophenylporphyrin was immobilized successfully on Versabeads 
A, and both resin-bound porphyrins were complexed successfully with manganese. It 
was demonstrated that the catalytic complex hereby generated was an efficient 
catalyst towards sulphide oxidation and styrene epoxidation, but unfortunately the 
resins were unstable towards the catalytic complexes, as demonstrated by the removal 
of catalyst from the reaction solutions during reactions. 
Although the resin thus proved not to be stable towards the oxidation catalysts these 
experiments have demonstrated the possibility for immobilizing metal complexes on 
Versabeads through nucleophilic addition and on-resin derivatization.  
Attempts to synthesise the tetraphenyl porphyrin complex directly on resin from resin-
bound 4-hydroxybenzaldehyde 26 proved unsuccessful. Addition of the lanthanide 
ytterbium to the resin was also unsuccessful.  
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7 Experimental 
 
7.1 Equipment used 
 
All chemicals and solvents were used as received unless otherwise stated. All 
reactions were run under nitrogen unless otherwise stated. All equivalents and yields 
in solid-phase reactions are based on initial Versabeads loading unless otherwise 
stated. Overnight reaction time is defined as 15-17 h. Solution-phase NMR were 
recorded on a Bruker 500 MHz spectrometer (Bruker 400 MHz for porphyrin 
experiments). 13C gel-phase NMR were recorded on a Bruker 250 MHz spectrometer 
using ordinary, disposable Norell NMR tubes. 1H MAS NMR were performed at 
11.75 Tesla on a Bruker Avance DRX-500 instrument. The MAS spin rate was 4 kHz. 
Automated flash chromatography was performed on an Argonaut Flash Master II 
using Isolute Flash Si II prepacked columns. Microwave heating was performed in 
closed vials on an Emrys Optimizer. LC/MS, UV and ELSD analysis were run in an 
integrated system. Key compounds were analyzed with a Waters Symmetry C18 
column (4.6x30 mm, particle diameter 0.035 mm). MS were acquired using an 
Applied Biosystems API300 triple quadrupole mass spectrometer with Atmospheric 
Pressure Photoionization (APPI) ionsource.  UV spectra were recorded with a 
Shimadsu SPD10A UV detector at 254 nm and ELSD with a Polymer Laboratories 
PL-ELS 2100 ELS-detector. ELSD analyzed screening was performed with a CDX85 
ELSD detector. HPLC of crude products were taken on a Varian Star HPLC using a 
LiChrosobe RP-8 column (4x250 mm, particle diameter 0.005 mm). Eluent 
acetonitrile/water 50:50 buffered to pH=3 with a triethylamine/phosphate buffer.   GC 
analysis was performed on a Hewlett Packard 5890 Series II instrument. Infrared 
spectra were taken on FT-IR instruments using attenuated total refractance (ATR). 
Melting points were recorded on a Büchi B-540 melting point apparatus and appear 
uncorrected. CHN analyses were performed at the analytical department at H. 
Lundbeck A/S, halogen and sulphur analysis at the University of Vienna, Department 
of Physical Chemistry (Vienna, Austria).
 110
 
7.2 The synthesis of Versabeads 
 
(3-ethyloxethan-3-yl) triethylene glycolyl acetate (1) 
 
(3-ethyloxethan-3-yl) triethylene glycol (201 g, 0.81 mol, 1 equiv) was slowly 
dissolved in pyridine (400 mL) on an ice bath. Acetic acid anhydride (200 ml, 216 g, 
2.12 mol, 2.6 equiv) was added slowly with cooling, and the reaction was allowed to 
proceed overnight at room temperature. The reaction mixture was dissolved in ethyl 
acetate (1000 mL). The organic solution was washed with water (2 x 1000 mL) and 
brine (2 x 250 mL) and dried (anhyd magnesium sulphate). The solvent was removed 
in vacuo to give 166 g (71% yield) of 1 as a light yellow oil.  
  
1H-NMR (CDCl3; 250 MHz): δ = 0.9 (3H, t, H1); 1.7 (2H, q, H2); 2.0 (3H, s, Ac-) 
3.5-3.8 (12H, m,(-(CH2CH2O)n-); 4.1 (2H, m, H3) 4.2-4.5 (4H, m, oxethane ring)  
 
(3-ethyloxethane-3-yl)methyl tosylate (2) 
 
(3-ethyloxethane-3-yl)methanol (203 g, 1.75 mol, 1 equiv) was cooled to 0°C on a dry 
ice bath. An aqueous solution of sodium hydroxide (3 M, 700 mL, 2.1 mol, 1.2 equiv) 
was added followed by addition of a solution a solution of tosyl chloride (398 g, 2.08 
mol, 1.2 equiv) in THF (700 mL). The temperature was kept below 5°C. After 
addition the solution was allowed to stand for 3 h. NaCl was added until an organic 
phase separated. The organic phase was evaporated and the remains were dissolved in 
ethyl acetate (200 mL). This solution was washed with water (2 x 200 mL), saturated 
aqueous sodium bicarbonate (1 x 200 mL) and brine (1 x 200 mL), dried  (anhyd 
magnesium sulphate) and evaporated. 
To remove excess tosyl chloride the product was dissolved in  ethyl acetate (250 m L) 
and washed with saturated aqueous sodium bicarbonate (1x200 mL) and 1 M aqueous 
sodium carbonate (2 x 200 mL). The organic phase was washed with brine (200 ml), 
dried  (anhyd magnesium sulphate) and evaporated. 
The product was dissolved in ethyl acetate (250 mL) then washed with 1 M aqueous 
ammonia (3 x 200 mL), dried (anhyd magnesium sulphate) and evaporated to give 
product 2. Product contains 4.4 % (w/w) of p-toluenesulphonic acid as an impurity. 
Yield: 311 g (64%) 
 
1H-NMR: (CDCl3; 250 MHz) δ = 0.7 (3H, t, H1); 1.7 (2H, q, H2); 2.3 (3H, s, Tosyl- + 
water) 4.1 (2H, s, H3); 4.2-4.3 (4H, m, oxethane ring); 7.3 (2H, d, Tosyl-) 7.8 (2H, d, 
Tosyl-) 
 
Bis(3-ethyloxethan-3-yl)PEG-12 (3) 
 
(3-ethyloxethan-3-yl) PEG-12 (333 g, 0.51 mol, 1 equiv) was slowly added to a 
suspension of potassium tert-butoxide (87 g, 0.78 mol, 1.5 equiv) in THF (200 mL) at 
room temperature. 2 (172 g, 0.64 mol, 1.2 equiv) was added slowly as a solution in 
THF (total volume 500 mL). 
THF (1400 mL) was gradually added to the mixture over the next hour, to make it less 
viscous, and the reaction was allowed to stand overnight without stirring and then 
filtered. The filtrate was concentrated in vacuo and the residue was dissolved in 
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dichloromethane (500 mL). The organic phase was washed with water (2 x 500 mL), 
1 M aqueous sodium carbonate (2 x 250 mL) and brine (2 x 250 mL), dried (anhyd 
magnesium sulphate) and evaporated. 
End weight: 257 g with 3% (w/w) of p-toluensulphonic acid as an impurity. Yield 67 
% 
 
1H-NMR (500 MHz; CDCl3): δ = 0.82 (6H, t, H1) 1.67 (4H, q, H2) 3.52 (2H, s, H3); 
3.57 (56H, s, -(CH2CH2O)n-)) 4.35 (8H; m; oxethane rings) 7.8 (TsOH impurity) 
 
Polymerization process to form Versabeads. 
 
1 (18 g, 25 mmol, 1 equiv) and 3 (5.8 g, 20 mmol, 0.8 equiv) was dissolved in 
acetonitrile (10 mL) with 1% surfactant (Polysurf 30). The solution was cooled to -
20°C under Ar and boron trifluoride diethyletherate (0.6 mL (ρ=1.120), 0.71 g, 5 
mmol, 0.2 equiv) was added. The solution was quickly transferred to silicon oil (600 
mL) in a polymerization reactor. The suspension was stirred at 250 rpm at room 
temperature for 2 h and then left standing overnight. 
The silicon oil suspension was filtered and the beads were washed successively with a 
hexane/heptane mixture, dichloromethane, tetrahydrofurane, methanol and water. 
Sieving of the beads yielded equal amounts of 120-80 μm beads and 80-40 μm beads. 
IR = 1734 cm-1 
The beads were suspended in 4 M aqueous HCl and heated for 2 h at 60°C, and then 
washed repeatedly with water until the pH of the washing water was above 6, then 
dried.  
IR showed no trace of the ester stretch at 1734 cm-1.  
Total yield 6.69 g 
 
13C gel phase NMR (62.5 MHz; CD2Cl2): δ = 73.4 (-CH2CH2OH), 71.3 (-
(CH2CH2O)n-), 62.3 (-CH2CH2OH), 44.1 (C1), 22.2 (C2), 8.3 (C3). 
 
Loading by Fmoc – glycine method: 0.5-0.6 mmol/g ~ 25% of theory. 
 
13C gel phase NMR of Versabeads O400 (Batch 1050007) (62.5 MHz; CDCl3): δ =  
72.3 (-CH2CH2OH), 70.3 ( -(CH2CH2O)n-), 61.3 (-CH2CH2OH); 43.1/40.9 (C1) 23.0 
(C2) 17.2(C3) 7.5 (-) (C4) (Appendix A - Spectrum 1) 
 
Fmoc Glycine Loading measurement general method 
 
Fmoc-glycine (3 equiv relative to supposed loading), methyl imidazole (6 equiv) and 
2,4,6-mesitylenesulfonyl-3-nitro-1,2,4-triazolide (6 equiv) was dissolved in dry 
dichloromethane at room temperature. The solution was added to ca. 50 mg 
Versabeads and the suspension was left for 45 min. The resin was washed with dry 
dichloromethane and dry DMF and the coupling reaction was repeated. The 
suspension was washed with dry dichloromethane (6 x 5 mL); dry DMF (6 x 5 mL) 
and dry methanol (1 x 5 mL) then dried on lyophilizer overnight. 
Samples (size 5-10 mg) were treated with 5.00 mL of piperidine in DMF (20% v/v). 
The UV absorbance of the resulting solution was measured at 290 nm and compared 
to standard solution. 
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7.3 Linker synthesis 
 
7.3.1 Carbamate linker synthesis 
7.3.1.1 Initial synthesis 
 
Initial synthesis of chloroformyl linker 4 on Versabeads  
 
Versabeads O400 (2.5 g, 1.25 mmol, 1 equiv) were suspended in dry dichloromethane 
(15 mL). Triphosgene (1 g, 3.4 mmol, 8 equiv) was added and the suspension was 
cooled on ice. After 20 min pyridine (0.25 mL (ρ= 0.978 g/mL), 0.24 g, 3.1 mmol, 2.5 
equiv) was added slowly, the cooling bath was removed and the reaction was stirred at 
room temperature overnight. The resin was filtered, washed with DMF (5 x 5 mL) and 
dried. 
IR = 1770 cm-1 
Cl elemental analysis: 1.08% ~ 0.30 mmol/g (65% yield) 
 
Addition of nucleophile to form 5 
 
Resin 4 (1 g, 0.3 mmol, 1 equiv (based on elemental analysis of 4)) was suspended in 
DMF (8 mL) N-benzyl-N-methylamine (645 μL (ρ= 0.94 g/mL), 0.61 g, 5.0 mmol, 17 
equiv) was added to the suspension, followed by DIPEA (0.13 mL ( ρ= 0.74 g/mL), 
0.10 g, 0.77 mmol,  4 equiv). The reaction was shaken at room temperature overnight, 
filtered, washed with DMF (5 mL), DCM (5 mL) and ethanol (5 mL) and then dried, 
to give resin 5. 
IR = 1705 cm-1 
1H MAS NMR (500 MHz, CD2Cl2): 2.8 ppm (-NCH3); 4.4 ppm (PhCH2N-); 7.1-7.4 
ppm (Ph-) 
 
Proof of concept: Reaction of 4 with 4-fluoroaniline to yield 6  
 
Versabeads O400 (0.51 g, 0.25 mmol, 1 equiv) was suspended in THF (3 mL) in a 
syringe. A solution of phosgene in toluene (20% w/w, 1.25 mL (ρ = 0.935 g/mL), 
0.23 g, 2.3 mmol, 9 equiv) was added and the mixture was agitated at room 
temperature overnight.   
Th resin was washed with THF (3 x 5 mL), then suspended in a solution of 4-
fluoroaniline (0.66 g, 6 mmol, 24 equiv) in THF (5 mL) and agitated by rotating for 6 
h at room temperature. 
The resin was filtered, washed with THF (3 x 5 mL), DCM (5 mL), methanol (5 mL), 
DCM (5 mL) and methanol (5 mL) and then dried. 
 
13C gel-phase NMR (62.5 MHz, CDCl3): δ = 156 ppm (C1); 153 ppm (C2); 135 ppm 
(C3); 120 ppm (C4); 115 ppm (C5). 
19F NMR (470 MHz, CDCl3): – 121 ppm 
1H MAS NMR (500 MHz, CD2Cl2) 7.4 ppm; 7.2 ppm; 7.1 ppm; 6.8 ppm (aromatic 
protons) 
IR: 1732 cm-1 
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Proof of concept: Reaction between Versabeads and 4-fluorophenyl isocyanate to 
form 6 
 
Versabeads O400 (0.53 g, 0.27 mmol, 1 equiv) was suspended in a solution of 4-
fluorophenyl isocyanate (0.49 g, 3.6 mmol, 13 equiv) in dichloromethane (3 mL). 
After 1 h at room temperature a catalytic amount of trietyl amine was added and the 
suspension was agitated for 20 h. The suspension was filtered and the resin was 
washed with DCM (6 x 5 mL), THF (6 x 5 mL) and methanol (2 x 5 mL) and then 
dried to give resin 6. 
13C gel-phase NMR (62.5 MHz, CDCl3): δ = 156 (C1); 153 (C2); 135 (C3); 120 (C4); 
115 (C5). 
19F NMR (470 MHz, CDCl3): δ =  – 121. 
1H MAS NMR (500 MHz, CD2Cl2): δ = 7.4, 7.2, 7.1, 6.8. (aromatic protons). 
IR: 1732 cm-1 
7.3.1.2 Investigation of cleavage conditions 
 
Initial synthesis of 7 
 
Resin 4 (1.8 g, 1.2 mmol, 1 equiv) was suspended in a solution of 1-
dimethylphenylpiperazine (3.1 g, 12 mmol, 10 equiv) and triethylamine (0.25 mL (ρ = 
0.73 g/mL), 0.18 g, 1.8 mmol, 1.5 equiv) in THF (6 mL), and the suspension was 
agitated at room temperature overnight. The suspension was filtered and the resin was 
washed with THF (6 x 5 mL), DCM (3 x 5 mL) and methanol (2 x 5 mL), then dried 
to give resin 7. 
 
13C gel phase NMR (62.5 MHz, CD2Cl2): δ = 156.9 (C1); 143.4 (C2); 129.4 (C3); 
128.6 (C4); 127.9 (C5); 76.7 (C6); 71.3 (framework); 65.3 (CH2CH2OR); 52.4 (C7); 
44.7 (C8) 24.0, 8.4 (framework). 
1H MAS NMR (500 MHz; CD2Cl2): δ = 0.9 (framework) 2.4 (H1); 3.5 (H2); 3.6 
(framework); 4.3 (H3); 7.2 (H4); 7.3 (H5); 7.4 (H6);  
IR: 1701 cm-1 
N analysis gave 2.6 % ~ 0.92 mmol compound/g (160 % of theoretical content) 
 
7.3.1.3 Acid/base mediated cleavage 
 
Initial attempts to cleave 1-diphenylpiperazine (8) from resin (table 4) 
 
Trifluoracetic acid/dichloromethane (entry 1) 
 
Resin 7 (0.92 g, 0.48 mmol, 1 equiv) was suspended in a mixture of dichloromethane 
and trifluoroacetic acid (1:1, 5 mL) and agitated for 1 h at room temperature. The 
suspension was filtered and the resin was washed with dichloromethane (3 x 10 mL). 
The cleavage reaction was repeated. The combined filtrates were evaporated to give a 
crude yield of 0.01 g. (< 10%). CHN analysis: 1.1 % N  
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HBr/acetic acid (entry 2) 
 
Resin 7 (0.88 g, 0. 46 mmol, 1 equiv) was suspended in a mixture of concentrated 
hydrobromic acid (48 % (w/w), 3 mL) and glacial acetic acid (3 mL). The suspension 
was agitated at room temperature overnight. The suspension was filtered and the resin 
was washed with water (3 x 10 mL) and dichloromethane (3 x 10 mL) and then dried. 
13C gel-phase NMR (62.5 MHz, CD2Cl2): δ = 156 (C1); 129 (C2/C3); 77.2 (C4); 71.3 
(framework); 65.7 (CH2CH2OR); 52.4 (C5); 44.2 (C6) 24.0, 8.4 (framework). 
CHN analysis: 2.4 % N  
The filtrate from the washing was made basic with aqueous potassium hydroxide 
(20%) and extracted with dichloromethane (6 x 25 mL). The combined organic phases 
were dried and concentrated in vacuo. No detectable yield of compound by LC/MS. 
 
LiOH/ethanol (Entry 3) 
 
Resin 7 (0.16 g, 0.08 mmol, 1 equiv) was suspended in a solution of lithium 
hydroxide (1.5 mmol, 20 equiv) in water/ethanol (1:2) in an Emrys Process Vial (2.5 
mL). The vial was sealed and the suspension was heated with microwaves (80 °C, 1.5 
h). The suspension was filtered, and the resin was washed with water (3 x 10 mL) and 
dichloromethane (3 x 10 mL) and then dried 
CHN: N analysis 2.4 %  
 
HBr/Acetic acid/heat (Entry 4) 
 
Resin 7 (0.13 g, 0.07 mmol, 1 equiv) was suspended in a mixture of hydrobromic acid 
(48% w/w, 0.75 mL) and acetic acid (0.75 mL) in an Emrys Process Vial (2.5 mL). 
The vial was sealed and the suspension was heated with microwaves (80 °C, 1.5 h). 
The suspension was filtered, and the resin was washed with water (3 x 10 mL) and 
dichloromethane (3 x 10 mL) and then dried. 
CHN: N analysis 2.17 % 
 
Trifluoracetic acid/dichloromethane /heat (Entry 5) 
 
Resin 7 (0.12 g, 0.06 mmol, 1 equiv) was suspended in a mixture of trifluoroacetic 
acid (0.75 mL) and dichloromethane (0.75 mL) in an Emrys Process Vial (2.5 mL). 
The vial was sealed and the suspension was heated with microwaves (80 °C, 1.5 h). 
The suspension was filtered, and the resin was washed with water (3 x 10 mL) and 
dichloromethane (3 x 10 mL) and then dried. 
CHN: N analysis 2.38 % 
 
Ammonia/methanol (Entry 6) 
 
Resin 7 (1.2 g, 0.6 mmol, 1 equiv) was suspended in 4 ml of a solution of ammonia in 
methanol (4 M). The suspension was stirred at room temperature overnight. 
LC/MS of the solution phase showed no compound. 
The suspension was filtered, and the resin was washed with methanol (3 x 10 mL) 
then resuspended in a solution of ammonia in methanol (4 M, 4 mL) in an Emrys 
Process Vial (5 mL). The vial was sealed and the suspension was heated with 
microwaves (1.5 h, 60 °C). The suspension was filtered, and the resin was washed 
with ethanol (4 x 10 mL) then dried. 
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IR showed no change from the starting material. 
 
KOH/ethanol (entry 7) 
 
Resin 7 (0.8 g, 0.48 mmol, 1 equiv) was suspended in ethanol (2 mL) in an Emrys 
Process Vial (5 mL). Potassium hydroxide (0.14 g, 2.5 mmol, 5 equiv) was added, the 
vial was sealed and the suspension was heated with microwaves (150 °C, 2 h). The 
suspension was filtered, and the resin was washed with ethanol (3 x 10 mL); 
dichloromethane (3 x 10 mL) and ethanol (3 x 10 mL) and then dried. 
IR of resin showed no carbonyl stretch (1701 cm-1) 
13C gel-phase NMR (62.5 MHz; CD2Cl2) showed none of the characteristic peaks 
from 7 
The filtrate was evaporated and the residue was purified with ion-exchange SCX-
columns. End weight: 57 mg of 8 polluted with acetic acid from column activation. 
Yield, judged from 1H NMR: 42-45% 
1H NMR (500 MHz, CDCl3) δ = 1.94 (acetic acid); 2.35-2.45 (4 H, m, H1); 2.91-2.95 
(4H, m, H2); 4.24 (1H, s, H3); 4.56-4.66 (m, NH); 7.16 (2H, dd, J = 6.8 Hz, H4); 7.26 
(4H, dd, J = 6.8 Hz, H5); 7.40 (4H, d, J = 6.7 Hz, H6).  
 
Attempted optimization of nucleophilic cleavage of 7 
 
Resin 7 (0.28 g, 0.24 mmol, 1 equiv) was suspended in solvent (1.5 mL) with base in 
Emrys Process Vials (5 mL) and heated for the stated time with microwaves. The 
resin was washed with ethanol (3 x 10 mL) and THF (3 x 10 mL), and then dried.  
The yield of 8 was estimated from ELSD by evaporating the filtrate from the resin 
wash, dissolving the residue in methanol (4 mL), diluting a sample (0.1 mL) to 1 mL 
and analyzing.  
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Attempted optimization of nucleophilic cleavage of 7 (Cont.) 
 
Entry Base /equiv Solvent conditions IR 
(cm-1) 
Yield 
8 
Carbamate 
content 
by ELSD 
1 KOH/ 
1.5 equiv 
ethanol/ 
6% water 
150°C, 30 min 1702 16 % 29 % 
 
2 LiOH/ 
1.5 equiv 
ethanol/ 
6% water 
150°C, 30 min 1701 16 % 25 % 
3 NaOH/ 
1.5 equiv 
ethanol/ 
6% water 
150°C, 30 min 1701 16 % 27 % 
4 LiOH/ 
1.5 equiv 
methanol/ 
6% water 
150°C, 30 min 1702 41 % none 
5 LiOH/ 
1.5 equiv 
methanol/ 
53% water 
150°C, 30 min 1701 15 % none 
6 LiOH/ 
1.5 equiv 
methanol/ 
6% water 
150°C, 60 min 1702 41 % none 
7 HBr/ 
5 equiv 
methanol/ 
water (5 %) 
150°C, 30 min 1704 none none 
8 KOH/ 
5 equiv 
methanol/ 
water (25%) 
150°C, 30 min 1702 45% none 
9 LiOH*H2O/ 
5 equiv 
methanol/ 
water (25 %) 
150°C, 30 min 1701 45% none 
10 LiOH*H2O/ 
5 equiv 
methanol/ 
water (25 %) 
150°C, 90 min 1701 56 % none 
11 LiOH*H2O/ 
5 equiv 
AND 
H2O2/ 
5 equiv 
methanol/ 
water (6 %) 
150°C, 30 min 1701 45% none 
12 KOH/ 
5 equiv 
methanol 150°C, 60 min no 
peak 
55% none 
13 LiOH*H2O/ 
10 equiv 
methanol 150°C, 60 min 1701 52% none 
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7.3.1.4 Optimization of addition and reductive cleavage 
 
Comparison of phosgene and triphosgene as substrates for the formation of 
carbamate linker in the synthesis of 1-diphenylmethyl-4-methylpiperazine (9) 
 
With Phosgene: 
 
Versabeads O400 (3.0 g, 4.5 mmol, 1 equiv) was suspended in THF (30 mL) at room 
temperature. After 1 h a solution of phosgene in toluene (20 % w/w, 12 mL (ρ= 0.935 
g/mL), 2.2 g, 22 mmol, 5 equiv) was added and the solution was stirred for 7 h. The 
suspension was filtered and the resin was washed successively with THF (3 x 30 mL), 
water (3 x 30 mL), methanol (3 x 30 mL), THF (3 x 30 mL), water (3 x 30 mL), and 
methanol (3x30 mL), then dried, to give resin (4). White beads. 
IR= 1777 cm-1 
Elemental analysis: Cl – 4.3% ~ 1.21 mmol Cl/g ~ 88% loading 
Resin 4 was suspended in a solution of 1-diphenylmethylpiperazine (5.67 g, 22.5 
mmol, 5 equiv) in THF (60 mL) at room temperature. Triethylamine (3.1 mL (ρ= 0.73 
g/mL), 2.3 g, 22.5 mmol, 5 equiv) was added and the suspension was stirred 
overnight. The resin was filtered, washed with THF (3 x 30 mL), water (3 x 30 mL), 
methanol (3 x 30 mL), THF (3 x 30 mL), water (3 x 30 mL) and methanol (3 x 30 
mL), then suspended in THF (40 mL). Methanol (1.8 mL (ρ= 0.79 g/mL), 1.4 g, 45 
mmol, 10 equiv) was added, followed by solid LiBH4 (0.98 g, 45 mmol, 10 equiv). 
The suspension was heated to reflux and kept at reflux overnight. The reaction was 
quenched through slow addition of acetone (40 mL). The suspension was filtered and 
the resin was washed with 1 M aqueous HCl (2 x 200 mL), diethyl ether (50 mL), 1M 
aqueous KOH (50 mL) and diethyl ether (2 x 150 mL), then dried. IR of resin showed 
no CO stretch at 1701 cm-1  
The organic phase was separated from the filtrate and the aqueous phase was made 
basic with aqueous NH3 (20 mL, 25 % v/w) and extracted with diethyl ether (50 mL, 
then 2 x 150 mL). The combined organic phases were washed with saturated aqueous 
sodium bicarbonate (2 x 100 mL), brine (2 x 100 mL) and water (2 x 100 mL), dried 
(anhyd sodium sulphate) and evaporated. 
End weight 1.02 g of a mixture of 8 and 9. 
1H NMR (500 MHz, CDCl3): δ = 2.20 (s, 3 H, H1, 9); 2.24-2.50 (m, 4H, H2, 8 and 9); 
2.84 (m , 4H,, H3, 8 and 9 ); 4.14 (s, H4, 9 ); 4.15 (s, H4, 8), 7.06-7.11 (m, H5, 8 and 
9); 7.16-7.21 (m, H6, 8 and 9); 7.30-7.36 (m, H7, 8 and 9). 
Distribution by 1H NMR (4.14/4.15 peak comparison): 62 mol % 9. 
 
With triphosgene/pyridine: 
 
Versabeads O400 (3.0 g, 4.5 mmol, 1 equiv) was suspended in THF (30 mL) at room 
temperature. After 45 min triphosgene (2.2 g, 7.5 mmol, 5 equiv) was added and the 
suspension was cooled on ice/water bath. After 15 min py (1.7 mL (ρ= 0.978 g/mL), 
1.66 g, 21 mmol, 5 equiv) was added, the cooling bath was removed and the 
suspension was stirred for 7 h.  The suspension was filtered, and the resin was washed 
successively with THF (3 x 30 mL), water (3 x 30 mL), methanol (3 x 30 mL), THF 
(3 x 30 mL), water (3 x 30 mL) and methanol (3 x 30 mL) and then dried to give resin 
4. Reddish beads. (IR= 1777 cm-1; 1745 cm-1 
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Elemental analysis: Cl – 3.8% ~ 1.08 mmol Cl/g ~ 79% loading.)  
The resulting resin 4 was suspended in a solution of 1-diphenylmethylpiperazine (8)  
(5.67 g, 22.5 mmol, 5 equiv) in THF (60 mL) at room temperature. Triethylamine (3.1 
mL (ρ= 0.73 g/mL), 2.3 g, 22.5 mmol, 5 equiv) was added and the suspension was 
stirred overnight.  The suspension was filtered, and the resin was washed with THF (3 
x 30 mL), water (3 x 30 mL), methanol (3 x 30 mL), THF (3 x 30 mL),  water (3 x 30 
mL) and methanol (3 x 30 mL), then suspended in THF (40 mL). Methanol (1.8 mL 
(ρ= 0.79 g/mL), 1.4 g, 45 mmol,, 10 equiv) was added, followed by solid LiBH4 (0.98 
g, 45 mmol, 10 equiv). The suspension was kept at reflux overnight. The reaction was 
quenched through slow addition of acetone (40 mL) (CAREFUL! Exothermic!). The 
resin was filtered and washed with 1M aqueous HCl  (2 x 200 mL), diethyl ether (50 
mL), 1 M aqueous KOH (50 mL), diethyl ether (2 x 150 mL), then dried. IR of resin 
showed no CO stretch at 1701 cm-1  
The organic phase was separated from the filtrate and the aqueous phase was made 
basic with aqueous NH3 (20 mL, 25 % v/w) and extracted with diethyl ether (50 mL, 
2 x 150 mL). The combined organic phases were washed with saturated aqueous 
sodium bicarbonate (2 x 100 mL), brine (2 x100 mL) and water (2 x 100 mL), dried 
(anhyd sodium sulphate) and evaporated. 
End weight 0.63 g of a mixture of 8 and 9. 
1H NMR (500 MHz, CDCl3): δ = 2.28 (s, 3H, H1, 9); 2.24-2.74 (m, H2, 8 and 9); 2.90 
(dd, H3, 8 and 9); 4.21 (s, 1H, H4, 9) 4.22 (s, 1H, H4, 8); 7.14-7.19 (m, 2H, H5, 8 and 
9); 7.23-7.28 (m, 4H, 8 and 9, H6); 7.38-7.43 (m, 4H, H7, 8 and 9). 
Percent 9 (by NMR): 44 mol% 
 
Identification of the impurities from reductive cleavage (10 and 11205) through 
treatment of Versabeads with lithium borohydride.  
 
Versabeads VO400 (12.2 g, 23.3 mmol, 1 equiv) were suspended in THF (300 mL). 
Methanol (9 mL (ρ= 0.79 g/mL), 7.1 g, 220 mmol, 10 equiv) was added and the 
suspension was cooled on an ice/wate bath. Lithium borohydride (5.0 g, 230 mmol, 10 
equiv) was added and the suspension was heated at reflux for 21 h. 
The reaction was quenced with acetone (40 mL) and the suspension was filtered. The 
resin was washed with THF (3 x 100 mL) and 1 M aqueous HCl (3 x 100 mL). The 
filtrate was made basic with aqueous ammonia (25 % w/v, 100 mL) and extracted 
with diethyl ether (1 x 200 mL and 2 x 100 mL). The combined organic phases are 
washed with saturated aqueous sodium bicarbonate (2 x 50 mL), brine (2 x 50 mL) 
and water (2 x 50 mL), dried (anhyd sodium sulphate) and evaporated)  
End weight 400 mg 
Resin end weight 12.1 g (Difference 0.3 g) 
 
1H NMR (500 MHz, CDCl3): δ = 1.10 (3H, d, 11, H1); 1.15 (3H, s, 11, H2); 1.21 (3H, 
s, 11, H3); 1.35 (9H, s, 10, H1); 1.38 (1H, dd, J1 = 2 Hz; J2 = 14.5 Hz, 11, H4); 1.56 
(1H, dd, J1 = 10.9 Hz, J2 = 14.3 Hz, 11, H5); 2.18 (3H, s, 10, H2); 4.11 (1H, d sextet, J 
= 2.3 Hz, 11, H6); 4.30-4.06 (m, 2H, 11, -OH); 4.97 (1H, s, 10, H3); 6.89 (2H, s, 10, 
H4). 
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Comparison of reductive cleavage of 7 with lithium borohydride and lithium 
aluminium hydride: 
 
With lithium borohydride: 
 
Resin 7 (5.3 g, 6.3 mmol, 1 equiv) was suspended in THF (80 mL) with methanol (2.4 
mL (ρ= 0.75 g/mL), 1.8 g, 58 mmol, 9 equiv) and lithium borohydride (1.4 g, 64 
mmol, 10 equiv) and heated to reflux. The reaction was kept at reflux overnight, then 
quenched with acetone (10 mL) and filtered. The resin was washed with THF (2 x 100 
mL), 2 M aqueous HCl (2 x 100 mL) and THF (100 mL), then made basic with 
aqueous ammonia (25 % w/v, 100 mL) and extracted with diethyl ether (3 x 100 mL). 
The combined organic phases were washed with saturated aqueous sodium 
bicarbonate (2 x 50 mL), brine (2 x 50 mL) and water (2 x 50 mL), dried (anhydrous 
sodium sulphate) and evaporated. 
Yield: 1.0 g 
1H NMR (500 MHz, CDCl3): 50:50 mixture of 8 and 9 judged by the peaks at 4.2 
ppm. 
13C gel phase NMR of resin after cleavage shows very small aromatic peaks at δ = 
127.5 and 126.8.  
 
With lithium aluminium hydride 
 
Resin 7 (5.0 g, 6.2 mmol, 1 equiv) was suspended in THF (80 mL). Lithium 
aluminium hydride (2.4 g, 63 mmol, 10 equiv) was added and the suspension was 
heated at reflux temperature overnight. The reaction was quenched by the addition of 
water (2.5 mL), aqueous sodium hydroxide (28 %, 2.5 mL) and water (7 mL). The 
suspension was filtered and then the resin was washed with THF (2 x 100 mL) and 2 
M aqueous hydrochloric acid (3 x 75 mL). An organic phase was separated from the 
filtrate and the aqueous phase was made basic with aqueous ammonia (25 % w/v, 100 
mL), and extracted with diethyl ether (3 x 100 mL). The combined organic phases 
were washed with saturated aqueous sodium bicarbonate (2 x 50 mL), brine (2 x 50 
mL) and water (2 x 50 mL), dried (anhydrous sodium sulphate) and evaporated. 
Yield 0.6 g of crude 9 (NO compound 8 by NMR) (36%) 
 
1H NMR (500 MHz, CDCl3): δ = 1.42 (water); 2.26 (s, 3 H, H1); 2.28-2.58 (m, 8 H, 
H2/H3) ; 4.21 (s, 1H, H4); 7.15 (m, 2H, H5); 7.25 (m, 4H, H6); 7.41 (m, 4H, H7) 
13C gel-phase NMR (62.5 MHz, CDCl3) of resin showed incomplete cleavage of 7 
(Peaks from aromatic at δ = 142.1, 128.5, 127.8 and 127.3, and aliphatic at 51.5). 
 
Optimization of the synthesis of resin 4 with phosgene (Table 6) 
 
Versabeads O400 (1 g, 1.91 mmol, 1 equiv) were suspended in THF (11 mL). A 
solution of phosgene in toluene (20% w/w, amounts as stated in table 6) was added 
and the stirred for the time. The resins were filtered, washed with THF (2 x 10 mL), 
methanol (2 x 10 mL), THF (10 mL), then dried. Cl - analysis results as stated in table 
6. 
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7.3.1.5 Attempted nucleophilic cleavage of carbamate linker 
 
Synthesis of resin 12 from 1-(3,4-dichloropiperazine) 
 
Versabeads O400 (5.4 g, 10.3 mmol, 1 equiv) were suspended in THF (70 mL). A 
solution of phosgene in toluene (20 w/w, 12 mL (ρ = 0.935 g/mL), 2.2 g phosgene, 23 
mmol, 2.2 equiv) was added and the suspension was stirred for 2 h. Solvent was 
removed and the resin was washed with THF (2 x 70 mL) and methanol (2 x 70 mL). 
1-(3,4 – dichlorophenyl)-piperazine (6 g, 26 mmol, 2.5 equiv) and triethylamine (7.1 
mL (ρ = 0.73 g/mL), 9.7 g, 96 mmol, 9 equiv) was added as a solution in THF (50 
mL) and the suspension was agitated overnight. The suspension was sucked dry and 
the resin was washed with THF (2 x 70 mL), methanol (2 x 70 mL), water (2 x 70 
mL) and THF (2 x 70 mL) then dried, to give resin 12  
13C gel-phase NMR (62.5 MHz, CDCl3): 154.9 (C1); 150.3 (C2); 132.6 (C3); 130.3 
(C4); 122.6 (C5); 117.6 (C6); 72.3 (-CH2CH2OH); 70.3 (framework) 69.3 (-
CH2CH2OR); 64.5 (-CH2CH2OR); 61.4 (-CH2CH2OH); 48.5 (C7); 43.2 (C8); 40.9, 
23.0, 17.3, 7.5 (framework). 
Conversion judged by peaks and 64 and 61 ppm: 50 % 
 
Attempted cleavage of resin 12 with aqueous base 
 
Resin 12 was suspended in water (20 mL). KOH (0.73 g, 12.5 mmol, 5 equiv) was 
added. The suspension was heated to reflux and kept at this temperature for 6 h. The 
suspension was filtered and the resin was washed with THF (2 x 20 mL), 1 M aqueous 
HCl (2 x 70 mL) and THF (2 x 70 mL) and then dried. 
13C gel-phase NMR (62.5 MHz, CDCl3) showed no change from resin 12. 
 
Attempted synthesis of 1-(3,4-dichlorophenyl)-piperazine 1-decyl carbamate 13. 
 
Resin 12 (2 g, ca. 1.3 mmol, 1 equiv) was suspended in DME (20 mL). 1-decanol (1.0 
g, 6.9 mmol, 5 equiv) and potassium tert-butoxide (0.72 g, 6.4 mmol, 5 equiv) was 
added and the suspension was heated to reflux and kept at this temperature for 2 h. 
The suspension was filtered and the resin was washed with DME (3 x 20 mL), 1 M 
aqueous HCl (3 x 20 mL), DME (1 x 20 mL) and 1 M aqueous HCl (3 x 20 mL) and 
then dried. DME was evaporated from filtrate and the aqueous phase were washed 
with ethyl acetate (2 x 50 mL) then made basic with aqueous ammonia (25 % w/v, 
100 mL). The aqueous phase was extracted with diethyl ether (3 x 50 mL). The 
combined organic phases were washed wit saturated aqueous sodium bicarbonate (30 
mL), brine (30 mL) and water (2 x 30 mL) and dried (anhyd sodium sulphate) and 
evaporated) to yield only free 1-(3,4 dichlorophenylpiperazine and 1 –decanol by 
NMR. 
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7.3.2 REM linker synthesis 
 
7.3.2.1 Attempted synthesis of sulphone REM linker 14 based on 
Hoffmann addition of divinyl sulphone (Table 7). 
 
 
With DBU (table 7, entry 1) 
 
Versabeads O400 (1 g, 0.5 mmol, 1 equiv) was suspended in dichloromethane (12 
mL) with DBU (75 μL (ρ = 1.018 g/mL), 76 mg, 0.5 mmol, 1 equiv) at room 
temperature. Divinyl sulphone (0.6 mL (ρ = 1.177 g/mL), 0,71 g, 6 mmol, 12 equiv) 
was added slowly and the suspension was left at room temperature overnight. The 
resin was filtered, washed with dichloromethane (3 x 5 mL) and methanol (6 x 5 mL), 
then dried. 
1H MAS NMR: Small peaks between 6 and 7 ppm. 
IR showed no vinylic stretch (2000-1500 cm-1) 
Elemental analysis for S: calc: 1.5% (w/w) found 0.6 % (w/w) 
13C-NMR: no change 
A sample of the resin (0.5 g) was suspended in dry DMF (7.5 mL). N-benzyl-N-
methylamine (0.1 mL (ρ = 0.94 g/mL), 94 mg, 0.78 mmol) was added and the 
suspension was shaken overnight. The suspension was filtered and the resin was 
washed with dichloromethane (3 x 5 mL) and dried. 
1H MAS NMR showed no change after the reaction. 
 
With Triton B (table 7, entry 2) 
 
Versabeads O400 (2.02 g, 1 mmol, 1 equiv) was suspended in dichloromethane (50 
mL) with divinyl sulfone (0.15 mL (ρ = 1.177 g/mL) 0.18 g, 1.5 mmol, 1.5 equiv) at 
room temperature. After 1 h 3 drops of Triton B (a 40 % aqueous solution of N-
benzyl-N-trimethylammonium hydroxide) was added and the reaction was left for 4 
days. The resin was filtered, washed with toluene (6 x 20 mL) and dichloromethane (6 
x 20 mL) and then dried. 
IR did not change. 
1H-MAS NMR (500 MHz; CD2Cl2) showed no vinylic protons (5-7 ppm). 
Elemental analysis for S: calc: 1.5 % (w/w) found 0.7 % (w/w) 
Resin (0.97 g, 0.5 mmol, 1 equiv) was suspended in DMF(3 mL) at room temperature. 
1-benzyl piperazine (0.86 mL (ρ = 0.87 g/mL), 0.88 g, 5 mmol, 10 equiv) was added, 
and the suspension was left overnight. The suspension was filtered and the resin was 
washed with DMF(10 mL), THF (10 mL) and toluene (10 mL), then dried. 
13C gel phase NMR (CDCl3, 62.5 MHz) showed no aromatic protons and no vinylic 
protons. Peaks at 72.1 ppm (-CH2CH2OH) and 61.0 ppm (-CH2CH2OH) indicated 
unloaded resin. 
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With NaOH (table 7, entry 3) 
 
Versabeads O400 (1.5 g, 0.75 mmol, 1 equiv) were suspended in THF (9 mL). After 1 
h divinyl sulphone (0.69 mL  (ρ = 1.177 g/mL), 0.81 g, 6.9 mmol, 9 equiv) was added 
followed by slow addition of  1 M aqueous sodium hydroxide (0.26 mL, 0.26 mmol, 
0.35 equiv). The suspension was stirred for 3 days. 
The resin was filtered, washed with alternating THF (20 mL) and water (20 mL) 6 
times, then with dichloromethane (2 x 20 mL). Dried in vacuo at room temperature. 
1H MAS NMR (500 MHz, CD2Cl2) showed no vinylic peaks (6-7 ppm) 
IR showed no vinylic stretch (2000-1500 cm-1) 
A sample of the resin (0.5 g) was suspended in DMF (2 mL). 1-benzyl piperazine (0.7 
mL (ρ = 0.87 g/mL), 0.61 g, 3.5 mmol) was added and the suspension was allowed to 
stand overnight, then sucked dry 
1H MAS NMR (500 MHz, CD2Cl2) showed a new peak at 8.0 ppm (Probably DMF) 
IR showed stretch at ca. 1700 cm-1 (DMF) 
 
 
7.3.2.2 Attempted synthesis of resin 15 through metathesis with allyl-
functionalized Versabeads. 
 
With Grubbs catalyst: 
 
Allylated Versabeads O400 (1.0 g, 0.5 mmol, 1 equiv) were thoroughly dried, then 
placed in a dry flask under N2, and suspended in dichloromethane (30 mL) dried over 
anhydrous calcium chloride.  Divinyl sulphone (0.10 mL (ρ = 1.177 g/mL), 118 mg, 1 
mmol, 2 equiv) was added and the suspension was degassed. Grubbs catalyst (43 mg, 
0.05 mmol, 0.1 equiv) was added, and the suspension was kept at reflux overnight. 
1H MAS NMR: no vinyl sulfone protons visible (6-7 ppm) 
IR stretch at 1720 cm-1 replaced by small stretch at 1630 cm-1 
Elemental analysis for S: calc: 1.1% (w/w) found 0.02 % (w/w) 
 
With Hoveyda carbene catalyst:  
 
Allylated Versabeads O400 (1.0 g, 0.5 mmol, 1 equiv) were thoroughly dried, then 
placed in a dry flask under N2 and suspended in dichloromethane (40 mL) dried over 
anhyd calcium chloride. Divinyl sulfone (0.30 mL (ρ = 1.177 g/mL) 0.36 g, 3 mmol, 
6 equiv) was added and the suspension was degassed. Hoveyda carbene catalyst (38 
mg, 0.05 mmol, 0.1 equiv) was added, and the suspension was kept at reflux for 20 h, 
then filtered. the resin was washed with DCM (6 x 10 mL) and THF (6 x 10 mL) then 
dried. 
IR and 1H MAS NMR was identical to starting material. 13C gel-phase NMR showed 
no carbons corresponding to those expected from metathesis (128-149 ppm). 
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7.3.2.3 Synthesis and test of acrylic acid based REM linker 
 
Acrylic acid linker 16 – general procedure 
 
Versabeads O400 (5.15 g, 5.6 mmol, 1 equiv) were suspended in dichloromethane (70 
mL) at room temperature. DIPEA (10 mL (ρ=0.75 g/mL), 7.3 g, 56 mmol, 10 equiv) 
was added, followed by slow addition of acryloyl chloride (5.7 mL (ρ= 1.11 g/mL), 
5.2 g, 56 mmol, 10 equiv). The suspension was stirred overnight, then filtered, and the 
resin was washed with dichloromethane (3 x 50 mL) and THF (3 x 50 mL) and then 
dried to give 5.56 g (131% of theoretical weight gain) of resin 16. 
 
IR: 1724 cm-1 (CO stretch) 
13C gel phase NMR: (CD2Cl2, 62.5 MHz): δ = 171.0 (resin impurity); 166.5 (C1); 
131.5 (C2); 129.1 (C3); 74.4; 71.3 (framework); 69.8 (CH2CH2OR); 67.6 
(framework); 64.5  (CH2CH2OR); 41.9, 41.0, 39.9, 21.6, 17.9 (framework).  
 
Hoffmann Addition of 1 - diphenylmethyl piperazine to resin 16 to form resin 17. 
  
Resin 15 (0.5 g, 0.25 mmol, 1 equiv) was suspended in dry DMF (3 mL) in a syringe. 
A solution of 1-dimethylphenylpiperazine (0.65 g, 2.6 mmol, 10 equiv) in DMF (3 
mL) was added and the suspension was agitated at room temperature overnight. The 
suspension was filtered and the resin was washed with DMF (3 x 5 mL) and THF 
(3x5 mL), then with THF overnight (5 mL) then alternating THF and DCM for 3 
cycles, then dried to yield 0.56 g (78% of theoretical weight gain) of resin 17. 
 
13C gel phase NMR: (62.5 MHz, CDCl3): 171.5 (C1); 142.0 (C2); 127.7 (C3); 127.2 
(C4); 126.3 (C5; 69.9 (framework); 62.8 (-CH2CH2OR); 52.6 (C6/C7); 51.1 (C8); 
42.7 (framework); 31.6 (C9); 22.4; 7.1 (framework) 
1H MAS NMR: 2.4; 2.6 (piperazine) 7.0 – 7.4 (aromatics) 
IR=1732 cm-1 
 
Alternative addition of 1-diphenylmethylpiperazine to 16, using THF as solvent. 
 
Versabeads O400 (4.3 g, 4.7 mmol, 1 equiv) was suspended in dichloromethane (60 
mL). DIPEA (8.5 mL (ρ = 0.73 g/mL), 6.4 g, 50 mmol, 10 equiv) was added followed 
by slow addition of acroloyl chloride (5 mL (ρ= 1.11 g/mL), 5.5 g, 61 mmol, 13 
equiv). The suspension was stirred overnight at room temperature, then filtered, and 
the resin was washed with dichloromethane (3 x 60 mL), to give resin 16 
The resin was suspended in a solution of 1-diphenylmethylpiperazine (6.0 g, 24 
mmol, 5 equiv) in THF (65 mL) and the suspension was stirred overnight at room 
temperature. The suspension was filtered, washed with THF (3 x 30 mL), methanol (3 
x 30 mL), DCM (3 x 30 mL) and THF (3 x 30 mL) then dried. 
13C gel-phase NMR: (62.5 MHz, CD2Cl2): δ = 173.2 (C1); 171.0 (resin impurity); 
144.0 (C2); 129.3 (C3); 128.6 (C4); 127.7 (C5); 77.0 (C6); 71.4 (framework); 64.4 (-
CH2CH2OR); 52.7 (C7); 41.9 (framework); 33.1 (C8); 21.6, 18.0 (framework). 
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Solid phase synthesis of 19 on gram-scale from REM functionalized resin 16 with 
quaternization in water   
 
Resin 16 (3.1 g, 3.8 mmol, 1 equiv), was suspended in a solution of 1-
dimethylphenylpiperazine (4.6 g, 18.3 mmol, 4.8 equiv) in THF (120 mL) and the 
suspension was stirred overnight at room temperature. The suspension was filtered 
and the resin was washed with THF (3 x 30 mL), methanol (3 x 30 mL) and THF (3 x 
30 mL) and then dried. The resin was suspended in water (20 mL). Allyl bromide (2.0 
g, 16 mmol, 5 equiv) was added and the suspension was stirred at room temperature 
overnight. The suspension was filtered, and the resin was washed with water (3 x 30 
mL), methanol (3 x 20 mL), THF (3 x 20 mL) and methanol (1 x 30 mL). 
Analysis of the washing by LC/MS revealed the presence of significant amounts of 
compound 19, cleaved off prematurely.  
The resin was suspended in dichloromethane (20 mL). DIPEA (1.2 mL (ρ = 0.73 
g/mL), 0.88 g, 6.7 mmol, 2 equiv) was added and the suspension was stirred for 8 h. 
The suspension was filtered and the resin was washed with alternating DCM (30 mL) 
and methanol (30 mL) three times and then dried. 
IR CO stretch = 1725 cm-1 (= 16) 
The filtrate was evaporated and dissolved in diethyl ether (50 mL) and water (50 mL). 
The phases were separated and the water phase was extracted with diethyl ether (3 x 
50 mL). The combined organic phases were washed with saturated aqueous sodium 
carbonate (20 mL), dried (anhydrous sodium sulphate) and evaporated to give 
compound 19 as off-white crystals. 
Yield: 0.24 g (21 %)   
 
1H-NMR (CDCl3, 500 MHz): δ = 2.00 – 2.90 (m, 8H, H1); 2.99 (d, J= 6.7 Hz, 2H, 
H2); 4.21 (s, 1H, H3); 5.11 (d, J= 10.3 Hz, 1H, H4); 5.16 (d, J= 17.3 Hz, 1H, H5); 
5.85 (ddt, J1= 17.1 Hz, J2= 10.4 Hz, J3 = 6.4 Hz, 1H, H6); 7.15 (dd, J1 = 7.4 Hz, J2 = 
7.4 Hz, 2H, H7); 7.25 (dd, J1 = 7.4 Hz, J2 = 7.4 Hz, 4H, H8); 7.40 (d, 7.8 Hz, 4H, H9). 
 
13C NMR (62.5 MHz, CDCl3): δ = 142.1 (C1); 134.4 (C2); 127.8 (C3); 127.3 (C4); 
126.2 (C5); 117.3 (C7); 75.6 (C8); 61.1 (C9); 52.7 (C10); 51.2 (C11). 
 
Anal Calcd for C20H23N2: C, 82.14; H, 8.27; N, 9.58. Found: C, 82.05; H, 8.16; N, 
9.50.  
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7.3.2.4 Microwave assisted synthesis of 19 from resin 16 
 
Versabeads O400 (3.4 g, 5.5 mmol, 1 equiv) were suspended in dichloromethane (50 
mL). DIPEA (2.8 mL (ρ= 0.755 g/mL), 2.1 g, 16 mmol, 3 equiv) was added at room 
temperature, followed by a slow addition of acryloyl chloride (4.45 mL (ρ= 0.755 
g/mL) 5 g, 55 mmol, 10 equiv) in dichloromethane (15 mL). The suspension was 
stirred for 19 h, then filtered, washed with DCM (3 x 30 mL), acetonitrile (1x 30 mL) 
DCM (1x 30 mL) then dried. End weight 3.9 g (88% of theoretical weight gain.) 
 
13C- gel phase NMR (62.5 MHz, CD2Cl2): 170.0 (C1); 131.5 (C2); 129.2 (C3); 71.3 
(framework); 69.8 (CH2CH2OR); 64.5 (CH2CH2OR); 44.2, 24.0, 8.3 (framework). 
IR (Carbonyl): 1724 cm-1 
 
Resin (1.2 g, 1.3 mmol, 1 equiv) was suspended in a solution of 1 -
diphenylmethylpiperazine (1.63 g, 6.5 mmol, 5 equiv) in THF (4 mL) in an Emrys 
Process Vial (5 mL) and heated with microwaves (60 °C, 1 h), The resin was filtered 
and washed with THF (1 x 5 mL), methanol (1 x 5 mL), water (1 x 5 mL), THF (1 x 5 
mL), DMF (1 x 5 mL), dichloromethane (1 x 5 mL),  water (1 x 5 mL) and THF (1x5 
mL), to give resin 17 
The resin 17 was suspended in water (4 mL) with allyl bromide (0.54 mL (ρ= 1.43 
g/mL), 0.77 g, 6.4 mmol, 5 equiv) in an Emrys Process Vial (5 mL), the vial was 
sealed and the suspension heated with microwaves (60°C, 1 h). The suspension was 
filtered and the resin was washed with THF (1 x 5 mL), DMF (1 x 5 mL), THF (1 x 5 
mL), Methanol (1 x 5 mL) THF (1 x 5 mL), DCM (2x 5 mL) and THF (2 x 5 mL).  
The resin was suspended in dichloromethane (5 mL) in an Emrys Process Vial (5 
mL). DIPEA (0.45 mL (ρ= 0.77 g/mL), 0.35 g, 2.8 mmol, 2.2 equiv) was added, the 
vial was sealed and the suspension was heated with microwaves  (60 °C, 45 min). The 
suspension was filtered and the resin was washed with DCM (3 x 5 mL) and methanol 
(3 x 5 mL). The filtrate was evaporated to give 153 mg (40%) of 19. 
 
1H NMR (500 MHz, CDCl3): 2.47 (br s, 8H, H1); 3.00 (d, 2H, J = 6.6 Hz, H2) 4.22 (s, 
2H, H3) 5.10 – 5.13 (m, 1H, H4); 5.14-5.19 (m, 1H, H5); 5.85 (ddt, J1= 17.3 Hz, J2= 
10.6 Hz, J3 = 6.2 Hz, 1H, H6); 7.14-7.19 (m, 2 H, H7); 7.22 – 7.28 (m, 4H, H8); 7.39 
– 7.43 (m, 4H, H9) 
 
13C NMR (62.5 MHz, CDCl3): δ = 142.8 (C1); 135.0 (C2); 128.4 (C3); 127.9 (C4); 
126.9 (C5); 118.0 (C7); 76.2 (C8); 61.7 (C9); 53.3 (C10); 51.8 (C11). 
 
CHN calc for C20H24N2: C, 82.14 H, 8.27; N, 9.58 Found: C, 81.81 H, 8.04 N, 9.56 
 126
 
7.3.2.5 Addition of piperazine to resin 16 and subsequent 
derivatization 
 
Hofmann addition of piperazine to REM-functionalized resin 16 to form resin 
20. 
 
Resin 16 (4.65 g, 3.9 mmol, 1 equiv) was suspended in a solution of piperazine (4 g, 
46 mmol, 12 equiv) in DMF (90 mL) at room temperature and the suspension was 
stirred overnight. The suspension was filtered and the resin was washed with DMF (3 
x 40 mL), methanol (3 x 40 mL), THF (3 x 40 mL) and DCM (3 x 40 mL) and then 
dried. 
End weight: 4.85 g  (59% of theoretical weight gain) of resin 20. 
 
13C gel phase NMR: (CD2Cl2, 62.5 MHz): δ = 171.0 (resin impurity); 71.5 
(framework); 64.5 (CH2CH2OR); 61.8 (CH2CH2OH); 46.8 (C1); 41.9 (framework); 
33.1 (C2); 21.5, 18.0 (framework). 
IR: 1734 cm-1 (CO stretch); 1641 cm-1 (possibly DMF) 
 
Synthesis of 1-allyl-4-phenylaminocarbonyl (22) 
 
Resin 20 (1.52 g, 1.17 mmol, 1 equiv) was suspended in DMF (20 mL). Phenyl 
isocyanate (1.26 mL (ρ=1.096 g/mL), 1.39 g, 11.7 mmol, 10 equiv) was added and 
the solution was agitated in a syringe at room temperature overnight. The suspension 
was filtered, washed with DMF (3 x 20 mL), THF (3 x 20 mL), methanol (3 x 20 mL) 
and THF (3 x 20 mL) and then dried 
End weight 1.61 g of resin 21 (65% of theoretical weight gain) 
 
13C gel phase NMR: (CD2Cl2, 62.5 MHz): δ = 172.8 (C1); 171.0 (resin impurity); 
156.1 (C2); 141.1 (C3); 129.5 (C4); 123.0 (C5); 120.9 (C6); 71.4 (framework); 67.6 
(framework); 64.4 (CH2CH2OR); 44.8 (C7) 42.0, 40.0 (framework); 33.1 (C8) 21.6, 
17.9 (framework). 
 
Resin 21 (1.22 g, 0.76 mmol, 1 equiv) was suspended in water (10 mL) in a syringe. 
Allyl bromide (0.361 mL (ρ=1.43 g/mL), 0.51 g, 4.2 mmol, 5.5 equiv) was added and 
the suspension was agitated overnight at room temperature. The suspension was 
filtered, and the resin was washed with THF (3 x 10 mL), methanol (3 x 10 mL) and 
THF (3 x 10 mL) and then dried. The resin was suspended in dichloromethane (7.5 
mL) at room temperature. DIPEA (0.42 mL (ρ=1.096 g/mL), 0.31 g, 2.3 mmol, 3 
equiv) was added and the suspension was stirred for 7 h under N2, then filtered. The 
resin was washed with THF (3 x 10 mL) and DCM (3 x 10 mL) and then dried. 
13C gel phase NMR (62.5 MHz, CD2Cl2) shows remaining compound on resin, but 
very little cleavage of the REM linker from resin (small peak at 62 ppm compared to 
64 ppm) 
IR of resin: 1726 cm-1 (= 16);  
Filtrate from cleavage was evaporated. The residue was dissolved in a solution of 
ammonium chloride (1.7 g in 16 mL) which was acidified to pH = 0 with HCl (conc.), 
then basified with NaOH to pH=14 and extracted with ethyl acetate (6 x 20 mL). The 
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combined organic phases were washed with saturated aqueous sodium carbonate (2 x 
20 mL) then dried (anhyd sodium sulphate) and evaporated to give 100 mg of crude 
22 (35%) (UV purity = 83%) 
 
1H-NMR (CDCl3, 500 MHz): δ = 0.9-1.3 (impurities); 1.43 (water); 2.38-2.44 (4H, m, 
H1); 2.99 (2H, d, J = 6.6 Hz, H2); 3.44-3.50 (4H, m, H3); 5.17 (1H, d, J = 9 Hz, H4); 
5.20 (1H, d, J =15.5 Hz, H5); 5.84 (1H, ddt, J1 = 16.3 Hz, J2 = 10.3 Hz, J3 = 6 Hz, 
H6); 6.79-6.88 (1H, m, H7); 6.97-7.03 (1H, m, H8); 7.21-7.26 (2H, m, H9); 7.34 (2H, 
d, H10).   
 
13C-NMR (CDCl3, 100 MHz) 155.6 (C1); 139.6 (C2); 134.9 (C3); 129.2 (C4); 125.9 
(impurity) 123.4 (C5); 120.6 (C6); 118.8 (C7); 62.0 (C8); 53.1 (C9); 44.4 (C10); 30.7, 
30.1 (impurity)  
 
 
Synthesis of 1-allyl-4-benzoylpiperazine (24) 
 
Resin 20 (1.22 g, 0.94 mmol, 1 equiv) was suspended in dichloromethane (10 mL) at 
room temperature. Triethylamine (0.26 mL (ρ= 0.73 g/mL), 0.19 g, 1.9 mmol, 2 
equiv) was added followed by dropwise addition of benzoyl chloride (0.22 mL (ρ= 
1.211 g/mL), 0.27 g, 1.9 mmol, 2 equiv). The resulting suspension was stirred 
overnight at room temperature. Resin was filtered, washed with DCM (3 x 10 mL), 
THF (3 x 10 mL), methanol (3 x 10 mL) and THF(3 x 10 mL)and then dried to give   
1.30 g (82% of the theoretical weight gain) of resin 23. 
 
13C gel phase NMR (62.5 MHz, CD2Cl2): 172.6 (C1); 171.0 (C2); 137.0 ppm (C3); 
130.2 ppm (C4); 129.2 (C5); 127.8 (C6); 71.4 ppm, 67.9 ppm (framework) 64.4 (-
CH2CH2OR) 48.3 (C7) 33.1 (C8) 21.5 18.0 (framework) 
 
Resin 23 (1.11 g; max. 0.79 mmol 1 equiv) was suspended in water (5 mL) with allyl 
bromide (0.33 mL, (ρ=1.43 g/mL), 0.48 g, 3.9 mmol, 5 equiv) and stirred overnight at 
room temperature. Resin was filtered, washed with THF (3 x 10 mL), methanol (3 x 
10 mL) and THF (3 x 10 mL), then dried. LC/MS of the washing solution reveals 
presence of prematurely cleaved product. 
Resin was suspended in dichloromethane (7 mL) with stirring at room temperature. 
DIPEA (0.30 mL, ((ρ=0.73 g/mL) 0,41 g, 3.1 mmol, 4 equiv) was added and the 
suspension was stirred for 6 h. The resin was filtered and washed with DCM (10 mL) 
and methanol (10 mL) alternating 3 times. The filtrate was evaporated, and the residue 
was dissolved in a two-pase system of diethyl ether (40 mL) and saturated aqueous 
sodium carbonate (20 mL). The two phases were separated and the aqueous phase was 
washed with diethyl ether (2 x 20 mL). The combined organic phases were dried 
(anhyd sodium sulphate) filtered and evaporated to give 70 mg of crude compound 24  
(38 %) (UV purity = 97%) 
 
1H-NMR (CDCl3, 500 MHz): δ = 2.30-2.64 (m, 4H, H1), 3.03 (d, J=6.9 Hz, 2H, H2); 
3.36-3.88 (m, 4H, H3); 5.17 (dd, J1=10.4 Hz, 1H, H4); 5.20 (dd, J1= 17.7 Hz, 1H, 
H5); 5.85 (ddt, J1=6.7 Hz, J2 =6.6 Hz, J3= 13.5 Hz, H6); 7.40 (5H, m, H7) 
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13C-NMR (CDCl3, 100 MHz): 170.7 (C1); 136.2 (C2); 134.8 (C3); 130.0 (C4); 128.8 
(C5); 127.4 (C6); 118.9 (C7); 62.0 (C8); 53.7 (C9); 53.1 (C10); 48.1 (C11); 42.5 
(C12). 
 
7.3.3 Wang linker synthesis 
 
Synthesis of Br functionalized Versabeads (25) 
 
Versabeads O 400 (2.1 g, 2.3 mmol, 1 equiv) was suspended in dichloromethane (23 
mL). Triphenylphosphine (2.8 g, 11 mmol, 4.8 equiv) and imidazole (0.84 g, 12 
mmol, 5.4 equiv) was added and the suspension was cooled on an ice bath. Bromine 
(0.55 mL (ρ=3.119 g/mL), 1.7 g, 11 mmol, 4.8 equiv) was added slowly and the 
reaction was allowed to warm to room temperature. After 21 h the suspension was 
filtered and the resin was washed with DMF (2 x 20 mL), water (2 x 20 mL), 10% 
aqueous sodium thiosulfate (2 x 20 mL), water (2 x 20 mL), DMF (2 x 20 mL), 
dichloromethane (2 x 20 mL), then dried to give 2.4 g ~ (200 % of theoretical weight 
gain) of resin 25. 
 
13C gel-phase NMR (62.5 MHz; CD2Cl2): δ =171.0 (resin impurity); 71.3 
(framework); 68.5 (-CH2CH2Br); 43.9 (possibly oxethane formed?); 41.8 
(framework); 26.3 (-CH2CH2Br); 21.6, 18.2 (framework) 
Br elemental analysis: 2.75%; 2.57% 0.34 mmol Br/g  (33% of theoretical loading)  
 
Resin 25 (1.2 g, 1.2 mmol, 1 equiv) was suspended in a solution of 4-
hydroxybenzylalcohol  (0.46 g, 3.3 mmol, 2.8 equiv) and potassium iodide (5.3 mg, 
32 μmol, 0.03 equiv) in DMF (8 mL). Potassium carbonate (0.53 g, 3.8 mmol, 3.2 
equiv) was added and the suspension immediately grew dark. The suspension was 
heated to 60 ° C for 20 h, then filtered. The beads were very dark, mixed with crystals 
and seemed to have broken down to a significant degree. The resin was washed with 
DMF (3 x 10 mL), water (3 x 10 mL), N-methylpyrrolidone (3 x 10 mL), methanol (3 
x 10 mL) and dichloromethane (2 x 10 mL), then suspended in water for 3 days. The 
resin was washed with 0.1 M aqueous HCl (3 x 10 mL), water (3 x 10 mL), methanol 
(3 x 10 mL) and THF (6 x 10 mL).  
13C gel-phase NMR (62.5 MHz, CDCl3): δ = 169.7 (resin impurity); 70.0 
(framework); 42.1 (oxethane); 40.4, 20.4, 17.0 (framework). 
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Synthesis of Wang linker 27 by Mitsunobu reaction and reduction. 
 
Versabeads O 400 (1.4 g, 1.5 mmol, 1 equiv) was suspended in distilled THF (15 mL) 
at room temperature. Triphenylphosphine (0.86 g, 3.3 mmol, 2.2 equiv) and 4-
hydroxybenzaldehyde (0.40 g, 3.3 mmol, 2.2 equiv) were added as a solution in 
distilled THF (10 mL). Diethyl azadicarboxylate (0.58 g, 3.3 mmol, 2.2 equiv) was 
added slowly as a solution in distilled THF (3 mL). The suspension was stirred at 
room temperature for 22 h, then filtered and the resin was washed with THF (3 x 20 
mL), methanol (3 x 20 mL), THF (3 x 20 mL) and DCM (3 x 20 mL), then dried to 
give 1.46 g of resin 26 (33 % of theoretical yield). Beads strongly red. 
13C gel phase NMR (62.5 MHz, CD2Cl2):  δ = 191.2 (C1); 171.0 (resin impurity); 
132.8 (C2); 129.9 (C3); 116.9 (C4); 115.7 (C5); 71.4 (framework); 68.7  (-
CH2CH2OR); 62.3 (-CH2CH2OH); 41.8 (framework); 39.9 (possible oxethane 
closure); 21.6, 18.1 (framework); 15.0 (possible oxethane closure) 
IR: 1735 cm-1; 1689 cm-1; 1601 cm-1; 1578 cm-1 (similar to 4-methoxybenzaldehyde 
(Aldrich)) 
 
Resin 26 (1.23 g, 1.18 mmol, 1 equiv) was suspended in THF (12 mL) at room 
temperature. Sodium borohydride (0.21 g, 5.5 mmol, 4.7 equiv) was added as a 
suspension in N-methylmorpholine (7.8 mL) and ethanol (7.8 mL). The suspension 
was stirred overnight and then quenched through addition of water (10 mL). The 
suspension was filtered and the resin was washed with THF (3 x 20 mL), methanol (3 
x 20 mL) and DCM (3 x 20 mL) and then dried to form resin 27. 
 
13C gel phase NMR (62.5 MHz, CD2Cl2): δ = 159.0 (C1), 135.0 (C2) 129.0 (C3) 
115.2 (C4) 71.3 (framework) 68.3 (-CH2CH2OR) 64.9 (C5) 41.7, 18.1 (framework) 
1H MAS NMR (CD2Cl2): 6.9, 6.7 (aromatics) 4.1 (-OC6H4CH2OH) 
IR showed no peaks between 1800-1500 cm-1 (aldehyde) 
 
Synthesis of resin bound 4-hydroxybenzaldehyde 24 by nucleophilic addition to 
mesyl-functionalized Versabeads 
 
Versabeads VO 400 (0.5 g, 0.75 mmol, 1 equiv) was suspended in freshly distilled 
dichloromethane (4 mL) at room temperature under Ar. Mesyl chloride (1.1 mL 
(ρ=1.48 g/mL), 1.7 g, 15 mmol, 20 equiv) was added and the suspension was cooled 
on an ice bath. Pyridine (0.5 mL (ρ=0.978 g/mL), 0.5 g, 6.2 mmol, 8 equiv) was 
added and the suspension was stirred for 1.5 h. The suspension was filtered and the 
reaction was repeated for 1 h, then the suspension was filtered, washed with DCM(3 x 
5 mL),  MeCN (3 x 5 mL) and DCM (1 x 5 mL) then dried to give resin 28. 
IR = 1174 cm-1 (SO)  
4-hydroxybenzaldehyde (0.52 g, 4.3 mmol, 5.7 equiv) and sodium hydroxide (0.16 g, 
4.0 mmol, 5.3 equiv) was suspended in DMF (10 mL) and heated to 90°C. After 30 
min. the mesylated resin was added, and the suspension was stirred at 90 °C 
overnight. The suspension was filtered and the resin was washed with DMF (3 x 5 
mL) and DCM (3 x5 mL) and dried. 
New IR peaks showed the characteristic peaks for 26. 
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7.4 Synthesis of aryl piperazines from resin-bound mustards 
 
7.4.1 Immobilization of the mustard 
 
7.4.1.1 Initial synthesis (Table 11) 
 
Initial synthesis of resin 29 in dichloromethane  
 
Versabeads O400 (0.8 g, 0.4 mmol, 1 equiv) was suspended in THF (4 mL). A 
solution of phosgene in toluene (20% w/w, 2.5 mL, (ρ= 0.935 g/mL), 0.46 g 
phosgene, 4.7 mmol, 12 equiv) was added and the suspension was agitated overnight. 
The resin was washed with dry THF (4 mL), then suspended in a solution of 
bis(bromoethyl)amin, hydrobromide (0.60 g,  1.9 mmol, 5 equiv)  and triethylamine 
(0.78 mL (ρ= 0.73 g/mL) 0.58 g, 5.7 mmol, 15 equiv) in dry dichloromethane (8 mL). 
The suspension was agitated for 24 h. The suspension was filtered and the resin was 
washed with dichloromethane (4 x 10 mL), THF (6 x 10 mL) and methanol (2 x 10 
mL)) and then dried to give resin 29 (weight not recorded) 
 
13C- gel phase NMR (62.5 MHz, CDCl3): 154.8 (C1) 73.0, 69.9 (framework) 65.8 
(morpholin, 30) 64.1 (-CH2CH2OR) 49.8 (C2) 43.3 (morpholin, 30) 40.6 (framework) 
28.9 (C3) 16.7 (framework), 13.4 (possible ring closure artefact)  
IR = 1702 cm-1 (Carbonyl stretch) 
 
Estimated yield by 13C gel phase NMR ~ 100 % (No (-CH2CH2OH) peak (61 ppm)) 
Br-analysis 6.4%/6.5% ~ 0.4 mmol mustard/g. (80 %) 
 
Synthesis of resin 29 in water (table 11, entry 2) 
 
Versabeads O400 (5.7 g, 8.6 mmol, 1 equiv) was suspended in THF (70 mL). A 
solution of phosgene in toluene (20% w/w, 22 mL, (ρ= 0.935 g/mL) 4.1 g phosgene, 
41 mmol, 5 equiv) was added and the suspension was stirred at room temperature for 
6 h. The suspension was filtered and the resin was washed with THF (3 x 50 mL) and 
methanol (3 x 50 mL). The resin was then suspended in a solution of 
bis(bromethyl)amine, hydrobromide (13.3 g, 43 mmol, 5 equiv) in water (80 mL). 
Triethylamine (6 mL (ρ= 0.73 g/mL), 4.4 g, 43 mmol, 5 equiv) was added and the 
suspension was stirred overnight at room temperature. 
The suspension was filtered and the resin was washed with water (3 x 50 mL), 
methanol (3 x 50 mL), THF (3 x 50 mL) and methanol (3 x 50 mL) and then dried to 
give 8.3 g of resin 29 (118% of theoretical weight gain) 
 
13C- gel phase NMR (62.5 MHz, CDCl3): δ =155.0 (C1); 70.0 (framework); 68.7 (-
CH2CH2OR); 64.3 (-CH2CH2OR); 61.6 (possible (-CH2CH2OH)); 50.4/50.0 (C2); 
45.5-41.5 (resin anomaly); 29.1 (C3); 22.8, 17.0, 7.3 (framework). 
IR = 1702 cm-1 
Br-analysis: 19.7%/19.6% ~ 1.2 mmol mustard/g (114%) 
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After 7 months: 
13C- gel phase NMR (62.5 MHz, CD2Cl2):  δ =156.3 (C1) 74.9 , 71.3 (framework) 
70.0 (-CH2CH2OR) 65.6 (-CH2CH2OR) 62.8 (-CH2CH2OH) 51.6/51.2 (C2) 46.7-42.0 
(resin anomaly) 30.6 (C3) 24.1, 18.2, 8.5 (framework) 
Br-analysis 19.3%/19.3% ~ 1.2 mmol mustard/g (114%) 
 
Synthesis of resin-bound morpholine 30 
 
Versabeads O (2.7 g, 5 mmol, 1 equiv) was suspended in THF (40 mL). A solution of 
phosgene in toluene (20% w/w, 5.3 mL (ρ= 0.935 g/mL), 4.4 g phosgene, 10 mmol, 2 
equiv) was added and the suspension was stirred at room temperature for 2 h. The 
solvent was removed and the resin was washed with THF (30 mL), methanol (2 x 30 
mL) and THF (30 mL). The resin was suspended in THF (50 mL) and the suspension 
was cooled on an ice/water bath. Morpholine (3.0 g, 34 mmol, 7 equiv) was added 
slowly and the suspension was stirred at room temperature for 3.5 h. The suspension 
was filtered and the resin was washed with THF (3 x 50 mL), methanol (3 x 50 mL), 
water (3 x 50 mL) and THF (3 x 50 mL) and then dried. 
 
13C gel-phase NMR (62,5 MHz, CDCl3): δ = 171.6 (resin impurity); 156,1 (C1); 72.5 
(-CH2CH2OH); 70.4 (framework); 69.5 (-CH2CH2OR); 66.6 (C2); 65.3 (-CH2CH2OR) 
61.0 (-CH2CH2OH); 43.9 (C3); 40.7, 23.5, 17.9, 8.0 (framework). 
 
Synthesis of resin-bound bis(chloroethyl)amine 31 on a 0.15 mol scale with 
triethylamine as base 
 
Versabeads O400 (75.6 g, 0.15 mol, 1 equiv) was suspended in THF (750 mL) and 
cooled on an ice/water bath. A solution of phosgene in toluene (20 % w/w, 160 mL (ρ 
= 0.935 g/mL), 29.5 g phosgene, 0.3 mol, 2 equiv) was added slowly and the 
suspension was stirred at room temperature for 2.5 h, then sucked dry. The resin was 
washed with THF (300 mL), methanol (2 x 300 mL) and THF (300 mL) and then 
suspended in a solution of bis(chloroethyl)amine, hydrochloride (134 g, 0.75 mol, 5 
equiv) in water (300 mL). The suspension was cooled on an ice/water bath and 
triethylamine (310 mL (ρ = 0.73 g/mL), 228 g, 2.25 mol, 15 equiv) was added slowly 
and the suspension was stirred at room temperature for 4 h. The suspension was 
filtered and the resin was washed with THF (2 x 250 mL), methanol (2 x 250 mL), 
water (2 x 250 mL), THF (2 x 250 mL) and methanol and then dried to give 103 g 
(110 %) of resin 31 as white beads. 
 
13C gel-phase NMR (62.5 MHz, CDCl3): δ = 155.4 (C1); 73.6, 70.2 (framework); 69.0 
(-CH2CH2OR); 66.5 (framework); 64.4 (-CH2CH2OR); 63.3 (framework); 51.0/50.5 
(C2); 43.1, 42.3 (framework); 41.6 (C3); 23.0, 20.6, 17.2, 7.5 (framework). (See 
appendix A – spectrum 2) 
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7.4.1.2 Optimization of mustard addition 
 
Attempt to synthesise 29 with only 2 equivalents of bromomustard salt  
 
Versabeads O400 (10 g, 19.1 mmol, 1 equiv) was suspended in THF (150 mL) and 
the suspension was cooled down on an ice bath. A solution of phosgene in toluene (20 
% (w/w), 52 mL, (ρ= 0.935 g/mL), 9.7 g phosgene, 98 mmol, 5.1 equiv) was added 
slowly and the suspension was allowed to heat to room temperature. The suspension 
was stirred for 5 h, and then filtered and the resin was washed with THF (2 x 100 
mL), methanol (2 x 100 mL), water (2 x 100 mL) and THF (2 x 100 mL). 
The resin was then suspended in a solution of bis(bromoethyl)amine, hydrobromide 
(11.8 g, 93% (w/w), 35 mmol, 1.8 equiv) in water (80 mL) and cooled on an ice/water 
bath. Triethylamine (16 mL (ρ= 0.73 g/mL), 11.6 g, 110 mmol, 6 equiv) was added 
slowly and the suspension was stirred for 19 h. The suspension was sucked dry and 
the resin was washed with water (2 x 100 mL), THF (2 x 100 mL) and methanol (2 x 
100 mL) and then dried. 
End weight: 10.6 g (71 % of theoretical weight) 
 
13C gel-phase NMR (62.5 MHz, CDCl3): 160.7 (possible cross linking) 155.4 (C1) 
72.3 (-CH2CH2OH) 70.3 (framework) 69.0 (-CH2CH2OR) 64.6 (-CH2CH2OR) 62.7 
(possible cross-linking) 61.4 (-CH2CH2OH) 50.7/50.3 (C2) 43.2; 41.1 (framework) 
29.3 (C3) 23.0; 17.3; 7.5 (framework) 
 
Estimated loading from 13C gel-phase NMR: 56%  
Br-analysis 11.8% ~ 0.75 mmol mustard/g (58%) 
 
Attempted synthesis of 29 with 2 equivalents of bromomustard salt and heat   
 
Versabeads O400 (7.0 g, 13.4 mmol, 1 equiv) was suspended in THF (70 mL) and the 
suspension was cooled down on an ice/water bath. A solution of phosgene in toluene 
(20 % (w/w), 15 mL, (ρ= 0.935 g/mL), 2.8 g phosgene, 28 mmol, 2.1 equiv) was 
added slowly, the ice/water bath was removed and the suspension was stirred for 2.5 h 
at room temperature  
The suspension was sucked dry and the resin was washed with THF (50 mL), water 
(50 mL), THF (50 mL) and water (50 mL). The resin was then suspended in a solution 
of bis(bromethyl)amine, hydrobromide (9.2 g, (92% (w/w), 27 mmol, 2 equiv) in 
water (40 mL) and cooled on an ice/water bath. A solution of potassium carbonate 
(5.5 g, 40 mmol, 3 equiv) in water (30 mL) was added slowly. The suspension was 
heated to 80°C and kept at this temperature overnight. The suspension was allowed to 
cool, then sucked dry and the resin was washed with THF (2 x 70 mL) methanol (2 x 
70 mL) water (2 x 70 mL) and THF (2 x 70 mL) then dried. End weight: 6.3 g 
 
13C gel phase NMR (62.5 MHz, CDCl3) was not different from Versabeads. 
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7.4.1.3 Resin 31 stabillity test 
 
Resin 31 (3.0 g, 4.3 mmol, 1 equiv) was suspended in a solution of potassium 
carbonate (1.5 g, 11 mmol, 2.5 equiv) and potassium iodide (0.14 g, 0.87 mmol, 0.2 
equiv) in water (15 mL) and heated to 80°C. 
After 4 h a sample was removed for, washed with water and methanol and dried. 13C- 
gel phase NMR (62.5 MHz, CDCl3) showed no change from 31. 
After 21 h a sample was removed for NMR experiment, washed with water and 
methanol and dried 13C- gel phase NMR (62.5 MHz, CDCl3) showed almost all 
mustard cleaved judged by peaks at 72.6 ppm and 61.2 ppm. 
 
Screening of bases in the formation of 31 (Table 12) 
 
General procedure: Versabeads O400 (2.0 g, 3.9 mmol, 1 equiv) were suspended in 
THF (20 mL) at room temperature. A solution of phosgene in toluene (20% (w/w), 4 
mL (ρ= 0.935 g/mL), 0.75 g phosgene, 7.6 mmol, 1.9 equiv) was added and the 
suspension was stirred at room temperature for 2.5 h and then sucked dry. The resin 
was washed with THF (20 mL), methanol (20 mL) and THF (20 mL), then suspended 
in water (10 mL). Bis(chloroethyl)amine, hydrochloride (1.4 g, 7.9 mmol, 2.0 equiv) 
was added, followed by base (23 mmol, 6 equiv). The suspensions were stirred for 4 h 
at room temperature and then filtered, and the resins were washed with water (2 x 10 
mL), THF (2x 20 mL), methanol (2 x 20 mL) and THF (2 x 20 mL) and then dried. 
Analyzed with 13C gel phase NMR. 
 
Entry base Amount NMR Peak 
height (64 
ppm) 
NMR Peak 
height (61 
ppm) 
NMR 
conversion 
1 Triethylamine 3.2 mL  
(2.4 g) 
59 mm - full 
2 Potassium  
carbonate 
3.2 g 55 mm - full 
3 Pyridine 1.9 mL (1.8 g) - 35 mm none 
4 Diisopropyl 
ethylamine 
2.4 mL (3.0 g) 75 mm - full 
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7.5 Synthesis of N-aryl piperazines  
 
7.5.1 Initial experiments 
 
7.5.1.1 Addition of aromatic nucleophiles to resin bound mustards 29 
and 31 (Table 13) 
Synthesis of resin bound 1-(4-fluorophenyl)piperazine (32) 
 
Synthesis of resin-bound 1-(4-fluoropiperazine) 32 at room temperature in water 
 
 
Resin 29 (0.27 g, 0.18 mmol, 1 equiv) was suspended in water (2 mL) with potassium 
carbonate (77 mg, 0.56 mmol, 3 equiv). 4-fluoroaniline (0.17 g, 1.5 mmol, 8 equiv) 
was added and the suspension was agitated overnight. 
The suspension was filtered and the resin was washed with water (2 x 2 mL), THF (6 
x 2 mL), dichloromethane (6 x 2 mL) and methanol (2 x 2 mL) and then dried. 
 
13C gel phase NMR (62.5 MHz, CD2Cl2): δ = 156.2 (C1); 119.1 (C2); 116.3 (C3) 
79.7-74.4 (resin artefacts); 71.3 (framework); 67.2 (-CH2CH2OR); 65.4 (30); 62.2  (-
CH2CH2OH) 51.0 (C4 + 29); 44.9 (C5 +30) 30.4 (29) 21.5,18.1(framework) 
 
19F gel phase NMR (470 MHz, CD2Cl2): δ -124.9 ppm 
1H MAS NMR: (500 MHz, CD2Cl2): New protons between 6.7 ppm and 7.0 ppm 
(aromat) 
N elemental analysis: 1.01% ~ 0.72 mmol N/g  
F elemental analysis: 0.35% ~ 0.18 mmol F/g (47%) 
 
 
Synthesis of resin-bound 1-(4-fluoropiperazine) 32 on gram-scale at room 
temperature and attempted cleavage  
 
Versabeads O400 (17.4 g, 33.2 mmol, 1 equiv) were suspended in THF (200 mL). A 
solution of phosgene in toluene (20% (w/w), 120 mL (ρ =  0.935 g/mL), 22.4 g 
phosgene, 230 mmol, 6.8 equiv) was added slowly and the suspension was stirred at 
room temperature for 5 h. The suspension was sucked dry and the resin was washed 
with THF (2 x 100 mL), water (2 x 100 mL) and THF (100 mL). 
The resin was suspended in a solution of bis(bromoethyl)amine, hydrobromide (70.3 g 
(93% (w/w), 65.4 g bis(bromoethyl)amine, hydrobromide, 210 mmol, 6.3 equiv). 
Triethylamine (87 mL (ρ = 0.73 g/mL), 64 g, 630 mmol, 19 equiv) was added slowly 
with cooling and the suspension was stirred at room temperature overnight. The 
suspension was sucked dry and the resin was washed with water (3 x 100 mL), THF 
(1 x 100 mL), water (2 x 100 mL) and THF (3 x 100 mL), to form resin 29. 
IR = 1701 cm-1 
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The resin was suspended in THF (100 mL). 4-fluoroaniline (23 g, 210 mmol, 6.3 
equiv) was added, followed by slow addition of potassium carbonate (14.7 g, 105 
mmol, 2.5 equiv) in water (100 mL). The suspension was stirred for 21 h at room 
temperature, then sucked dry. The resin was washed with water (3 x 100 mL) and 
THF (3 x 200 mL), then with alternating THF (200 mL) and methanol (100 mL) until 
the washing was colorless. The resin was dried. 
 
13C gel phase NMR (62.5 MHz; CDCl3): δ 159.1 (C1); 155.3 (C2); 147.5 (C3); 118.4 
(C4); 115.5/115.2 (C5) 73.8 (framework) 72.3 (-CH2CH2OH); 70.3 (framework); 
69.3, 69.0 (-CH2CH2OR) 66.2 (30); 64.5, 64.4 (-CH2CH2OR) 61.4 (-CH2CH2OH); 
50.7; 50.2 (C6 + bromethylamine) 43.5 (C7) 43.2 (30) 42.3; 41.0 (framework); 29.3 
(bromethylamine); 23.0; 17.2 (framework) 13.7 (artefact), 7.5 (framework). 
Estimated conversion by relative heights of 43.5 ppm and 29.3 ppm ~ 30%. 
 
The resin was suspended in THF (350 mL). Methanol was added (16.5 mL (ρ = 0.79 
g/mL), 13 g, 0.42 mol, 10 equiv) and the suspension was cooled on an ice/water bath. 
Lithium borohydride (9.0 g, 0.42 mol, 10 equiv) was added. The suspension was 
heated to reflux and kept at this temperature overnight. The reaction was quenched 
through slow addition of acetone (150 mL), the suspension was filtered and the resin 
was washed with THF (4 x 100 mL), 1 M aqueous HCl (3 x 20 mL) and THF (100 
mL). THF was removed through evaporation and the water phase was made basic 
with aqueous ammonia (50 mL, 25 % w/v) and extracted with diethyl ether (5 x 200 
mL). The combined organic phases were washed with saturated aqueous sodium 
bicarbonate (2 x 50 mL), brine (2 x 50 mL) and water (4 x 50 mL), dried (anhyd 
sodium sulphate) and evaporated to give 1.72 g of a brown oil. 
The oil was dissolved in 2-propanol (10 mL). Oxalic acid dihydrate (0.8 g, 6.3 mmol) 
was dissolved in 2-propanol and slowly added to give 2.07 g of white crystals. 
1H NMR (500 MHz, D2O): δ = 2.81 (s, 3H, Me-); 2.93-3.05 (m, 2H, H1/H2); 3.05-
3.20 (m, 2H, H1/H2); 3.40-3.70 (m, 4H, H3); 6.95-7.02 (m, 4H, H4). 
13C NMR (125 MHz, D2O): δ = 164.4 (C1); 159.8 (C2); 145.3 (C3); 120.2 (C4); 
116.4 (C5); 53.3 (C6); 48.4 (C7); 43.2 (C8). 
LC/MS / UV254 showed two impurities with a mass of 292/306 amu  
Free-base of the oxalate was made through suspension in aqueous ammonia (5 % w/v) 
and extraction with diethyl ether 
1H NMR (500 MHz, CDCl3) of the free base contained double doublet at 2.88 ppm 
and 3.12 ppm, which correlates to 13C NMR (125 MHz, CDCl3) peaks at 44.7 ppm 
and 48.8 ppm. This corresponds to aliphatic peaks in the spectra of similar triamines 
in literature,281 which makes it plausible that diaddition products 34/35 are formed 
(appendix A spectrum 3 and 4). 
 
Attempted synthesis of 32 with heating  
 
Resin 29 (7.25 g, 9.3 mmol, 1 equiv) was suspended in water (70 mL) with 4 –
fluoroaniline (5.2 g, 46.5 mmol, 5 equiv). A solution of potassium carbonate (3.2 g, 
23 mmol, 2.5 equiv) in water (70 mL) was added slowly and the suspension was 
heated to reflux (100 °C) and kept at this temperature for 18 h. The suspension was 
filtered and the resin was washed with THF (3 x 100 mL), methanol (2 x 100 mL), 
water (2 x 100 mL), THF (2 x 100 mL) and acetone (3 x 100 mL) and then dried. 
End weight: 5.86 g 
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13C gel phase NMR (62.5 MHz, CDCl3): δ = 155.5 (C1); 148.5 (C2); 118.9 (C3); 
116.0/115.7 (C4); 114.1 (diaddition product?); 74.4 (framework); 72.9 (-CH2CH2OH); 
70.8 (framework); 64.9 (-CH2CH2OR); 61.9 (-CH2CH2OH); 50.6 (C5); 44.0/43.7 (C6 
+ framework); 41.3; 23.5; 17.7; 8.0 (framework).  
Estimated cleavage from resin ~ 89%. 
 
Resin-bound 4-fluoropiperazine (32) from 31 with heating  
 
Resin 31 (1.5 g, 2.2 mmol, 1 equiv) was suspended in water (20 mL) with 4 – 
fluoroaniline (1.2 g, 11 mmol, 5 equiv). A solution of potassium carbonate (0.75 g, 
5.4 mmol, 2.5 equiv) was added and the suspension was heated to reflux and kept at 
reflux overnight. The suspension was filtered and the resin was washed with THF (2 x 
20 mL), methanol (2 x 20 mL), water (2 x 20 mL) and THF (2 x 20 mL), and then 
dried. 
13C gel phase NMR (62.5 MHz, CDCl3): δ = 155.5 (C1); 147.5 (C2); 118.5 (C3); 
115.4 (C4); 72.3 (-CH2CH2OH); 70.2 (framework); 64.4 (-CH2CH2OR); 61.3 (-
CH2CH2OH); 50.0 (C5); 43.4/43.1 (C6 + framework); 41.6/40.8, 22.9, 17.2, 7.4 
(framework).  
Estimated cleavage from resin ~ 91%. (See appendix A - spectrum 3) 
 
Attempt to form 32 with chloromustard, potassium iodide and heat (Table 13, 
entry 7) 
 
Resin 31 (6.6 g, 9.5 mmol, 1 equiv) was suspended in water (30 mL) with 4- 
fluoroaniline (5.3 g, 48 mmol, 5 equiv) and cooled down on an ice/water bath. A 
solution of potassium carbonate (3.3 g, 24 mmol, 2.5 equiv) and potassium iodide 
(0.32 g, 1.9 mmol, 0.2 equiv) was added and the suspension was heated to 80 °C and 
stirred at this temperature for 23 h. The suspension was sucked dry and the resin was 
washed with water (2 x 50 mL), THF (2 x 50 mL), methanol (2 x 50 mL), THF (3 x 
50 mL) then dried. 
13C gel phase NMR (62.5 MHz, CDCl3): δ = 155.0 (C1); 147.5 (C2); 118.2 (C3); 
115.4 (C4); 113.1 (possible diaddition product); 72.2 (-CH2CH2OH); 70.2 
(framework); 64.3 (-CH2CH2OR); 61.2 (-CH2CH2OH); 50.0 (C5); 43.4/43.1 (C6 + 
framework); 40.7, 26.8 (artefact), 22.9 (framework); 19.0 (artefact), 17.2, 7.4 
(framework).  
19F gel-phase NMR (470 MHz, CDCl3): δ =  - 123.7 ppm (32), -129.3 ppm (diaddition 
product?).  
Estimated cleavage from resin ~ 87%. 
 
Attempted synthesis of resin-bound 1-(4-iodophenyl)-piperazine and 1-(4-
methoxyphenyl)-piperazine (table 13)  
 
Attempted synthesis of 4-iodopiperazine 36 on resin and attempted cleavage to 
37  
 
Resin 29 (2 g, 2.4 mmol, 1 equiv) was suspended in a solution of 4-iodoaniline (2.6 g, 
12 mmol, 5 equiv) and potassium carbonate (0.83 g, 6 mmol, 2.5 equiv) in a 
water/acetonitrile mixture (3:1, 20 mL) at room temperature. After 24 h the 
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suspension was filtered and the resin was washed with 1 M aqueous HCl (4 x 50 mL), 
5% aqueous ammonia (5 x 50 mL), acetonitrile (3 x 50 mL), 1M aqueous HCl (4 x 50 
mL), 5% aqueous ammonia (5 x 50 mL), MeCN (3 x 50 mL), THF (3 x 50 mL) and 
acetone (3 x 50 mL) and then dried. 
 
13C gel phase NMR (62.5 MHz, CD2Cl2): δ = 156.3 (C1); 138.5 (C2); 119.5 (C3); 
115.8 (Most likely diaddition byproduct) 71.3 (-CH2CH2OH); 70.0 (framework); 67.9 
(-CH2CH2OR); 65.6 (-CH2CH2OR); 62.3 (-CH2CH2OH) 51.2/50.1 (29) 49.5 (C4); 
44.3 (C6); 30.5 (29); 24.1, 18.2, 8.4 (framework). 
Estimated cleavage by peaks at 65.6 ppm and 62.3 ppm: 33% 
 
The resin was suspended in THF (20 mL). Methanol (0.94 mL, (ρ =  0.79 g/mL) 0.74 
g, 24 mmol, 10 equiv) and lithium borohydride (0.56 g, 26 mmol, 11 equiv) was 
added and the suspension was heated to reflux overnight. The reaction was quenched 
with acetone (30 mL) and filtered, then washed with 1 M aqueous HCl (200 mL), 
THF (200 mL), 1 M aqueous HCl (200 mL) and water (100 mL). 
The filtrate was made basic with aqueous ammonia (25% w/v, 100 mL) and extracted 
with diethyl ether (4 x 150 mL). The combined organic phases were washed with 
saturated aqueous sodium bicarbonate (2 x 100 mL), brine (2 x 100 mL) and water (2 
x 100 mL), dried (anhyd sodium sulphate) and evaporated. 
Yield: 41 mg of crude compound 37. 
 
1H NMR (500 MHz, CDCl3): δ = 2.23 (s, 3H, -Me); 2.54-2.57 (m, 4H, H1); 3.16-3.19 
(m, 4H, H2); 6.68 (d, J = 8.9 Hz, 2H, H3); 7.50 (d, J = 9.0 Hz, 2H, H4) 
 
 
Attempt to form 36 with heating  
 
 Resin 29 (1.5 g, 2.1 mmol, 1 equiv) was suspended in water (20 mL) with potassium 
carbonate (0.74 g, 5.4 mmol, 2.5 equiv). 4-iodoaniline (2.8 g, 13 mmol, 6 equiv) was 
purified by recrystallization from heptane, then dissolved in acetonitrile (20 mL) and 
added to the suspension, which was then heated to reflux (78°) and kept at this 
temperature for 21 h. The suspension was filtered and the resin was washed with THF 
(3 x 20 mL), methanol (3 x 20 mL), water (3 x 20 mL) and methanol (3 x 20 mL) and 
then dried.  
13C gel phase NMR (62.5 MHz, CD2Cl2) shows that almost all compound have been 
cleaved from resin (strong peaks at δ = 73.9 (-CH2CH2OH) and 62.8 (-CH2CH2OH)). 
 
 
Attempt to form 38 (Table 13, entry 8) 
 
Resin 29 (5.0 g, 6.4 mmol, 1 equiv) was suspended in water (35 mL) with 4-
methoxyaniline (3.9 g, 32 mmol, 5 equiv). A solution of potassium carbonate (2.2 g, 
16 mmol, 2.5 equiv) in water (15 mL) was added and the suspension was heated to 60 
°C and kept at this temperature overnight. The suspension was sucked dry and the 
resin was washed with THF (3 x 50 mL), methanol (2 x 50 mL) water (2 x 50 mL) 
and THF (2 x 50 mL), then dried. 
 
 13C gel phase NMR (62.5 MHz, CDCl3): δ = 154.9 (C1); 154.0 (C2); 145.2 (C3); 
118.6 (C4); 114.2 (C5); 73.9 (framework); 72.3 (-CH2CH2OH); 70.3 (framework); 
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69.3 (-CH2CH2OR); 64.3 (-CH2CH2OR); 61.3 (-CH2CH2OH); 55.2 (C6); 50.6 (C7); 
43.6 (C8); 40.9, 23.0, 17.2, 7.5 (framework). 
Estimated cleavage from resin ~ 55%. 
 
Attempted synthesis of piperazines bearing nitrogen heterocyclic substituents 
(table 13) 
 
Attempted synthesis of resin-bound 1-(2-pyridyl)-piperazine (39) 
 
Resin 29 (0.75 g, 1.2 mmol, 1 equiv) was suspended in a mixture of 2-aminopyridine 
(0.57 g, 5 mmol, 5 equiv) and potassium carbonate (0.41 g, 3 mmol, 2.5 equiv) in 
water (15 mL). The suspension was agitated for 26 h then filtered, and the resin was 
washed with water (3 x 10 mL), THF (3 x 10 mL) and methanol (3 x 10 mL). This 
washing cycle was repeated until no trace of starting material was left in the washing 
by HPLC.    
13C- gel phase NMR (62.5 MHz, CDCl3) was not different from starting material. 
 
Attempted synthesis of resin-bound 1-(pyrimidin-2-yl)-piperazine (40) 
 
Resin 29 (1.2 g, 1.1 mmol, 1 equiv) was suspended in water (10 mL). Pyrimidin-2-
ylamine (0.52 g, 5.3 mmol, 5 equiv) and potassium carbonate (0.35 g, 2.6 mmol, 2.5 
equiv) was added and the suspension was agitated overnight. The suspension was 
filtered, and the resin was washed with THF (3 x 10 mL), methanol (3 x 10 mL) and 
THF (3 x 10 mL) and then dried. 
13C- gel phase NMR (62.5 MHz, CD2Cl2) showed only negligible conversion (very 
small peaks at δ = 128-130 ppm). 
 
 
Attempted synthesis of resin-bound 1-(pyrimidin-2-yl)-piperazine (40) with 
microwave heating 
 
Resin 31 (0.55 g, 0.71 mmol, 1 equiv) was suspended in water (4 mL) with pyrimidin-
2-ylamine (0.31 g, 3.3 mmol, 4.6 equiv) and potassium carbonate (0.24 g, 1.7 mmol, 
2.5 equiv) in an Emrys Process Vial. The vial was closed and the suspension heated 
with microwaves (100 °C, 6 min). The suspension was filtered and the resin was 
washed with THF (3 x 10 mL), methanol (3 x 10 mL) water (3 x 10 mL) and 
methanol (1 x 10 mL) and then dried. 
13C- gel phase NMR (62.5 MHz, CDCl3) showed that mustard have been converted to 
morpholine 30 (δ = 66.3 ppm). 
 
7.5.1.2 Optimization of addition to resin-bound mustard 31 
Solvent screening process (Table 14) 
 
Resin 31 (2.0 g, 2.9 mmol, 1 equiv) was suspended in solvent (20 mL; 1.DMF, 2. 
THF, 3. MIBK, 4. water, 5. 1-butanol, 6. ethanol, 7. dimethoxyethyl ether) with 4- 
methoxyaniline (1.8 g, 14.4 mmol, 5 equiv), potassium carbonate (0.99 g, 7.2 mmol, 
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2.5 equiv) and potassium iodide (0.10 g, 0.58 mmol, 0.2 equiv). The suspension was 
heated to 80 °C overnight. The resins were filtered, washed with water (20 mL) and 
THF (20 mL) and analyzed by 13C gel phase NMR (CDCl3).  
 
Resin 38 from reaction 3 (2.0 g) and 7 (1.6 g) were suspended in THF (20 mL). 
Methanol (1.0 mL (ρ = 0.79 g/mL), 0.81 g, 26 mmol) and lithium borohydride (0.56 
g, 26 mmol) were added and the suspension were kept at reflux temperature 
overnight. The reaction was quenched with ethyl acetate (20 mL) and the suspensions 
were filtered, washed with THF (2 x 20 mL); 1M aqueous hydrochloric acid (2 x 20 
mL); THF (20 mL) 1M aqueous hydrochloric acid (2 x 20 mL) and THF (20 mL) then 
dried. The filtrates were washed with ethyl acetate (20 mL) and made basic, then 
extracted with diethyl ether (3 x 20 mL). The combined organic phases were washed 
with saturated sodium bicarbonate (10 mL), brine (10 mL) and water (10 mL), dried 
(anhydrous sodium sulphate) and evaporated. 
Crude yield 1: 290 mg 2: 40 mg. 
1 gave satisfactory NMR spectrum for 45a  
 
Base screening (table 15) 
 
Resin 31 (2.0 g, 2.9 mmol, 1 equiv) was suspended in MIBK (20 mL) with 4- 
methoxyaniline (1.8 g, 14.4 mmol, 5 equiv), base (1. pyridine (1.2 mL (ρ = 0.978), 
1.1 g, 14.4 mmol, 5 equiv); 2. DIPEA (2.46 mL (ρ = 0.755), 1.9 g, 14.4 mmol, 5 
equiv); 3. 4-dimethylaminopyridine (1.76 g, 14.4 mmol, 5 equiv)) and potassium 
iodide (0.10 g, 0.58 mmol, 0.2 equiv)). The suspensions were kept at reflux overnight, 
then filtered, washed with methanol (3 x 20 mL), water (3 x 20 mL), THF (20 mL) 
and methanol (20 mL) and then dried. The samples were analyzed by 13C gel-phase 
NMR (62.5 MHz, CDCl3). 
1 and 2 gave complete reaction judge by 13C gel-phase NMR 
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7.5.2 Synthesis and cleavage of N-aryl piperazine derivatives 
7.5.2.1 Gram scale synthesis of. N-Aryl and –N-aryl-N’- methyl 
piperazines 
 
Versabeads™ O400 (90.0 g, 177 mmol, 1 equiv) were suspended in THF (900 mL). A 
solution of phosgene in toluene (20% w/w, 190 mL (ρ = 0.935 g/mL), 355 mmol, 2.0 
equiv) was slowly added and the suspension was stirred mechanically at room 
temperature. for 2 h. The liquid was removed and the resin was washed successively 
with THF (750 mL), methanol (2 × 500 mL), and THF (900 mL). 
Bis(chloroethyl)amine hydrochloride (110 g, 0.61 mol, 3.5 equiv) was dissolved in 
water (450 mL) and was added to the resin. The suspension was cooled on an ice-
water bath and potassium carbonate (147 g, 1.06 mol, 6.0 equiv) was added 
portionwise with mechanical stirring. The ice-water bath was removed and the 
suspension was stirred for 6 h at room temperature. The resin was recovered by 
filtration and washed successively with water (3 × 500 mL), THF (3 × 500 mL), 
Methanol (3 × 500 mL), water (2 × 500 mL), THF (1 750 mL), and methanol (2 × 500 
mL) before drying in vacuo to give 123.1 g (103% of theoretical weight gain) of resin 
31. 
Cl analysis: 11.9% Cl 1.68 mmol/g bis(chloroethyl)amine/g resin, (113% of 
theoretical maximum loading). 
 
13C NMR (CDCl3): δ = 155.4 (C1); 73.8, 70.2 (framework); 69.0 (-CH2CH2OR); 66.7, 
64.5 (-CH2CH2OR), 63.2, 50.9/50.5 (C2); 43.1 (C3); 42.3, 23.0, 20.6, 17.2, 7.5 
(framework). 
 
 Resin-bound N-arylpiperazines 32, 38, 43 and 44. 
 
Resin 31 (10.0 g, 14.8 mmol, 1 equiv) was suspended in MIBK (75 mL) in the 
presence of the aniline (74 mmol, 5 equiv) and KI (0.5 g, 3 mmol, 0.2 equiv). Then 
pyridine (12.0 mL (ρ = 0.978 g/mL), 12 g, 0.15 mol, 10 equiv) was added and the 
suspension was heated to 100 °C with mechanical stirring. After the reaction time 
stated in table 15, the solvent was removed and the resin was washed successively 
with THF (3 × 100 mL), methanol (3 × 100 mL), water (3 × 100 mL) and THF (3 × 
100 mL), and dried in vacuo to give the immobilized piperazines. Completion of the 
reactions was confirmed through 13C gel-phase NMR spectroscopy (For an example 
of reaction monitoring see appendix, spectrum 5).  
 
N-Aryl-N′-methylpiperazines 45a-d (Table 15); General Procedure 
 
The appropriate resin (14.8 mmol) was suspended in THF (100 mL). Then, lithium 
aluminium hydride (5.7 g, 0.15 mol, 10 equiv) was added as pellets and the 
suspension was heated at reflux for 19 h with mechanical stirring. The reaction was 
cooled on an ice-water bath, quenched by the sequential addition of water (6 mL), 
aqueous NaOH soln (13% w/v, 6 mL), and water (17 mL). The suspension was 
filtered and the resin was washed successively with THF (3 × 100 mL), 1 M aqueous 
HCl (3 × 100 mL), THF (1 × 60 mL), and 1 M aqueous HCl (2 × 100 mL). 
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The THF was removed from the filtrate under reduced pressure. The residual filtrate 
was washed with ethyl acetate (2 × 50 mL) and made basic with aqueous ammonia 
(25% w/v, 100 mL). The resulting suspension was shaken with toluene (100 mL) and 
filtered. The solid was washed with toluene (2 × 100 mL). The filtrate was separated 
and the aqueous phase was washed with toluene (3 × 100 mL). The combined organic 
phases were washed with sat. aqueous sodium bicarbonate (40 mL), brine (40 mL), 
and water (2 × 40 mL), dried (anhyd sodium sulphate), and evaporated. 
 
1-(4-methoxyphenyl)-4-methylpiperazine (45a) 243 
Red solid. Yield: 1.85 g (60%). Mp 63-65 °C  
1H NMR (500 MHz, CDCl3): δ = 2.34 (s, 3 H, H1); 2.57 (t, J = 4,7 Hz, 4 H, H2); 3.10 
(t, J = 5.2 Hz, 4 H, H3); 3.76 (s, 3 H, H4); 6.83 (ddd, J1 = 10.4 Hz, J2 = 9.0 Hz, J3 = 
2.8 Hz, 2 H, H6); 6.90 (ddd, J1 = 10.4 Hz, J2 = 9.0 Hz, J3 = 2.3 Hz, 2 H, H6). 
13C NMR (62.5 MHz, CDCl3): δ = 154.2 (C1); 146.1 (C2); 118.5 (C3); 114.8 (C4); 
55.9 (C5); 55.7 (C6); 51.0 (C7); 46.5 (C8). 
Anal. Calcd for C12H18N2O: C, 69.86; H, 8.80; N, 13.58. Found: C, 69.70; H, 8.88; N, 
13.43. 
 
1-Methyl-4-phenylpiperazine (45b) 243 
Purified by flash chromatography (ethyl acetate-heptane-triethyl amine). Yellow oil; 
yield: 0.96 g (37%). 
1H NMR (500 MHz, CDCl3): δ = 2.31 (s, 3 H, H1); 2.53 (t, J = 4.7 Hz, 4 H, H2); 3.18 
(t, J = 4.7 Hz, 4 H, H3); 6.81-6.85 (m, 1 H, H4); 6.88-6.92 (m, 2 H, H5); 7.21-7.26 
(m, 2 H, H6). 
13C NMR (250 MHz, CDCl3): δ = 151.7 (C1); 129.5 (C2); 120.1 (C3); 116.5 (C4); 
55.6 (C5); 49.5 (C6); 46.6 (C7). 
 
1-(4-Fluorophenyl)-4-methylpiperazine (45c) 
Purified by flash chromatography (ethyl acetate-heptane-triethyl amine). Yellow 
solid; yield: 0.6 g (21%); mp 42-44 °C. 
1H NMR (500 MHz, CDCl3): δ = 2.34 (s, 3 H, H1); 2.56 (t, J = 5.2 Hz, 4 H, H2); 3.12 
(t, J = 5.2 Hz, 4 H, H3); 6.84-6.88 (m, 2 H, H4); 6.92-6.98 (m, 2 H, H5). 
13C NMR (62.5 MHz, CDCl3): δ = 158.5; 156.6 (C1); 148.3 (C2); 118.2; 118.1 (C3); 
115.9; 115.8 (C4); 55.5 (C5); 50.5 (C6); 46.5 (C7). 
Anal. Calcd for C11H15N2F: C, 68.01; H, 7.78; N, 14.42. Found: C, 67.89; H, 7.89; N, 
14.38. 
 
1-(3,4-Dichlorophenyl)-4-methylpiperazine (45d) 
Byproduct 1-(4-chlorophenyl)-4-methylpiperazine 47 was removed by Kugelrohr 
distillation at 160-165 °C (1 mbar), and the residue was purified by flash 
chromatography (ethyl acetate-heptane-triethyl amine). 
Brown oil, which solidified upon standing; yield: 0.13 g (4%); mp 52-53 °C. 
1H NMR (500 MHz, CDCl3): δ = 2.34 (s, 3 H, H1); 2.55 (t, J = 5.2 Hz, 4 H, H2); 3.18 
(t, J = 4.7 Hz, 4 H, H3); 6.74 (dd, J1 = 9.0 Hz, J2 = 2.8 Hz, 1 H, H4); 6.95 (d, J = 2.8 
Hz, 1 H, H5); 7.26 (d, J = 8 Hz, 1 H, H6). 
13C NMR (62.5 MHz, CDCl3): δ = 151.1 (C1); 133.1 (C2); 130.8 (C3); 122.4 (C4); 
117.5 (C5); 115.6 (C6); 55.2 (C7); 49.0 (C8); 46.5 (C9). 
Anal. Calcd for C11H14N2Cl2: C, 53.89; H, 5.76; N, 11.43. Found: C, 54.12; H, 5.97; 
N, 11.38. 
 
 142
N-Aryl piperazines 46a-d; General procedure 
 
The appropriate resin (14.8 mmol) was suspended in DME (100 mL). Then, 
potassium tert-butoxide (3.7 g, 33 mmol, 2.2 equiv) was added and the suspension 
was heated at reflux temperature for 3 h. The suspension was filtered and washed 
successively with DME (3 × 100 mL), 1 M aqueous HCl (3 × 100 mL), DME (1 × 50 
mL), 1 M aq HCl (3 × 100 mL), and DME (2 × 50 mL). The DME was removed from 
the filtrate under reduced pressure, and the residual filtrate was washed with ethyl 
acetate (2 × 50 mL) and made basic with aqueous ammonia (25% w/v, 100 mL). The 
aqueous phase was extracted with toluene (6 × 100 mL). The combined organic 
phases were filtered to remove impurities, washed with urated aqueous  sodium 
bicarbonate (50 mL), brine (50 mL), and water (2 × 50 mL), dried (anhyd sodium 
sulphate), and evaporated. 
The crude products were dissolved in ethanol (10 mL) and a solution of oxalic acid 
dihydrate (1.1 equiv) in ethanol (9 mL) was added with stirring. The oxalate formed 
was allowed to precipitate in the fridge overnight. In the case of 46a, the equivalents 
of acid were calculated based on the HPLC purity, otherwise they were calculated on 
the total weight of the crude product. 
 
1-(4-Methoxyphenyl)piperazine Oxalate (46a) 
Light-brown crystals; yield: 0.85 g (20%); mp 199-200 °C. 
1H NMR (500 MHz, D2O): δ = 3.30-3.40 (m, 8 H, H1), 3.76 (s, 3 H, H2), 6.97 (ddd, 
J1 = 10.8 Hz, J2 = 3.8 Hz, J3 = 2.4 Hz, 2 H, H3), 7.08 (ddd, J1 = 10.4 Hz, J2 = 3.8 Hz, 
J3 = 2.4 Hz, 2 H, H4). 
13C NMR (62.5 MHz, D2O): δ = 166.4 (C1), 155.2 (C2), 143.8 (C3), 120.3 (C4), 
115.3(C5), 56.1 (C6), 48.5 (C7), 43.5 (C8). 
Anal. Calcd for C13H18N2O5: C, 55.20; H, 6.49; N, 9.91. Found: C, 55.22; H, 6.48; N, 
9.80. 
 
1-Phenylpiperazine Oxalate (46b) 
Light-brown crystals; yield: 0.64 g (17%); mp 167-169 °C. 
1H NMR (500 MHz, D2O): δ = 3.35-3.43 (m, 8 H, H1), 7.03-7.07 (m, 1 H, H2), 7.08-
7.12 (m, 2 H, H3), 7.34-7.39 (m, 2 H, H4). 
13C NMR (62.5 MHz, D2O): δ = 166.5 (C1), 149.9 (C2), 130.1 (C3), 123.0 (C4), 
118.2 (C5), 47.3 (C6), 43.5 (C7). 
Anal. Calcd for C12H16N2O4: C, 56.90; H, 6.77; N, 11.06. Found: C, 56.65; H, 6.49; 
N, 11.10. 
 
1-(4-Fluorophenyl)piperazine Oxalate (46c) 
Light-brown crystals; yield: 0.93 g (23%); mp 172-173 °C. 
1H NMR (500 MHz, D2O): δ = 3.32-3.40 (m, 8 H, H1), 7.07-7.12 (m, 4 H, H2). 
13C NMR (62.5 MHz, D2O): δ = 166.3 (C1), 157.8 (C2), 146.3 (C3), 120.2/120.2 (C4) 
116.4/116.2 (C5), 48.1 (C6), 43.5 (C7). 
Anal. Calcd for C12H15N2O4F: C, 53.33; H, 5.59; N, 10.37. Found: C, 53.35; H, 5.68; 
N, 10.37. 
 
1-(3,4-Dichlorophenyl)piperazine Oxalate (46d) 
Recrystallized (2-propanol). Light-brown crystals; yield: 0.27 g (6%); mp 230-232 
°C. 
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1H NMR (500 MHz, D2O): δ = 3.22-3.32 (m, 8 H, H1), 6.86 (dd, J1 = 8.9 Hz, J2 = 2.8 
Hz, 1 H, H2), 7.11 (d, J = 2.8 Hz, 1 H, H3), 7.32 (d, J = 9.0 Hz, 1 H, H4). 
13C NMR (62.5 MHz, D2O): δ = 149.7 (C1), 131.2 (C2), 119.1 (C3), 117.6 (C4), 46.7 
(C5), 43.3 (C6). 
Anal. Calcd for C12H14N2O4Cl2: C, 44.81; H, 4.39; N, 8.71. Found: C, 45.21; H, 4.61; 
N, 8.58. 
7.5.2.2 Nucleophilic cleavage to form carbamate 48 
 
Resin 31 (10.0 g, 14.8 mmol, 1 equiv) was suspended in MIBK (100 mL). 4-
Methoxyaniline (8.9 g, 75 mmol, 5 equiv) and KI (0.48 g, 3 mmol, 0.2 equiv) were 
added, followed by pyridine (6 mL, 75 mmol, 5 equiv). The mixture was heated to 
100 °C for 15 h. The resin was washed successively with THF (2 × 100 mL), 
methanol (2 × 100 mL), water (2 × 100 mL), THF (2 × 100 mL), and methanol (2 × 
100 mL), and then was suspended in Methanol (100 mL). Then, KOH (8.2 g, 140 
mmol, 10 equiv) was added and the suspension was heated at reflux for 3.5 h. The 
suspension was filtered and the resin was washed successively with THF (2 × 100 
mL), 1 M aqueous HCl (2 × 100 mL), THF (1 × 100 mL), 1 M aqueous HCl (2 × 100 
mL), and THF (1 × 100 mL). The THF was removed by evaporation in vacuo and the 
remaining solution was washed with ethyl acetate (2 × 50 mL). The aqueous phase 
was made basic with aqueous ammonia (25 w/v, 25 mL) and extracted with diethyl 
ether (5 × 100 mL). The combined organic phases were washed with saturated 
aqueous sodium bicarbonate (50 mL), brine (50 mL), and water (2 × 50 mL), dried 
(anhyd sodium sulphate), and evaporated to give compound 4 as an oil that solidified 
upon standing. 
Yield: 1.15 g (32%); mp 94-97 °C. 
1H NMR (500 MHz, CDCl3): δ = 3.00-3.04 (m, 4 H, H1), 3.59-3.65 (m, 4 H, H2), 
3.73 (s, 3 H, H3), 3.77 (s, 3 H, H4), 6.84 (ddd, J1 = 9.4 Hz, J2 = 3.3 Hz, J3 = 2.8 Hz, 2 
H, H5), 6.90 (ddd, J1 = 9.4 Hz, J2 = 3.3 Hz, J3 = 2.8 Hz, 2 H, H6). 
13C NMR (62.5 MHz, CDCl3): δ = 156.3 (C1), 154.7 (C2), 146.0 (C3), 119.3 (C4), 
114.9 (C5), 55.9 (C6), 53.0 (C7), 51.3 (C8), 44.3 (C9). 
Anal Calcd for C13H18N2O3: C, 62.38; H, 7.25; N, 11.19. Found: C, 62.06; H, 7.30; N, 
11.06. 
 
7.5.2.3 Zinc borohydride mediated reductive cleavage of 44  
 
Screening reaction 
 
Resin 44 (1.0 g, 1.5 mmol, 1 equiv) was suspended in THF (10 mL) in an Emrys 
Process Vial (20 mL). ZnCl2 (0.3 g, 2.3 mmol, 1.5 equiv) and sodium borohydride 
(0.17 g, 4.5 mmol, 3 equiv) was added, the vial was sealed and the reaction was 
heated with microwaves (110°C, 30 min). The suspension was filtered and the resin 
was washed with THF (2 x 20 mL), water (20 mL), THF (3 x 20 mL), 1M aqueous 
HCl (3 x 10 mL), THF (20 mL), 1M aqueous HCl (3 x 10 mL), THF (2 x 20 mL). 
THF was evaporated from the filtrate and the aqueous phase were washed with ethyl 
acetate (10 mL), and then made basic with aqueous ammonia (25% (w/v), 25 mL) and 
extracted with toluene (6 x 20 mL). The combined organic phases were washed with 
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saturated aqueous sodium bicarbonate (10 mL); brine (5 mL) and water (10 mL), 
dried (anhydrous sodium sulphate) and evaporated. 
End weight 10 mg. 
1H NMR (500 MHz; CDCl3) of crude product: Largest aromatic proton signals: δ = 
7.25 (dd, 1H); 6.95 (d, 1 H); 6.84 (dd, 1H) corresponds to aromates from 1-(3,4 – 
dichlorophenyl)-4-methylpiperazine 45d 
No peaks from 1-(4-chlorophenyl)-4-methylpiperazine 47 (δ = 7.20 ppm and 6.84 
ppm) 
Methyl peaks at 2.34 ppm (main product); 2.27 and 2.71 (impurities, possibly boron 
complexes of product)  
Distribution 2.34: 2.27: 2.71 ~ 5.9: 2.5: 3.1 ~ 51 % product 45d. 
 
Gram-scale cleavage of resin 44 
 
Resin 31 (10 g, 14 mmol, 1 equiv) was suspended in MIBK (75 mL) with 3.4-
dichloroaniline (11.1 g, 69 mmol, 5 equiv) and potassium iodide (0.5 g, 3 mmol, 0.2 
equiv). Pyridine (12.0 mL (ρ = 0.978 g/mL), 11.7 g, 150 mmol, 10 equiv) was added 
and the suspension was heated to 100 °C and stirred at this temperature for 112 h. The 
suspension was sucked dry and the resin was washed with THF (2 x 100 mL), ethanol 
(2 x 100 mL), water (2 x 100 mL) and ethanol (2 x 100 mL) then dried. 
13C gel phase NMR (62.5 MHz, CDCl3) corresponded to resin 44. 
Resin 44 was suspended in THF (100 mL). Zinc chloride (5.8 g, 43 mmol, 3 equiv) 
and sodium borohydride (3.2 g, 85 mmol, 6 equiv) was added and the suspension was 
stirred for 3 h at reflux. The reaction was quenched with water (20 mL), and the 
suspension was filtered. The resin was washed with THF (2 x 50 mL), 1 M aqueous 
HCl (3 x 50 mL), THF (50 mL) and 1 M aqueous HCl (3 x 50 mL). THF was 
removed from filtrate by evaporation and the aqueous phase was washed with ethyl 
acetate (2 x 50 mL), and then made basic with aqueous ammonia (25 %, 100 mL). 
The aqueous phase was extracted with toluene (6 x 100 mL) and the combined 
organic phases were filtered, washed with saturated aqueous sodium bicarbonate (50 
mL), brine (50 mL) and water (2 x 50 mL), then dried (anhydrous sodium sulphate) 
and evaporated.  
70 mg of crude 45d was isolated. 
1H NMR (500 MHz, CDCl3): δ = 2.3 (s, 3H, H1); 2.5 (m, 4H, H2); 3.2 (m, 4H, H3) 
6.5 – 7.5 (Aryl, No peaks from 47) 
LC/MS showed no 47 
 
The resin was suspended in 4M aqueous hydrochloric acid (100 mL) overnight to 
remove salts, washed with water (2x100 mL) and ethanol (2 x 100 mL) then dried. 
13C gel phase NMR (62.5 MHz, CDCl3) still contained peaks from resin-bound 
compound 44 (peak at δ = 43 ppm). 
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7.5.2.4 Synthesis of the drug Sifaprazine (50) 
 
Condition screening for Sifaprazine 
 
Resin 31 (1.0 g, 1.5 mmol, 1 equiv) was suspended in MIBK (7 mL) with 2-
benzylaniline (1.36 g, 7 mmol, 5 equiv), pyridine (1.25 mL (ρ = 0.978 g/mL), 1.2 g, 
15 mmol, 10 equiv) and potassium iodide in an Emrys Process Vial (20 mL). The vial 
was sealed and the suspension was heated with microwave (150°C, 2 h). The 
suspensions were filtered and the resins were washed with THF (3 x 10 mL); ethanol 
(3 x 10 mL); water (3 x 10 mL) and THF (3 x 10 mL) and then dried. 
 
entry Potassium iodide 
added (g) 
equiv KI conversion by 13C  
NMR (43 ppm vs.41 
ppm) 
1 0.05 0.2 < 10 % 
2 0.75 3.0 complete 
 
Resin from Entry 2 was suspended in 1 M lithium aluminium hydride in THF (7 mL, 
7 mmol, 4.7 equiv) in an Emrys Process Vial (20 mL). The vial was sealed and the 
suspension was heated with microwave (90 °C, 15 min). 
The suspension was filtered and the filtrate was quenched with water (10 ml). The 
resin was washed with THF (3 x 10 mL); 1M aqueous HCl (3 x 10 mL), THF (10 
mL), 1M aqueous HCl (3 x 10 mL) and THF (2 x 10 mL). 
THF were evaporated from the filtrate, and the filtrate was washed with ethyl acetate 
(2 x 10 mL). The aqueous phase was made basic with aqueous ammonia (25 % w/v; 
20 mL) and extracted with toluene (6 x 10 mL). The combined organic phases were 
washed with saturated aqueous sodium bicarbonate (5 mL) and water (5 mL), dried 
(anhydrous sodium sulphate) and evaporated. 
13C gel phase NMR of resin showed complete cleavage (No peak at 64 ppm) 
1H NMR (500 MHz, CDCl3): 2.34 (s, H1); 2.55 (m, H2); 2.88 (m, H3); 4.07 (s, H4); 
7.0-7.3 (aryl) 
 
Gram scale Sifaprazine synthesis  
 
Resin 31 (5.1 g, 7.5 mmol, 1 equiv) was suspended in MIBK (40 mL) with 2-
benzylaniline (6.87 g, 37 mmol, 5 equiv) and potassium iodide (3.74 g, 22.5 mmol, 3 
equiv). Then, pyridine (6 mL (ρ = 0.978 g/mL), 5.6 g, 71 mmol, 9.5 equiv) was added 
and the suspension was heated to 100 °C for 67 h with magnetic stirring. The resin 
was washed successively with NMP (3 × 50 mL), THF (3 × 50 mL), Methanol (3 × 50 
mL), H2O (3 × 50 mL), NMP (3 × 50 mL), THF (3 × 50 mL), Methanol (3 × 50 mL), 
and THF (3 × 50 mL), and then dried. The resin was suspended in THF (50 mL). 
Pellets of LiAlH4 (2.8 g, 75 mmol, 10 equiv) were added and the suspension was 
refluxed for 19 h with magnetic stirring. The suspension was cooled on ice and 
quenched by the sequential addition of water (3 mL), aqueous NaOH (13% w/v, 3 
mL), and water (10 mL). The suspension was filtered and the resin washed 
successively with THF (3 × 50 mL), 1 M aqueous HCl (3 × 50 mL), THF (1 × 50 
mL), 1 M aqueous HCl (3 × 50 mL), and THF (3 × 50 mL). The filtrate was filtered 
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through Celite and the THF was removed under reduced pressure. The aqueous phase 
was made strongly acidic with conc. HCl and was washed with ethyl acetate (2 × 25 
mL). The aqueous phase was then made basic with aqueous ammonia (25% w/v, 50 
mL). The resulting suspension of salts was shaken with toluene (50 mL) and filtered. 
The solid was washed with toluene (2 × 50 mL). The filtrate was separated and the 
aqueous phase was washed with toluene (3 × 50 mL). The combined organic phases 
were washed with sat. aqueous sodium bicarbonate (25 mL), sat. aq NaCl (25 mL), 
and H2O (2 × 40 mL), dried (anhyd. sodium sulphate), and evaporated to give a brown 
oil (134 mg). Purification through automated flash chromatography (ethyl acetate- 
heptane-triethylamine) yielded 50 as a slightly yellow oil that solidified upon 
standing. 
Yield: 53 mg (2.7%), mp 77-79 °C. 
1H NMR (500 MHz, CDCl3): δ = 2.34 (s, 3 H), 2.39-2.74 (m, 4 H), 2.89 (t, J = 4.8 Hz, 
4 H), 4.07 (s, 2 H), 7.08-7.28 (m, 9 H). 
13C NMR (62.5 MHz, CDCl3): δ = 152.0 (C1), 142.2 (C2), 137.0 (C3), 131.3 (C4), 
129.4 (C5), 128.7 (C6), 127.5 (C7), 126.1 (C8), 124.4 (C9), 121.0 (C10), 56.1 (C11), 
53.0 (C12), 46.6 (C13), 37.0 (C14). 
Anal Calcd for C18H22N2: C, 81.16; H, 8.33; N, 10.20. Found: C, 80.72; H, 8.37; N, 
10.46. 
 
7.5.2.5 Attempted synthesis of N-aryl piperazines from sterically 
hindered anilines on resin (table 16) 
 
2,6 – methyl aniline and resin 31  
 
Resin 31 (10.0 g; 15 mmol; 1 equiv) was suspended in 75 mL MIBK with 2,6 – 
dimethylanilin (9.0 g; 74 mmol; 5 equiv); potassium iodide (0.5 g; 3 mmol; 0.2 equiv) 
and pyridine (12 mL; (ρ=0.978 g/mL); 5.9 g; 74 mmol; 10 equiv) and heated to 100 
°C for 6 days. 
Approximate conversion: (44 ppm/(41 ppm + 43 ppm))= 0.25. 
 
2,6 – methyl aniline and resin bound mustard with microwave heating 
 
Resin 31 (2 g, 3 mmol, 1 equiv) was suspended in MIBK (15 mL) with 2,6- 
dimethylaniline (1.9 g, 15 mmol, 5 equiv), pyridine (2.5 mL (ρ=0.978 g/mL), 2.4 g, 
30 mmol, 10 equiv) and potassium iodide (0.1 g, 0.6 mmol, 0.2 equiv) in an Emrys 
Process Vial (20 mL). The vial was sealed and the suspension was heated with 
microwaves (150 °C, 6 h). The suspension was filtered and the resin was washed with 
THF (3 x 20 mL), ethanol (3 x 20 mL), water (3 x 20 mL) and THF (3 x 20 mL) then 
dried. 
13C gel-phase NMR (62.5 MHz, CDCl3) showed complete conversion (no peak at 41 
ppm) but a complicated mixture of signals. 
 
The resin was suspended in DME (17 mL) in an Emrys Process Vial (20 mL). 
Potassium tert-butoxide (0.67 g, 6 mmol, 2 equiv) was added and the vial was sealed. 
The suspension was heated with microwaves (110 °C, 1 h) and filtered. The resin was 
washed with DME (3 x 20 mL), 1 M aqueous HCl (3 x 20 mL), DME (1 x 20 mL), 1 
M aqueous HCl (3 x 20 mL) and DME (2 x 20 mL). 
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Organic solvent were removed from the filtrate through evaporation and the acidic 
water phase was washed with ethyl acetate (2 x 10 mL). The water phase was made 
basic with aqueous ammonia (25% (w/v), 20 mL) and extracted with toluene (6 x 20 
mL), the combined organic phases were washed with saturated aqueous sodium 
bicarbonate (20 mL); brine (20 mL) and water (2 x 20 mL), dried (anhyd sodium 
sulphate) and evaporated. 
Yield: 10 mg. (< 2 %) 
LC/MS showed 1 major product at 188 amu (Expected piperazine at 190 amu) 
1H NMR (500 MHz, CDCl3): Mixture of products – possible piperazine at 2.2-2.4 
ppm and 3.0-3.3 ppm 
 
2,6- methoxyaniline and resin bound mustard 
 
Resin 31 (0.75 g, 1.1 mmol, 1 equiv) was suspended in MIBK (5 mL) with 2,6 – 
methoxyaniline (0.85 g, 5.5 mmol, 5 equiv), potassium iodide (38 mg, 0.22 mmol, 0.2 
equiv) and pyridine (0.9 mL (ρ=0.978 g/mL), 0.92 g, 12 mmol, 11 equiv) was added 
and the suspension was heated with microwave (150 °C, 1 h). The suspension was 
filtered and the resin was washed with THF (3 x 10 mL), ethanol (3 x 10 mL), water 
(3 x 10 mL) and ethanol (3 x 10 mL), then dried. 
13C gel-phase NMR (62.5 MHz, CDCl3) major peak at 41.6 ppm (-CH2CH2Cl ) 
Approximate conversion: (43 ppm/(41 ppm + 43 ppm)) = 15 mm/ (15mm + 110 mm) 
=  0.12 
 
7.5.3 Scale-up and reuse of resin 
 
7.5.3.1 Initial Experiments 
 
Microwave screening experiments for lowering the aniline excess (Table 17) 
 
Resin 31 (1.0 g, 1.4 mmol, 1 equiv) was suspended in MIBK (7mL) in an Emrys 
Process Vial (20 mL) with 4-methoxyanilin, potassium iodide and pyridine. Vessel 
was sealed and the contents were heated with microwaves  (150 °C, 1 h). The 
suspensions were filtered and the resins were washed with THF (2 x 20 mL), ethanol 
(2 x 20 mL), water (2 x 20 mL) and THF (2 x 20 mL) and then dried. 
Conversion measured through 13C gel-phase NMR (62.5 MHz, CDCl3) 
 
Cleavage of resin 38 from Table 17, entry 1 to form 45a 
 
Resin 38 was suspended in 1 M lithium aluminium hydride in THF (10 mL, 10 mmol, 
4.2 equiv) in an Emrys Process Vial (20 mL). When initial gas development had 
subsided the suspension was covered with nitrogen, the vial was sealed and the 
suspension was heated with microwaves (100 °C, 15 min). The suspension was 
filtered and the resin was washed with THF (3 x 10 mL), water (3 x 10 mL), 1M 
aqueous HCl (3 x 10 mL), THF (1x10 mL), 1M aqueous HCl (3x10 mL) and THF (2 
x 10 mL) and then dried. 
13C gel-phase NMR (62.5 MHz, CDCl3) showed complete cleavage of carbamate 
linker from resin. 
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THF was evaporated from the filtrate and the aqueous phase was made basic with 
aqueous ammonia (25 % w/v, 10 mL). The precipitated salts were removed by 
filtration and the crystals were washed with toluene (2 x 10 mL). The aqueous phase 
of the filtrate was extracted with toluene (2 x 10 mL). The combined organic phases 
were washed with saturated aqueous sodium bicarbonate (10 mL) and water (10 mL) 
and then dried (anhyd sodium sulphate) and evaporated to give 64 mg (32%) of 45a.  
 
1H NMR (500 MHz, CDCl3): δ = 2.34 (s, 3H, H1); 2.55-2.60 (m, 4H, H2); 3.07-3.11 
(m, 4H, H3); 3.76 (s, 3H, H4); 6.83 (d, J = 9.2 Hz, 2H, H5); 6.90 (d, J = 9 Hz, H6). 
13C NMR (125 MHz, CDCl3): δ = 154.2; 146.1; 118.5; 114.8; 55.9; 55.7; 51.0; 46.5.  
 
Test of the optimized conditions and resin reuse 
 
First run of reaction 
 
Versabeads VO400 (29 g, 54 mmol, 1 equiv) was suspended in THF (200 mL) and 
heated to 50 °C. Triphosgene (8.0 g, 27 mmol, 1.5 equiv) was dissolved in THF (100 
mL) and added slowly. The suspension was stirred for 2 h. The solvent was removed 
and the resin was washed successively with THF (250 mL) ethanol (2 x 150 mL) and 
THF (250 mL). The resin was resuspended in a solution of bis(chloroethyl)amine, 
hydrochloride (14.5 g, 81 mmol, 1.5 equiv) in water (150 mL) and a solution of 
potassium carbonate (30 g, 216 mmol, 4 equiv) in water (150 mL) was added slowly. 
The resulting suspension was stirred for 5 h at room temperature, then sucked dry and 
the resin was washed with THF (2 x 250 mL), ethanol  (2 x 150 mL), water (2 x 150 
mL) and THF (2 x 250 mL) then dried to yield resin 31. 
Cl-analysis: 10.2 % ~ 2.9 mmol Cl/g ~ 1.4 mmol compound/g 
13C gel-phase NMR (62.5 MHz, CDCl3):  δ = 155.3 (C1) 70.2 (framework) 68.9 
(CH2CH2OR) 64.4 (CH2CH2OR) 50.9/50.4 (C2) 43.0 (framework) 41.5 (C3) 22.9, 
17.1, 7.4 (framework) 
 
Resin 31 (10.0 g, 14 mmol, 1 equiv) was suspended in MIBK (75 mL) with 4-
methoxyaniline (3.4 g, 28 mmol, 2 equiv) and potassium iodide (9.3 g, 56 mmol, 4 
equiv) and heated to 100 °C. Pyridine (6 mL (ρ = 0.978 g/mL), 5.6 g, 71 mmol, 5 
equiv) was added slowly. The reaction was stirred for 28 h, then solvent was removed 
and the resin was washed with THF (3 x 100 mL), ethanol (2 x 100 mL); water (2 x 
100 mL) and ethanol (2 x 100 mL), then dried to give resin 38. 
  
The resin was suspended in THF (40 mL) and cooled on an ice/water bath. 1M 
lithium aluminium hydride in THF (60 mL, 60 mmol, 4.2 equiv) was added and the 
suspension was heated at reflux for 4 h. The reaction was quenched with water (10 
mL), then the suspension was filtered and the resin was washed with THF (3 x 50 
mL), 1M aqueous HCl (2 x 50 mL), THF (1 x 50 mL), 1M HCl (3 x 50 mL) and THF 
(2 x 50 mL). THF was removed from the filtrate in vacuo and the solution was 
washed with ethyl acetate (2 x 50 mL). The water phase was made basic with aqueous 
NH3 (200 mL, 25% w/v) and extracted with toluene (5 x 100 mL) The combined 
organic phases were washed with saturated sodium bicarbonate solution (50 mL) 
saturated aqueous NaCl- solution (50 mL) and water (2 x 50 mL), dried with 30 g 
anhydrous sodium sulphate, filtered and evaporated. Yield: 1.13 g (39%) of 45a. 
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1H-NMR: (500 MHz; CDCl3) 2.35 (s, 3H, H1) 2.58 (4H, m, H2) 3.10 (4H, m, H3) 
3.76 (3H, s H4) 6.83 (2H, ddd, (J1=10.3 Hz; J2=3.3 Hz; J3=2.8 Hz) H5) 6.90 (2H, ddd 
(J1=10.4 Hz; J2=3.7 Hz; J3=2.8 Hz) H6) 
 
13C-NMR (250 MHz, CDCl3): 154.2 (C1) 146.1 (C2) 118.5 (C3) 114.8 (C4) 56.0 (C5) 
55.7 (C6) 51.0 (C7) 46.5 (C8) 
 
Anal calcd for C12H18N2O: C, 69.86 H, 8.80 N, 13.58 Found C, 69.99 H, 9.04 N, 
13.56. 
 
13C gel-phase NMR of resin showed no trace of peaks from 38. 
The resin was suspended overnight in 4 M aqueous HCl (100 mL), filtered, washed 
with water (2 x 100mL) and ethanol (2 x 100 mL), then dried.  
 
End weight: 5.7 g (10.6 mmol) Yield 76 % of theory 
 
Second run of reaction (resin reuse) 
 
The previously used Versabeads (5.7 g, 10.6 mmol, 1 equiv) was suspended in THF 
(40 mL). The suspension was heated to 50°C. A solution of triphosgene (1.6 g, 5.3 
mmol, 1.5 equiv) in 10 mL THF was added and the suspension was stirred for 2 h at 
50 °C then cooled down and washed successively with THF (1 x 50 mL), ethanol (2 x 
50 mL) and THF (1 x 50 mL). The resin was suspended in a solution of 
bis(chloroethyl)amine, hydrochloride (2.8 g, 16 mmol, 1.5 equiv) in water (30 mL) 
and a solution of potassium carbonate (6 g, 42 mmol, 4 equiv) in water (30 mL) was 
added slowly. The resulting suspension was stirred for 5 h at room temperature, then 
sucked dry and the resin was washed with THF (2 x 60 mL), ethanol  (2x30 mL), 
water (2 x 30 mL) and THF (2 x 60 mL) then dried to give resin 31. 
 
13C gel phase NMR(62.5 MHz ; CDCl3): 155.3 (carbonyl) 70.2 (framework) 68.9 
(CH2CH2OR) 64.4 (CH2CH2OR) 50.9 50.4 (NCH2CH2Cl) 43.0 (framework) 41.5 
(NCH2CH2Cl) 22.9, 17.1, 7.4 (framework, methyl and ethyl) 
Cl – analysis: 10.3 % ~ 2.9 mmol Cl/g ~ 1.4 mmol/g 
 
Resin 31 (6.0 g, 8.5 mmol, 1 equiv) was suspended in MIBK (45 mL) with 4-
methoxyaniline (2.15 g, 17 mmol, 2 equiv) and potassium iodide (5.6 g, 34 mmol, 4 
equiv) and heated to 100°C. Pyridine (2.85 mL (ρ = 0.978 g/mL), 2.8 g, 34 mmol, 4 
equiv) was added slowly. The reaction was stirred for 28 h, then solvent was removed 
and the resin was washed with THF (3 x 60 mL), ethanol (2 x 60 mL), water (2 x 60 
mL) and ethanol (2 x 60 mL), then dried to give resin 38. 
13C gel-phase NMR (62.5 MHz, CDCl3):  153.8 (carbonyl) 144.8 (C1) 127.7 (C2) 
118.4 (C3) 113.9 (C4) 69.9 (framework) 64.0 (CH2CH2OR) 60.9 (CH2CH2OH) 55.0 
(MeO-) 50.3 (NCH2) 43.2 (NCH2) 22.6; 17.0; 7.3 (framework, methyl and ethyl) 
 
Resin 38 was suspended in THF (25 mL) and cooled on an ice/water bath. 1M lithium 
aluminium hydride in THF (35 mL, 35 mmol, 4.1 equiv) was added and the 
suspension was heated to reflux for 4 h. The reaction was quenched with water (10 
mL), then filtered and washed with THF (3 x 30 mL), 1 M aqueous (3 x 30 mL) HCl; 
THF (1 x 30 mL), 1M aqueous HCl (3 x 30 mL) and THF (2 x 30 mL). THF was 
removed from the filtrate in vacuo and the solution was washed with ethyl acetate (2 x 
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20 mL). The water phase was made basic with aqueous ammonia (25% w/v, 10 mL) 
and extracted with 60 mL toluene, then filtered. Precipitate was washed with toluene 
(2 x 60 mL). The water phase was separated from the filtrate and extracted with 
toluene (3 x 60 mL) The combined organic phases were washed with saturated 
sodium bicarbonate solution (20 mL), brine (20 mL) and water (2 x 20 mL), dried 
with 30 g anhydrous sodium sulphate, filtered and evaporated. Yield: 0.66 g (38%) of 
45a. 
 
1H-NMR (CDCl3, 500 MHz): 2.35 (s, 3H, H1) 2.58 (4H, m, H2) 3.10 (4H, m, H3) 
3.76 (3H, s H4) 6.83 (2H, ddd, (J1=10.4 Hz; J2=3.8 Hz; J3=2.3 Hz) H5) 6.90 (2H, ddd 
(J1=10.3 Hz; J2=3.7 Hz; J3=2.3 Hz) H6) 
 
13C-NMR (250 MHz, CDCl3): 154.2 (C1) 146.1 (C2) 118.5 (C3) 114.8 (C4) 56.0 (C5) 
55.7 (C6) 51.0 (C7) 46.5 (C8) 
 
Anal. Calcd. for C12H18N2O: C, 69.86; H, 8.80; N, 13.58, Found: C, 69.78; H, 8.80; 
N, 13.38. 
 
Large-scale (0.19 mol) synthesis of 45a on Versabeads 
 
Versabeads O400 (100 g, 0.19 mol, 1 equiv) was suspended in THF (750 mL) and 
heated to 50 °C. A solution of triphosgene (25 g, 84 mmol, 1.5 equiv) in THF (250 
mL) was added and the suspension was stirred for 3 h. The solvent was removed and 
the resin was washed successively with THF (500 mL), ethanol (2 x 500 mL) and 
THF (500 mL). The resin was then suspended in a solution of bis(chloroethyl)amine, 
hydrochloride (50 g, 0.28 mol, 1.5 eq) in water (250 mL). The suspension was cooled 
on an ice/water bath and a solution of potassium carbonate (103 g, 0.74 mol, 4 equiv) 
in water (250 mL) was added slowly. The suspension was stirred at room temperature 
for 4 h. The solvent was removed with the suction tube and the resin was washed with 
THF (2 x 500 mL), ethanol (2 x 500 mL), water (3 x 500 mL), THF (500 mL) and 
ethanol (500 mL) then dried to give 139 g (124 %) of resin 31 (Cl- analysis: 12.3 % ~ 
123 % of theory).  
13C gel-phase NMR (62.5 MHz, CDCl3) showed complete reaction (no peak at 61 
ppm) 
The resin was suspended in  MIBK (1 l ) with 4-methoxyanilin (45.8 g, 0.37 mol, 2 
equiv) and potassium iodide (124 g, 0.74 mol, 4 equiv) and heated to 100°C. Pyridine 
(63 mL (ρ = 0.978 g/mL), 59 g, 0.74 mol, 4 equiv) was added slowly. Reaction was 
stirred for 28 h, filtered and washed THF (2 x 700 mL), ethanol (2 x 700 mL), water 
(3 x 700 mL), THF (2 x 700 mL), ethanol (1 x 700 mL), water (1 x 700 mL), ethanol 
(2 x 700 mL) and then dried to give resin 38. (13C gel-phase NMR (62.5 MHz, 
CDCl3): 154.9 (C1); 153.9 (C2); 145.1 (C3); 118.5 (C4); 114.1 (C3); 55.2 (C6); 50.5 
(C7); 43.5 (C8)) 
The resin was suspended in 800 mL THF and cooled to –36 °C on a dry ice/diglyme 
bath. Lithium aluminium hydride was added as a 1 M solution in THF (880 mL, 0.88 
mol, 4.7 equiv). The resulting suspension was heated at reflux for 5 h then cooled 
down. The reaction was quenched through slow addition of ethyl acetate (250 mL).  
The resin was filtered and washed with THF (3 x 500 mL). The filtrate was 
concentrated in vacuo. The resin was further washed with 1 M aqueous HCl  (3 x 500 
ml) and THF (250 mL) and the pH of the second batch of filtrate was adjusted to 1 
with 100 mL conc.  HCl and combined with the first filtrate. The combined filtrates 
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were washed with ethyl acetate (2 x 200 mL), then made basic with aqueous ammonia 
(25% w/v, 600 mL). The resulting suspension was shaken with 300 mL toluene and 
then filtered. The precipitate was washed with toluene (2 x 300 mL). The combined 
filtrates were separated in organic and aqueous phases and the aqueous phase were 
extracted with toluene (3 x 300 mL). The combined organic phases were washed with 
saturated sodium bicarbonate solution (2 x 100 mL), brine (2 x 100 mL) and water (2 
x 100 mL), dried with 150 g anhydrous sodium sulphate, filtered and evaporated to 
yield 21 g of 45a which gradually turned red upon standing. Overall yield from 
unloaded Versabeads: 55%. 
m.p. 65.9°C-67.3°C 
 
1H-NMR (500 MHz, CDCl3): 2.34 (s, 3H); 2.56-2.58 (m, 4H); 3.09-3.11 (m, 4H); 
3.76 (s, 3H); 6.83 (dd, J1= 10.3 Hz, J2= 3.8 Hz, 2H); 6.90 (dd, J1= 10.4 Hz, J2= 3.7 Hz, 
2H). 
13C-NMR (250 MHz, CDCl3): 46.5; 51.0; 55.7; 55.9; 114.8; 118.5; 146.1; 154.2. 
 
Anal calcd for C12H18N2O: C, 69.86; H, 8.80; N, 13.58 found C, 69.95; H, 8.79; N, 
13.57. 
7.6 Synthesis of an imidazolidin-2-one by cyclative cleavage 
 
7.6.1 Preliminary experiments 
 
7.6.1.1 Initial investigation (Table 18) 
 
Resin 31 (2.0 g, 2.6 mmol, 1 equiv) was suspended in water (20 mL) with 4-
methoxyaniline (1.7 g, 14 mmol, 5.3 equiv), potassium carbonate (1.0 g, 7 mmol, 2.5 
equiv) and potassium iodide (1. (0.1 g, 0.6 mmol, 0.2 equiv); 2. (0.46 g, 2.8 mmol, 1 
equiv)).The suspension was heated to 80 °C and kept at this temperature for 23 h. The 
suspension was filtered and the resin was washed with water (3 x 20 mL), THF (3 x 
20 mL), methanol (3 x 20 mL), water (20 mL) and methanol (2 x 20 mL). 
The organic solvent was removed from the filtrate in vacuo, and the remaining 
aqueous phase was made strongly basic with aqueous ammonia (25% w/v, 20 mL), 
and extracted with ethyl acetate (6 x 20 mL). The combined organic phases were 
washed with saturated aqueous sodium bicarbonate (10 mL), brine (10 mL) and water 
(2 x 10 mL), dried (anhydrous sodium sulphate) and evaporated. The resulting brown 
residue was purified through automated flash chromatography (ethylacetate/heptan). 
 
Yield (1): 0.32 g (36 %): 
1H NMR (500 MHz, CDCl3): δ = 3.30 (t, J = 6.1 Hz, 2H, H1); 3.50 (dd, (J1 = 6.1 Hz, 
J2 = 8.1 Hz), 2H, H2); 3.55 (t, J = 6.9 Hz, 2H, H3); 3.73 (s, 3H, H4); 3.76 (dd, (J1 = 
7.5 Hz, J2 = 9.8 Hz) 2H, H5); 3.79 (s, 3H, H6); 6.60 (d, J = 9 Hz, 2H, H7); 6.77 (d, J = 
8.9 Hz, 2H, H8); 6.89 (d, J = 9.0 Hz, 2H, H9); 7.43 (d, J = 8.9 Hz, 2H, H10) 
 
Anal calc for C19H22N3O3: C, 66.84 H, 6.79 N, 12.31 found C, 66.75 H, 6.84 N, 12.22 
 152
 
Yield (2): 0.37 g (42 %): 
1H NMR (500 MHz, CDCl3): δ = 3.30 (t, J = 6.1 Hz, 2H, H1); 3.50 (dd, (J1 = 6.1 Hz, 
J2 = 8.1 Hz), 2H, H2); 3.56 (t, J = 6.9 Hz, 2H, H3); 3.73 (s, 3H, H4); 3.76 (dd, (J1 = 
7.5 Hz, J2 = 9.5 Hz) 2H, H5); 3.79 (s, 3H, H6); 6.60 (d, J = 9 Hz, 2H, H7); 6.77 (d, J = 
8.9 Hz, 2H, H8); 6.89 (d, J = 9.1 Hz, 2H, H9); 7.43 (d, J = 9 Hz, 2H, H10)  
 
Anal calc for C19H22N3O3: C, 66.84 H, 6.79 N, 12.31 Found C, 66.70 H, 6.91 N, 12.63 
 
Other residues from entry 2: 
 
Fraction 3 (Mix of hydrolysis products 41 and 53): 1H NMR (500 MHz, CDCl3): δ = 
3.30 (t, J = 5.6 Hz, 2H, 41, H1); 3.40-3.46 (m, 4H, 53, H1/H2); 3.47-3.52 (m, 41, H2, 
53, H3); 3.59 (dd, J1= 6.5 Hz, J2 = 7.1 Hz, 2H, 41, H3); 3.64 (dd, J1 = 4.5 Hz, J2 = 7.3 
Hz, H4, 53) 3.74 (s, 3H, 41, -OMe); 3.78 (s, 3H, 53, -OMe) 4.28 (dd, J1= 9.5 Hz, J2 = 
7.1 Hz), 2H, 41, H4); 6.55-6.61 (m, 2H, 41, H5); 6.74-6.82 (m, 2H, 41, H6); 6.84-
6.88 (m, 2H, 53, H5); 7.37-7.42 (m, 2H, 53, H6) 
 
Fraction 5 (crude 54):  
1H NMR (500 MHz, CDCl3): δ = 2.48-2.51 (m, NH); 2.62 (t, 4H, H1); 3.12 (t, 4H, 
H2); 3.58-3.68 (m, NH); 3.75 (s, 6H, H3); 6.60 (d, 2H, H4); 6.79 (d, 2H, H5). 
 
7.6.1.2 Solution and solid phase experiments (table 19) 
 
Synthesis of 42 via the ethyl carbamate 55  
 
Bis(chloroethyl)amine, hydrochloride (0.25 g, 1.4 mmol, 1 equiv) was dissolved in 
water (5 mL). Ethyl chloroformate (0.18 g, 1.7 mmol, 1.2 equiv) and potassium 
carbonate (0.40 g, 2.8 mmol, 2 equiv) was added and the solution was stirred at room 
temperature for 2.5 h. 4-methoxyaniline (0.88 g, 7 mmol, 5 equiv), potassium 
carbonate (0.48 g, 3.5 mmol, 2.5 equiv) and potassium iodide (0.23 g, 1.4 mmol, 1 
equiv) was added, the vessel was sealed and heated with microwaves (120 °C, 40 
min). The solution was extracted with toluene (6 x 10 mL) and combined organic 
phases were washed with saturated aqueous sodium bicarbonate (10 mL) and water 
(10 mL), dried (anhydrous sodium sulphate) and evaporated. The residue was purified 
through automated flash chromatography (ethyl acetate/heptane) to give 20 mg (4 %) 
of 42, 50 mg of (4-methoxyphenyl) carbamic acid ethyl ester 59 (15 %) and trace 
amount of 41.  No piperazine 57 was found. 
 
1H NMR of 59 (500 MHz, CDCl3): δ = 1.23 (t, 3H, H1); 3.11 (q, 3H, H2); 3.74 (a, 
3H, H3); 6.58 (d, 2H, H4); 6.78 (d, 2H, H5). 
 
Synthesis of 42 via the 2-methoxyethyl carbamate of the mustard (56) 
 
Bis(chloroethyl)amine, hydrochloride (0.25 g, 1.4 mmol, 1 equiv) was dissolved in 
water (5 mL). 2-Methoxyethyl chloroformate (0.23 g, 1.7 mmol, 1.2 equiv) and 
potassium carbonate (0.43 g, 2.8 mmol, 2 equiv) was added and the solution was 
stirred at room temperature for 3.5 h. 4-methoxyaniline (0.86 g, 7 mmol, 5 equiv), 
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potassium carbonate (0.48 g, 3.5 mmol, 2.5 equiv) and potassium iodide (0.23 g, 1.4 
mmol, 1 equiv) was added, the vessel was sealed and heated with microwaves (120 
°C, 40 min). The solution was extracted with diethyl ether (3 x 20 mL) and the 
combined organic phases were washed with saturated aqueous sodium bicarbonate 
(10 mL) and water (10 mL), dried (anhydrous sodium sulphate) and evaporated. The 
residue was purified through automated flash chromatography (ethyl acetate/heptane) 
to yield 46 mg (10 %) of compound 42 and 45 mg of compound 58 (11 %) 
 
1H NMR of 58 (500 MHz, CDCl3): δ = 3.00-3.04 (m, 4H, H1); 3.40 (s, 3H, H2); 3.60 
(t, 2H, H3); 3, 63-3.66 (m, 4H, H4); 3.77 (s, 3H, H5); 4.26 (t, 2H, H6); 6.83-6.92 (m, 
4H, H7). 
 
 
Resin 31 (1.0 g, 1.4 mmol, 1 equiv) was suspended in water (5 mL). 4-methoxyaniline 
(0.87 g, 7 mmol, 5 equiv), potassium carbonate (0.48 g, 3.5 mmol, 2.5 equiv) and 
potassium iodide (0.23 g, 1.4 mmol, 1 equiv) was added, the vessel was sealed and 
heated with microwaves (120 °C, 40 min). The suspension was filtered and the resin 
was washed with THF (2 x 20 mL); ethanol (2 x 20 mL); water (2 x 20 mL); ethanol 
(2 x 20 mL); THF (20 mL) and ethanol (20 mL). The filtrate was washed with ethyl 
acetate (25 mL) made strongly basic with aqueous ammonia (25 % v/w; 25 mL) and 
extracted again with ethyl acetate (2 x 50 mL). The combined organic phases were 
washed with saturated aqueous sodium bicarbonate (10 mL) and water (10 mL), dried 
(anhydrous sodium sulphate) and evaporated. Purification through automated Flash 
Chromatography (ethyl acetate/heptane) to yield 100 mg (20 %) of 42 
 
1H NMR (500 MHz, CDCl3): δ = 3.29 (t, J = 6.1 Hz, 2H, H1); 3.49 (dd, (J1 = 6.3 Hz, 
J2 = 8.5 Hz), 2H, H2); 3.54 (t, J = 6.0 Hz, 2H, H3); 3.73 (s, 3H, H4); 3.75 (dd, (J1 = 
7.6 Hz, J2 = 9.6 Hz) 2H, H5); 3.79 (s, 3H, H6); 6.60 (d, J = 9 Hz, 2H, H7); 6.77 (d, J = 
8.9 Hz, 2H, H8); 6.88 (d, J = 9.1 Hz, 2H, H9); 7.43 (d, J = 9.1 Hz, 2H, H10) 
(Appendix A - spectrum 7) 
 
13C NMR (125 MHz, CDCl3): δ = 159.2 (C1); 155.8 (C2); 152.6 (C3); 142.7 (C4); 
134.2 (C5); 119.9 (C6); 115.4 (C7); 114.5 (C8); 114,4 (C9); 56.2 (C10); 55.9 (C11); 
44.5 (C12); 43.8 (C13); 43.5 (C14); 42.9 (C15). 
(Appendix A - spectrum 8) 
 
Anal calc for C19H22N3O3: C, 66.84 H, 6.79 N, 12.31 Found C, 67.00 H, 7.08 N, 11,64 
 
7.6.2 Resin microwave screening experiments (table 20) 
 
Resin (1.0 g, 1.5 mmol, 1 equiv) was suspended in 5 mL water with 4-methoxyaniline 
(0.91 g, 7.4 mmol, 5 equiv), potassium carbonate (0.51 g, 3.7 mmol, 2.5 equiv) and 
potassium iodide (1.2 g, 1.5 mmol, 1 equiv) in a 20 mL vessel. The vessel was sealed 
and the reaction was heated with microwaves (120 °C, 40 min). The suspension was 
filtered and the resin was washed with water (2 x 10 mL), THF (2 x 10 mL), ethanol 
(2 x 10 mL), water (2 x 10 mL), THF (2 x 10 mL) and ethanol (2 x 10 mL) and then 
dried. The organic solvent was evaporated from the filtrate and the water phase was 
extracted with toluene (3 x 20 mL). The combined organic phases were washed wit 
saturated aqueous sodium bicarbonate (10 mL) and water (10 mL) and evaporated. 
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The residue was purified through automated flash chromatography (ethyl 
acetate/heptane).  
All residues gave satisfactory 1H NMR spectra and LC/MS for 42. 
 
7.6.3 NMR experiments 
 
 
Addition of 4-methoxyaniline to 31 followed by 13C NMR 
 
Resin 31 (3.6 g; 5.0 mmol; 1 equiv) was suspended in 35 mL water with 4-
methoxyaniline (3.07 g; 25 mmol; 5 equiv), potassium carbonate (1.75 g; 12.5 mmol; 
2.5 equiv) and potassium iodide (1.66 g; 10 mmol; 2 equiv) and heated to 80°C. 
Samples of resin were removed at regular intervals, washed with deuterated water in 
an NMR tube and cooled to 5 degrees. 13C gel-phase NMR was taken, first in 
deuterated water, then in deuterated chloroform. 
 
Addition of iodide to 31 in situ in an NMR tube (table 21) 
 
Resin 31 (0.2 g, 0.3 mmol, 1 equiv) was suspended in 1 mL deuterated water in an 
NMR tube. Potassium iodide (50 mg, 0.3 mmol, 1 equiv) was added and the reaction 
was placed in the spectrophotometer and heated to 80°C. 13C NMR was recorded 
every half hour (scans) (Appendix spectrum 9 and 10) 
7.6.4 Parallel experiments at 60 °C, 80 °C and 100 °C 
 
General procedure for parallel experiments (Table 22, 23 and 24) 
 
Resin 31(1,0 g, 1.4 mmol, 1 equiv) was suspended in water (10 ml) with 4-
methoxyanilin (0.86 g, 7 mmol; 5 equiv) and the amounts of base and potassium 
iodide stated in the tables: K2CO3 (0.48 g, 3.5 mmol, 2.5 equiv OR 0.24 g, 1.75 mmol, 
1.25 equiv OR none) and KI (0.46 g, 2.8 mmol, 2 equiv OR 0.23 g, 1.4 mmol, 1 equiv 
OR none)  
The suspensions were heated to the stated temperature and shaken at the stated time. 
The suspensions were filtered and the resin was washed with THF (2x 20 ml); ethanol 
(2 x 20 ml), water (2 x 20 ml); THF (2 x 20 ml) and ethanol (2 x 20 ml) and then 
dried. The filtrates were concentrated to approximately 60 mL, aqueous ammonia 
(25% w/v; 10 mL) was added and the filtrates were extracted with toluene (4 x 20 
mL). The combined organic phases were washed with saturated sodium bicarbonate 
(10 mL) and water (10 mL), dried (anhyd sodium sulphate) and evaporated. Brown 
residue was purified using FlashMaster (ethyl acetate/heptane). 
Main products from all residues gave satisfactory 1H NMR and LC/MS for 42 
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The slower running hydrolysis products 41 and 53 were isolated in trace amounts and 
identified from their 1H NMR spectra. Examples of spectra: 
 
53 (from table 25, entry 3 – appendix A spectrum 11) 
1H NMR (500 MHz, CDCl3): δ = 3.40-3.46 (m, 4H, H1/H2); 3.51 (t, J = 6.5 Hz, 2H, 
H3); 3.65 (dd, J1 = 7.3 Hz, J2 =9.9 Hz, 2H, H4); 3.78 (s, 3H, H5, (OMe)); 6.88 (d, J = 
8.9 Hz, 2H, H6); 7.40 (d, J = 8.9 Hz, 2H, H7) 
 
41 (from table 25, entry 3 –appendix A spectrum 12) 
 
1H NMR (500 MHz, CDCl3): δ = 3.32 (t, J = 6.1 Hz, 2H, H1); 3.52 (t. J = 6.1 Hz, 2H, 
H2); 3.60 (dd, J1 = 6.8 Hz, J2 = 9.3 Hz, 2H, H3); 3.74 (s, 3H, H4 (OMe)); 4.30 (dd, J1 
= 7.6 Hz, J2 = 9.2 Hz, 2H, H5), 6.60 (d, J = 8.9 Hz, 2H, H6); 6.89 (d, J = 8.9 Hz, H7). 
 
7.7 Immobilized Metalloporphyrins as catalysts 
 
7.7.1 Porphyrin synthesis  
 
7.7.1.1 Synthesis of 5-(4-hydroxy)-10,15,20-tetraphenylporphyrin 
(66) 
 
5-(4-methoxy)-10,15,20-tetraphenylporphyrin (62) 
 
4-methoxybenzaldehyde (9.2 mL ( 10 g, 80 mmol, 1 equiv) and benzaldehyde (23 
mL, 24 g, 220 mmol, 3 equiv) were added to propionic acid at reflux (550 mL) in 
atmosphere. Distilled pyrrole (21 mL, 22 g, 330 mmol, 4 equiv) was added, the 
mixture turned black and was kept at reflux for 3 h open to the atmosphere. 
The solution was cooled down and the porphyrins precipitated over the following 
days as purple crystals. Extensive column chromatography (40-60 petroleum 
ether/dichloromethane) yielded 1.07 g (2 %) of the desired prophyrin. 
 
1H-NMR: (400 MHz, CDCl3): (-)2.75 – (-) 2.73 (m, 2H, NH); 4.10 (s, 3H, -OMe); 
7.30 (d, J = 8.6 Hz, 2H, H1); 7.73-7.83 (m, 9H, H2); 8.13 (d, J = 8.5 Hz, 2H, H3); 
8.20-8.24 (m, 6H, H4); 8.82-8.89 (m, 8H, H5). 
 
5-(4-hydroxy)-10,15,20-tetraphenylporphyrin (66) 
 
62 (650 mg, 1 mmol, 1 equiv) was dissolved in freshly distilled dichloromethane (30 
mL) under Ar. The solution was cooled to -78°C and BBr3 (3 mL, 1.1 g, 4.5 mmol, 
4.5 equiv) was added quickly. The cooling was removed and the reaction was stirred 
at room temperature overnight. Reaction was quenched by addition of methanol at -
78°C and made basic with 20 mL triethyl amine. The solution are diluted with 200 
mL ethyl acetate and washed with 100 mL Sodium bicarbonate (sat) and 2x 100 mL 
water. The organic phase was dried (anhydrous sodium sulphate) and evaporated. 
 156
Column chromatography (dichloromethane) yielded 760 mg (73%) of 66. 
Overall yield (1.5 %) 
 
1H-NMR (400 MHz, CDCl3): δ = (-)2.86 – (-)2.59 (m, 2H, NH); 7.19 (d, J = 8.3 Hz, 
4H, H1); 7.71-7.78 (9H, m, H2); 8.07 (d, J = 8.3 Hz, 2H, H3); 8.20-8.25 (m, 6H, H4); 
8.81-8.90 (m, 8H, H5). 
 
5-(4-hydroxy)-10,15,20-tetraphenylporphyrin (66) by deprotection of crude 
porphyrin mixture 
 
4-methoxybenzaldehyde (9.5 mL (ρ = 1.123 g/mL), 10.7 g, 78 mmol, 1 equiv) and 
benzaldehyde (22.5 mL (ρ = 1.04 g/mL), 23.4 g, 221 mmol, 3 equiv) were added to 
propionic acid (500 mL) at reflux temperature. Distilled pyrrole (20.5 mL (ρ = 0.969 
g/mL), 19.9 g, 297 mmol, 4 equiv) was added and the solution was kept at reflux 
temperature for 1.5 h, then placed in a freezer for 5 days. The precipitated porphyrins 
were removed by filtration. 
Yield: 1.87 g  
The product was deprotected in two batches. 
Representative procedure:  
Crystals (900 mg, 1.39 mmol, 1 equiv) were dissolved in dichloromethane (30 mL) 
under Ar. The solution was cooled to -78°C and boron tribromide (2.6 mL, (ρ = 2.65 
g/mL), 6.9 g, 28 mmol, 20 equiv) was added quickly and the cooling was removed. 
After 3 h the reaction was cooled again to -78°C and the reaction was quenched with 
methanol (20 mL), made basic with triethyl amine (10 mL), then allowed to warm to 
room temperature. Another batch (948 mg) was deprotected in the same way. The 
combined batches were evaporated and the residue dissolved in dichloromethane (70 
mL), which was washed with water (30 mL), dried (anhydrous sodium sulphate) and 
evaporated. The residue was purified by column chromatography (Eluent (40-60 
petroleum ether/ethyl acetate) 
 
Yield of 66 (both batches 640 mg (1.3 %).  
1H-NMR (400 MHz, CDCl3): δ = (-) 2.80 – (-) 2.71 (NH); 7.21 (d, J = 8.4 Hz, 2H, 
H1); 7.72-7.79 (m, 9H, H2); 8.08 (d, J = 8.3 Hz, 2H, H3); 8.19-8.25 (m, 6H, H4); 
8.81-8.90 (m, 8H, H5) 
 
7.7.1.2 Synthesis and metallation of porphyrin complexes 69 and 70. 
 
Initial synthesis of resin-bound porphyrin 67 
 
Resin (0.30 g, 0.45 mmol, 1 equiv) was suspended in freshly distilled 
dichloromethane (2 mL) under Ar and cooled on an ice bath. Mesyl chloride (0.7 mL 
(ρ=1.48 g/mL), 1.03 g, 9 mmol, 20 equiv) was added followed by pyridine (0.25 mL 
(ρ=0.935 g/mL), 0.27 g, 38 mmol, 84 equiv). The ice bath was removed and the 
suspension was stirred for 1.5 h at room temperature. The solvent was removed and 
the reaction was repeated. 
The suspension was filtered and the resin was washed with DCM (3 x 10 mL) and 
DMF (3 x 10 mL). The resin was suspended in a solution of 66 (370 mg, 0.59 mmol; 
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1.3 equiv) and sodium hydroxide (19 mg; 0.48 mmol; 1.1 equiv) in DMF (8 mL) at 90 
°C. The suspension was stirred overnight, then cooled down and filtered. The red 
resin was washed with DMF (3 x 10 mL), DCM (3 x 10 mL), acetone (3 x 10 mL), 
water (3 x 10 mL), methanol (3 x 10 mL) and DCM (3 x 10 mL), then dried 
End weight 198 mg (70% of theoretical gain)  
Elemental analysis: 3.54% N (71 % of theoretical gain from 0.4 % in starting 
material) 
IR showed new peaks at 1735 cm-1; 1606 cm-1; 1559 cm-1 
1508 cm-1, 1175 cm-1 (aromatic) 3320 cm-1 (NH) 
 
Example of synthesis of resin-bound catalyst 69 
 
Versabeads (0.60 g, 0.9 mmol, 1 equiv) was suspended in freshly distilled 
dichloromethane (5 mL) on ice. Mesyl chloride (1.5 mL (ρ=1.48 g/mL), 2.2 g, 19 
mmol, 21 equiv) was added followed by pyridine (1.0 mL (ρ=0.935 g/mL), 0.94 g, 12 
mmol, 13 equiv). The suspension was stirred for 1 h at room temperature, then the 
solvent was removed and the reaction repeated to give resin 28. 66 (900 mg; 1.4 
mmol; 1.6 equiv) were dissolved in DMF (15 mL). Sodium hydroxide (43 mg, 1.1 
mmol, 1.2 equiv) was added and the solution was heated to 90°C for 2 h. The 
mesylated resin 28 was added and the suspension was stirred at 90°C for 20 h. The 
suspension was filtered, and the resin was washed with DMF (3x10 mL), DCM (3 x 
10 mL), acetone (3 x 10 mL), water (3 x 10 mL), Methanol (3 x 10 mL) and DCM 
DCM (3 x 10 mL), then dried 
End weight 682 mg of 68  
557 mg of the resin was suspended in DMF (10 mL) under Ar. MnCl2*4H2O (8.3 g, 
42 mmol, > 100 equiv) was added and the suspension was heated under Ar and kept at 
reflux for 3 h. the suspension was filtered and the resin washed with water (3 x 10 
mL), acetone (3 x 10 mL), DCM (3 x 10 mL), methanol (3 x 10 mL). 
End weight: 562 mg  
NH stretch at 3320 cm-1 was gone. 
Mn- loading by AAS: 0.2 mmol Mn/g ~ 50% of theory (overall from Versabeads). 
 
 
Example of immobilization of 5,10,15,20-tetra(pentafluorophenyl)porphyrin on 
solid phase to form complex 68 and metallation to form 70 
 
Versabeads A800 (286 mg, 1 mmol, 1 equiv) was suspended in DMF (4 mL) with 
5,10,15,20-tetrakis(pentafluorophenyl)porphyrin (140 mg, 0.14 mmol, 1.4 equiv) in 
an Emrys Process Vial. DIPEA (20 μL (ρ=0.79 g/mL), 18 mg, 0.14 mmol, 1.4 equiv) 
was added, the reaction vessel was sealed and the suspension was heated to 110°C 
overnight. The suspension was filtered and the resin was washed with DCM and 
diethyl ether alternating (5 mL) until no visible colour was detected in the washing 
solution.  
End weight: 318 mg  
19F gel-phase NMR (400 MHz; CDCl3): -136 ppm; -141 ppm; -152 ppm; -160 ppm; -
162 ppm. (TPFPP: -136; -151; -161) (Appendix A – spectrum 13) 
FTIR: New peaks at 1500 cm-1 988 cm-1 and 759 cm-1 (aryl peaks) 
 
68 (122 mg) were suspended in DMF (3 mL) with MnCl2*4H2O (0.6 g; >100 equiv) 
and the suspension was heated at reflux temperature for 2 h. The suspension was 
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filtered and the resin was washed with water (3 x 10 mL), acetone (3 x 10 mL) and 
DCM (3 x 10 mL), then dried. 
AAS Mn Content: 78 μmol/g (12 % overall yield from PEGA resin) 
FTIR: Peak at 1500 cm-1 gone, new peak at 945 cm-1 compared to 68.  
 
7.7.2 Test reactions 
 
Oxidation of thioanisole with tert-butyl hydroperoxide (Table 28 and 29) 
 
Sulfide oxidations were performed at room temperature. Thioanisole and 1,2 – 
dichlorobenzene (internal standard) were added as a standard solution in acetonitrile. 
Imidazole and catalyst or other additives were added neat to the solution. Tert-butyl 
hydroperoxide was added as a commercially available 70% (w/w) solution in water. 
Reactions were performed under Ar and monitored by GC measurements of the 
substrate peak relative to the internal standard.  
 
 
Sodium periodate epoxidation 
 
70 (19 mg, 1.5 μmol, 1 equiv) was placed in an Irori Kan™ and added to a solution of 
styrene (12 mg, 0.11 mmol, 73 equiv), imidazole (4 mg, 57 μmol, 39 equiv) and 1,2 – 
dichlorobenzene (4 μL) in 2 mL acetonitrile. Sodium periodate (49 mg, 0.23 mmol, 
153 equiv) was added as a solution in water (1 mL) and the mixture was stirred at 
room temperature and monitored by GC.  
Time Conversion Comment 
12 h 54% Catalyst removed 
24 h 84%  
 
Catalyst was washed with acetonitrile (3 x 10 mL); water (3 x 10 mL); acetonitrile (3 
x 10 mL) and dichloromethane (3 x 10 mL), then reused. 
Reuse of catalyst under the same conditions gave 14% conversion after 12h. 
 
 
7.7.3 Attempted synthesis of porphyrins directly on solid-phase 
 
 
Synthesis of meso-phenyldipyrromethane 71 
 
Benzaldehyde (0.30 mL (ρ=1.044 g/mL), 0.32 g, 3 mmol, 1 equiv) was added to 
distilled pyrrole (15 mL) at room temperature. Trifluoracetic acid (20 μL) was added 
and the solution was stirred for 50 min, then diluted with dichloromethane. The 
organic phase was washed with aqueous NaOH solution (2 %, 2 x 40 mL) and water 
(2 x 50 mL), dried (anhydrous sodium sulphate) and evaporated. Column 
chromatography (diethyl ether/40-60 petroleum ether) yielded 350 mg of meso-
phenyldipyrromethane 71  (53%) as yellow oil. 
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1H – NMR (400 MHz, CDCl3): δ = 2.17 (acetone impurity) 5.48 (s, 1H, H1) 5.91-5.94 
(m, 2H, H2) 6.14-6.17 (m, 2H, H3) 6.68-6.71 (m, 2H, H4) 7.19-7.35 (m, 5H, phenyl-) 
7.92 (br s, 2H, NH) 
13C – NMR (100 MHz, CDCl3) δ = 142.1 (C1) 132.5 (C2) 128.6 (C3) 128.4 (C4) 
127.0 (C5) 117.2 (C6) 108.5 (C7) 107.2 (C8) 44.0 (C9) 30.9 (acetone impurity) 
 
 
Attempted synthesis of porphyrin on resin 
 
With boron trifluoride diethyletherate: 
 
Versabeads O400 (1.3 g, 2.0 mmol, 1 equiv) was suspended in freshly distilled 
dichloromethane (8 mL) under Ar. The suspension was cooled down on ice/water 
bath. Mesyl chloride (3.0 mL (ρ=1.48 g/mL), 4.47g, 39 mmol, 20 equiv) was added 
followed by pyridine (1 mL (ρ=0.935 g/mL), 0.94 g, 12 mmol, 6 equiv) and the 
reaction proceeded at room temperature for 1 h. The reaction was repeated under the 
same conditions, and the resin was filtered and washed (6x10 mL DCM). 
IR = 1174 cm-1 (SO stretch) 
4-hydroxybenzaldehyde (1.26 g, 10.3 mmol, 5.8 equiv) and sodium hydroxide (0.39 
g, 9.75 mmol, 5 equiv) were suspended in DMF (20 mL) and heated to 90 °C. The 
mesylated resin was added and the suspension was kept at 90°C overnight. 
The suspension was filtered and the resin was washed with DCM (3 x 10 mL), 
acetonitrile (3 x 10 mL), water (3 x 10 mL),  methanol (3 x 10 mL) and  DCM (3 x 10 
mL) then dried to give resin 26. 
IR: 1689 cm-1; 1600 cm-1; 1578 cm-1; 1509 cm-1; 834 cm-1 (Corresponds to IR of 4-
hydroxybenzaldehyde) 
Resin (250 mg, 0.33 mmol, 1 equiv) was carefully dried and placed in a flask with 26 
(215 mg; 0.975 mmol; 3 equiv). The flask was evacuated and filled with argon three 
times. Freshly distilled dichloromethane was added and the suspension was degassed 
3 times. Benzaldehyde (0.05 mL; (ρ=1.044 g/mL) 52 mg; 049 mmol; 1.5 equiv) was 
added followed after 20 minutes by BF3*OEt2 (0.05 mL (ρ=1.154 g/mL) 58 mg; 0.41 
mmol; 1.2 equiv). The flask was covered with foil and allowed to stand for 2 h. Resin 
was then filtered and washed with alternating acetone and dichloromethane until no 
colour remained in washing, then dried.  
End weight: 287 mg   
IR revealed none of the characteristic bands from porphyrin.  
 
With trifluoracetic acid: 
 
Resin 26 (0.3 g, 0.4 mmol, 1 equiv) was suspended in freshly distilled 
dichloromethane (10 mL) with 71 (0.24 g, 1.1 mmol, 2.8 equiv) at room temperature 
under Ar. Benzaldehyde (0.11 mL (ρ = 1.04 g/mL), 1.1 mmol, 2.8 equiv) was added 
and the suspension was stirred for 1 h. Trifluoracetic acid (0.03 mL (ρ = 1.98 g/mL), 
45 mg, 0.4 mmol, 1 equiv) was added and the suspension turned red. The suspension 
was stirred for 2 h, then DDQ (575 mg, 2.5 mmol, 6.3 equiv) was added and the 
suspension turned black. The suspension was heated at reflux for 1 h, the filtered and 
the black beads were washed with DCM (5 mL), DMF (5 mL), acetone (5 mL), DMF 
(2 x 5 mL), acetone (5 mL), methanol (5 mL) and DCM and then dried. 
IR showed no change from Versabeads O 
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With propionic acid: 
 
Resin 26 (250 mg; 0.33 mmol; 1 equiv) was suspended in propionic acid (5 mL) and 
the suspension was heated to reflux. Benzaldehyde (0.1 mL (ρ=1.044 g/mL), 104 mg, 
0.98 mmol, 3 equiv) was added, followed by freshly distilled pyrrole (0.09 mL 
(ρ=0.969 g/mL), 87 mg, 1.3 mmol, 4 equiv). The suspension was kept at reflux for 3 
h, then filtered and washed with alternating acetone and DCM (5 mL) until the 
washing was colourless, then dried. 
End weight 295 mg 
IR contained possible porphyrin peaks (1735 cm-1; 1606 cm-1;1175 cm-1) but the 
spectrum looked blurred. 
 
7.7.4 Attempted synthesis of a lanthanide porphyrin complex 
 
Resin 67 (77 mg, 0.06 mmol, 1 equiv) was suspended in DMF(5 mL). The suspension 
was heated to reflux, and Ytterbium(III) chloride, hexahydrate (2.0 g, 5.1 mmol, 85 
equiv) was added and the suspension was kept at reflux temperature for 3.5 h. The 
resin was filtered, washed with DMF(3 x 5 mL), THF (3 x 5 mL), water (3 x 5 mL) 
and DCM (3 x 5 mL) and then dried. 
IR still showed NH proton stretch: 3315 cm-1. 
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APPENDIX  
A 
 
Selected NMR spectra 
 
Spectrum 1:   13C gel-phase NMR of VersabeadsO400    
Spectrum 2:   Bis(chloroethyl)amine immobilized on Versabeads (31)  
Spectrum 3 and 4: 1H and 13C NMR of product from the reductive cleavage of 
resin 32 from Table 13, entry 2.     
Spectrum 5:  13C gel-phase NMR spectrum of resin 32    
Spectrum 6:  Example of 13C gel-phase NMR reaction monitoring  
Spectrum 7: 1H NMR of the imidazolidin-2-one 42    
Spectrum 8: 13C DEPT NMR of the imidazolidin-2-one 42   
Spectrum 9 and 10: The reaction between resin 31 and KI in an NMR tube  
Spectrum 11:   Hydrolysis product 53       
Spectrum 12:  Hydrolysis product 41      
Spectrum 13:   19F NMR of resin 68 compared to starting material   
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Spectrum 2 Bis(chloroethyl)amine immobilized on Versabeads  
Spectrum 1 13C gel-phase NMR of VersabeadsO400 
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Spectrum 3 and 4 1H and 13C NMR of product from the reductive cleavage of 
resin 32 from Table 13, entry 2. The peaks at 2.88 ppm and 3.12 ppm (obscured by 
piperazine peak) correlates to the 13C NMR peaks at 44.7 ppm and 48.8 ppm in the 
HSQC, which is in accordance with literature results for similar triamines.  
 
 184
 
 
 
 
 
 
 
 
C2
O
O
N
C6 C7
N
C7C6
C3
C4 C5
C1
C5C4
F
32
Spectrum 5 13C gel-phase NMR spectrum of resin 32 from Table 13, entry 6. 
Cleavage extent is estimated from the height of the peaks at 64.4 ppm (-
CH2CH2OR) and 61.3 ppm (-CH2CH2OH). 
Spectrum 6 Example of reaction monitoring using 13C gel-phase NMR: A 
sample from the reaction of 4-fluoroaniline with resin 31 (1024 scans). Note that 
the peak at 41 ppm (-NCH2CH2Cl) (31) has been replaced by a peak at 43 ppm (-
NCH2CH2N) (32). 
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Spectrum 7: 1H NMR of the imidazolidin-2-one 42. 
Spectrum 8: 13C DEPT NMR of the imidazolidin-2-one 42 
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Spectrum 9 and 10: Reaction in NMR tube at 80 °C between resin 31 and KI. 
Note the formation of CH2I peak at 3.6 ppm. 
start 
after 9 h 
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Spectrum 11: Hydrolysis product 53 from imidazolidinon synthesis with base 
(1.25 equiv (table 25, entry 3). 
Spectrum 12: Hydrolysis product from imidazolidinon synthesis with iodide 
(Table 25, entry 4) 
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Spectrum 13 A comparison between 19F NMR of resin 68 and the starting 
material meso-tetra(pentafluorophenyl)porphyrin. Note the two new peaks 
from the phenyl group attached to resin trough an amino function.  
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Appendix  
B 
 
Publications 
 
Some of the work presented in this thesis has been published as an article in Synthesis 
Fall 2005: 
 
Gram-Scale Synthesis of N-Aryl- and N-Aryl-N’-methyl-piperazines on a Novel, 
Water-Swellable, Oxethane-Linked Poly(ethylene glycol) High-Loading Resin. 
Hans Christian Rudbeck, Ib Johannsen, Ole Nielsen, Thomas Ruhland, Michael Bech 
Sommer, David Tanner and Robert Dancer, Synthesis, 2005, 3456-62. 
 
Another paper, concerning the scaling-up on resin and reuse is currently in 
preparation and will be submitted to Organic Process research and Development as 
soon as possible. 
 
 
